A study of the enzymatic mechanism responsible for the hepatic and renal excretion of certain carboxylic and sulfonic acids by Reynolds, Orland Bruce
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Dissertations and Theses (pre-1964)
1960
A study of the enzymatic
mechanism responsible for the
hepatic and renal excretion of
certain carboxylic and sulfonic
acids
Reynolds, Orland Bruce
Boston University
https://hdl.handle.net/2144/25823
Boston University
BOSTON UNIVERSITY 
GRADUATE SCHOOL 
DIVISION OF MEDICAL SCIENCES 
Dissertation 
A STUDY OF THE ENZYMATIC MECHANISM RESPONSIBLE FOR THE HEPATIC AND 
RENAL EXCRETION OF CERTAIN CARBOXYLIC AND SULFONIC ACIDS 
by 
Orland Bruce Reynolds 
(B. S., Idaho State College, 1944; A.M., Boston University, 1955) 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy 
1960 
Approved by 
First Reader 
CtuvR ~, ~~ 
Second Reader --~~~~~----~~--~--~------~~~~---­Earl R. Loew, Ph.D., Professor of Physiology 
ii 
ACKNOWLEDGMENTS 
The author is appreciative of the advice and guidance received from 
his readers, Dr. F. Marott Sinex and Dr. Earl R. Loew. This work was begun 
under the direction of Dr. Burnham S. Walker, and the author is grateful 
for his encouragement in undertaking these studies. 
This research was done during the tenure ot research fellowships of 
the Massachusetts Heart Association and the Worcester North Chapter of the 
Massachusetts Heart Association. 
PAH • hydroxamate was the gift of Dr. J. H. Copenhaver, Department 
of Zoology, Dartmouth College. 
Several samples of urographic and cholecystographic agents were 
generously supplied by Dr. Seymour A. Kaufman, Department of Radiology, Boston 
University School or Medicine • 
. Several compounds used were obtained, free or charge, f'rom the 
appropriate drug or chemical companies. In most cases, urographic and chole-
cystographic agents were supplied as the free acidt , • ' ' 2 often a different 
form from that usually dispensed. The author wishes to express his gratitude to: 
Winthrop Laboratories - Diodrast, Hypaque and Telepaque 
Schering Corporation - Priodax 
The Squibb Institute for Medical Research - Renografin .and Cholografin 
E. Fougera and Company - Orabilex 
The Merck Institute for Therapeutic Research - Benemid and Carinamide 
Matheson, Coleman and Bell - Rose Bengal from a specially prepared lot 
OBR 
iii 
TABLE OF CONTENTS 
INTRODUCTION 1 
II. THE NATtRE OF RENAL TUBULAR EXCRETION 4 
A. Early history 4 
B. Some methods used in tubular excretion studies 7 
1. The aglomerular kidney of certain fishes 7 
2. Clearance methods 9 
3. In vitro cultures of renal tubules 11 
4. Renal tissue slice techniques 12 
c. The acids excreted and their interactions 13 
D. The e~atic nature of this excretion mechanism 21 
III. THE NATT.RE OF BU.IARY EXCRETION 47 
rv. 
A. Active excretion b,y the liver 47 
B. Conjugation reactions associated with excretion 59 
c. The acids excreted and their interactions 66 
A CHEMICAL CLASSIFICATION OF THE CCMPOUNDS EXCRETED 
BY THE KIDNEY OR THE LIVER 76 
A. Glycine conjugates 77 
B. Other compounds with the N-c-cooH configuration 78 
c. Glucuronic acid conjugates 80 
D. Sulfate and taurine conjugates 80 
E. Other conjugates 82 
F. Phthaleins 82 
G. Sulfonates 84 
iv 
v 
Page 
H. Urographic agents 86 
I. Cholecystographic agents 87 
J. Benemid and Carinamide 88 
K. Miscellaneous 88 
v. THE INITIAL EKPERThiENTAL APPROACH TO THE RENAL 
TUBULAR l!XCRETION STUDIES 90 
A.. Background and rationale 90 
B. The possibility ot the involvement of coen~e A 96 
VI. EKPERDwlENTAL STUDIES OF RENAL TUBULAR EXCRETION 100 
A. Methods adapted for study of acid activation 100 
B. The possibility of the direct involvement of 
certain conjugation reactions 103 
1. Introduction 103 
2. Preliminary in vivo experiments to detect 
conjugates of excreted compounds 104 
c. Prelimin~ attempts to detect activation of 
PAH in respiring kidney homogenates 106 
VIL THE SELECTION OF THE SULFATE ACTIVATING SIST:EM FOR STUDY 
OF ITS POSSIBLE ROLE IN THE EXCRETION OF THESE SUBSTANCES 112 
VIII. ElCPER:oaNTA.L STl.IDIES WITH A. SULFATE-ACTIV.ATTI'iG SYST&i 
FROM LIVm 130 
A. Enzyme preparation and preliminary studies 130 
B. The testing of various compounds as inhibitors of 
a sulfate-activating system from mammalian liver 147 
c. Discussion and conclusions 179 
IX. SU~Y 194 
APPENDJX 201 
BIBLIOGRAPHY 215 
ABSTRACT 241 
LIST OF TABLES 
mHIBr!ION OF LAMB LIVER ATP..SULFlRYLASE 
TABLE I 
TABLE II 
TABLE III 
TABLE IV 
nffi!BITION OF LAMB LIV.m PYROPHOSPHATASE 
TABLE V 
TABLE VI 
TABLE VII 
vi 
166 
167 
168 
169 
175 
176 
177 
LIST OF ILLUSTRATIONS 
Figure Page 
1 Sulfate esterification with different amounts of enzyme 135 
2 Sulfate esterification at different levels of sulfate 139 
3 Inhibition of sulfate esterification b,y PAH 142 
4 Inhibition of sulfate conjugation b.1 selenate and 
mo:cybdate 146 
5 Rate of molYbdate-stimulated phosphate release vs. 
molybdate concentration (Lineweaver-Burk plot} 151 
6 Inhibition of sulfate esterification b.1 Telepaque 
(Lineweaver-Burk plot) 171 
7 Inhibition of sulfate esterification b,r Rose Bengal 
(Lineweaver-Burk plot) 172 
8 Shannon's equation. Tubular excretion ot phenol red 
in the normal dog. Ts vs. a 208 
9 Shannon•s equation. Tubular excretion of phenol red 
in the normal dog. 1/Ts vs. 1/(a - Ts/V) 213 
vii 
I 
INTRODUCTION 
A capability to establish and maintain striking concentration dif-
ferences across cell membranes is characteristic of all living things. 
This dissertation deals with the excretion of a large group of organic 
acids which demonstrate high concentration gradients in the course of pass-
ing through the cells lining the kidney tubules or the polygonal cells of 
the liver. They are concentrated many fold in passing from blood into urine 
or into bile. The groups of acids excreted by the liver and by the kidney 
are not identical, although many of them are excreted to some extent by both 
organs. These two groups of compounds are very closely interrelated. In 
general, however, a given substance is excreted predominantly or almost 
exclusively in either urine or bile. These two excretion routes will neces-
sitate a division of consideration which will extend all the way through the 
dissertation; a realization of this at the outset will help the reader 
follow the development of the thesis. 
These processes may be considered to be secretory or excretory, de-
pending to some extent upon the point of view. Substances added to the 
glomerular filtrate by transport through the renal tubule cells are excreted 
in the sense of being thereby eliminated from the body. Many substances 
secreted in bile are reabsorbed from the intestine so that the process is 
not an excretion in the same sense. The term excretion will be generally 
used in this thesis, although it may not be the more apt in every case. 
The use of a single term, however, seems justified from the standpoint of 
consistency and simplification in comparing the renal and hepatic excretory 
systems. 
1. 
This study originally had as its primary purpose the elucidation of 
the enzymatic pathway by which such substances as p-aminohippurate were 
actively excreted by the kidney. This approach has broadened in the course 
of the work to include the closely related process in the liver, and it is 
with liver preparations that the more successful experimental approaches 
to the problem have been made. This experimental work supports the concept 
that in liver the sulfate-activating system is also involved in the excre-
tion of these organic acids. It is felt that the elucidation of the mecha-
nism of hepatic excretion of these substances will have much pertinence to 
the closely parallel renal system. 
In the development of the rationale of the experimental approach 
which has been made to the problem of hepatic excretion, considerable re-
course has been made to concepts which have arisen from investigations of 
~ mechanisms by other workers. Mechanistic studies of these processes 
in the kidney have been more extensive than has been the case with the liver. 
This is true largely because of the relative availability of urine and bile 
and because biliary pigments often seriously interfere with quantitative 
procedures on bile. It is felt that the separate processes in the two organs 
are seen in better perspective as variations of a more general phenomenon. 
The significance of this problem is, of course, related to the sig-
nificance of the substances excreted. Many of the products of conjugation 
detoxication reactions in the body are actively excreted by this mechanism, 
e.g., hippuric acid. The bile pigment conjugates and the bile salts are 
excreted in this manner by the liver. Our knowledge of kidney function has 
2. 
1 been much advanced by studies of the dynamics of p-~~nohippuric acid (PAH) 
and phenolsulfonphthalein (P8P, phenol red) excretion. The dyes bromsulpha-
lein (BSP) and Rose Bengal have served a similar function in liver studies. 
Cholecystographic and urographic agents are concentrated in bile or urine, 
respectively, and enable the biliary or urinary tracts to be visualized by 
X-ray. Several of these substances are routinely used in diagnosis and eva-
luation of hepatic or renal disease. Penicillin is another important sub-
stance belonging to this group. The two drugs, Carinamide and Benemid, also 
seem to have an affinity for these excretion systems; they have been used 
for (among other things) blocking the excretion of penicillin to prolong its 
action in the body. 
A more intimate understanding of the enzymatic reactions which result 
in the excretion of these substances is needed in order to understand how 
the liver, for example, excretes what appears to be a rather diverse group 
of compounds by an apparently common mechanism. With few exceptions, such 
transport processes in general are not as yet well understood. 
1 A list of abbreviations used in this thesis is given in Appendix I. 
Several compounds will be referred to by a proprietary name. Appendix II 
lists the more common synonyms and gives the chemical name for these 
substances. 
Structural formulas for most of the excreted compounds are given in 
Section IV: A chemical classification of the compounds excreted by the 
kidney or the liver (p. 7' ) .
3. 
II 
THE NATURE OF RENAL TUBULAR EXCRETION 
A. Early history 
The two kidneys of man receive by the renal arteries one fifth or 
more of the total cardiac output of blood. This blood supply is distributed 
by afferent arterioles to the approximately one million glomeruli of each 
kidney. Each glomerulus is a capillary tuft situated between two arterioles 
(an incoming afferent arteriole and a smaller outgoing efferent arteriole). 
This arrangement gives the glomerulus a higher blood pressure than that of 
capillaries elsewhere in the body and suits the glomerulus to the formation 
of an ultrafiltrate from the plasma of the blood passing through it. Each 
glomerulus is intimately invested by a bulb-shaped Bowman's capsule which 
collects this filtrate and drains it into a long convoluted tubule. These 
tubules, in turn, drain into collecting ducts and eventually to the ureters. 
In the Philosophical Transactions of the Royal Society of London for 1842, 
Bowman (24) published an accurate description of these glomeruli, guessing 
at their function in producing a filtrate of plasma. The nature of this fil-
trate as representing an ultrafiltrate of plasma, essentially free of protein 
and protein-bound substances (to the extent of binding) was clearly shown by 
Richards, Walker and their co-workers (235, 233, 164) by micro-puncture 
techniques. 
The blood which has been filtered at the glomeruli then empties from 
the efferent arterioles into an extensive capillary bed which surrounds the 
renal tubules. The nature of the glomerular fluid is extensively altered by 
exchange of solutes and water between the tubules and this capillary bed. 
This exchange is largely reabsorptive; approximately 99 per cent of the 
water and all the glucose in the filtrate, for example, are reabsorbed into 
the blood. Some substances, however, are further cleared from the peritubu-
lar capillaries and actively transported by the activity of the cells lining 
the proximal segment of the renal tubules into the lumina of the tubules. 
Such substances as PAH or PSP may be almost wholly cleared from the blood in 
its passage from renal artery to renal vein. This would be impossible for a 
substances cleared by glomerular filtration alone, since only about 12 to 19 
per cent of the plasma water is filtered in man (201, p. 21). In addition 
to these processes certain substances in urine result from a tubular synthesis. 
The transport of these substances meets the criteria of 11 active11 
transport in all respects. Taggart (224) defines active transport briefly 
as follows: "The term active transport is generally applied only to those 
systems in which a substance is transported across one or more biological 
membranes against a concentration gradient (uphill transport) at the expense 
of energy derived from the metabolism of the cell. 11 Taggart emphasizes 
several limitations of this definition which will be brought out in later 
discussions. 
Bowman (24), and later Rudolph Heidenhain in 1874, attributed the 
formation of urine to filtration of water followed by addition of solutes to 
the urine by tubular excretion. In 1844, Carl Ludwig had challenged the 
theory of Bowman and maintained that urine formation resulted from production 
of a protein-free ultrafiltrate at the glomeruli and subsequent reabsorption 
of water and solutes. In an important monograph on the subject published in 
1917 and a second edition in 1926 (54), Cushny rejected the participation of 
tubular excretion in support of Ludwig's concept. Cushny's views have been 
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shown in many respects to be correct, but his rejection of tubular excretion 
as also playing a part in the process, was unwarranted. 
Phenol red (PSP) has been shown by Marshall (139) to be excreted by 
the tubules of members of all the orders of vertebrates. Marshall further 
noted that in the cases investigated this dye was also found in the gall 
bladder bile, this being the principal route in the lower vertebrates. Also, 
with regard to the widespread occurrence of this phenomenon, Homer Smith 
states (202, p. 51): 
Phenol red is excreted by the tubules in all animals thus 
far examined (the dogfish, aglomerular and other teleost fishes, 
the frog, chicken, guinea pig, rabbit, rat, dog and man). Rela-
ted sulphonephthaleins (chlorphenol red, bromcresol red, brom-
cresol purple, etc.) are similarly handled with varying tubular 
efficiency, and speculatively one supposes that these compounds 
can be excreted by the tubules of all vertebrates. 
After Gushnyts denial of tubular excretion (54), it was some time 
before this process was widely recognized. In 1909, Abel and Rowntree {1), 
in a study of various phthaleins as hypodermic purgatives, introduced phenol 
red and noted that it was freely excreted in the bile of dogs. The next year 
Rowntree and Geraghty introduced the phenol red test for kidney function (174). 
They asserted the complete elimination of this dye by the kidneys {that ex-
creted in bile is reabsorbed in the intestine), its chemical nature being 
unchanged. In 1912, these authors (175) extended these studies to show that 
phenol red was excreted by the renal tubules (in the frog and the cat). It 
was not until 1923, however, that Marshall and Vickers (142) demonstrated 
tubular excretion in a manner which was generally accepted as not being ex-
plainable by other means. They reduced the blood pressure of dogs to levels 
below 40 mm of mercury by section of the cord. This assured a stoppage of 
glomerular filtration. Under these conditions phenol red was seen to accumu-
late in high concentration in the proximal tubules. It was also shown that 
6. 
in blood most of the phenol red was plasma bound so that only about 20 per 
cent of the dye was ultrafiltrable. The dye was excreted at such a rate 
as would require an impossible glomerular filtration rate. 
B. Some methods used in tubular excretion studies. 
1. The aglomerular kidney of certain fishes. 
Marshall and co-workers (140, 138, 139) and independently 
Edwards and Condorelli (70) began studies on the excretion of various sub-
stances by certain aglomerular fishes (goosefish, toadfish, pipefish, etc.). 
These fishes lack glomeruli or have only a few non-functional pseudoglomeruli 
so that they produce a wholly tubular urine. Phenol red and the closely re-
lated tetrachlorphenolsulfonphthalein are excreted in high concentration by 
these fishes. 
These studies of the toadfish kidney were extended by Marshall and 
Grafflin (141) to show that all the following substances were readily excre-
ted when given by intramuscular injection: creatinine, uric acid, iodide, 
indigo carmine (indigo disulfonate), neutral red and phenol red. They noted 
that in the process of secretion, phenol red may be concentrated at least 150 
times. The excretion of creatinine and phenol red was studied more exten-
sively, and these authors pointed out that it is highly improbable that all 
these substances are handled in the same manner. Creatinine secretion, for 
example, increased at greater urine flow, whereas phenol red secretion ap-
peared to be quite independent of urine flow. They also showed that magne-
sium, creatinine, sulfate and phenol red were excreted by the tubules of the 
sculpin (a glomerular fish). Marshall and Grafflin (141) cite numerous 
references which, together with their own paper, support the assertion that 
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these dyes are secreted by the proximal segment of the renal tubule. 
Many of these substances excreted by the fish tubule are not excreted 
by the mammalian kidney tubule. The excretion of certain substances may 
vary in different animals. Tubular excretion of uric acid, for example, is 
a highly developed process in birds, whereas this substance is reabsorbed in 
mammals. As pointed out before, the tubular excretion of phenol red (and 
probably indigo carmine) seems to be a general process in vertebrates. The 
basic dye, neutral red, used by Marshall and Grafflin is apparently excreted 
by a process independent of that for phenol red. Kempton -- ------•~·••r-v. ... • 
_ .......... --~--~· .. ----- - (113) 
demonstrated by perfusion methods in the frog kidney, that phenol red excre-
tion is independent of induced changes in urine pH, whereas neutral red is 
excreted copiously in an acid urine but poorly in an alkaline urine. Neutral 
red accumulation continued after cyanide poisoning; phenol red was blocked 
by cyanide. The movement of neutral red is thus dependent on a pH gradient 
and is not as sensitive as phenol red transport to blockage of metabolic 
activity. 
An experiment of Shannon (196) with the toadfish demonstrates certain 
characteristics of active transport which have not yet been emphasized. He 
showed that over a wide range of plasma concentrations the maximal rate of 
tubular excretion of phenol red was found to be the same even though the 
plasma concentration of the free dye was raised to levels higher than in 
the tubular urine. The kidney of this fish, though aglomerular, can excrete 
considerable amounts of water, so that the phenol red excreted is subjected 
to considerable dilution in the tubules. An active transport system should 
thus exhibit a maximum rate when the system is fully loaded. This is in 
contrast to a free diffusion system which would have continued to increase 
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as the plasma concentration was raised. The fact that the rate remained 
constant in this instance demonstrates that a direct diffusion does not 
contribute significantly to phenol red transport. In fact, the toadfish 
tubule is shown to be essentially impermeable to phenol red, except by its 
unidirectional, active transport. An active transport, in addition, must 
also show a capability to initiate and maintain an uphill gradient (from a 
low to a high concentration), although in certain of Shannon's measurements 
the gradient was downhill. Note also that the direction of transport r&-
mained the same when the gradient was reversed. 
2. Clearance methods 
The term clearance was first used by M8ller, Mcintosh and Van 
Slyke (148) to apply to the virtual volume of blood cleared of urea per minute 
by the kidney. Clearance measurements now are generally applied to plasma 
volume cleared of any urinary constituent. The measurement and interpreta-
tion of clearances have been developed to a high art by Homer Smith and asso-
ciates (201, 202). These methods afford a relatively simple and non-destruc-
tive means for measuring reabsorptive and excretory processes, as well as 
other important renal dynamic factors, such as glomerular filtration rate 
and renal plasma flow. Our knowledge of the kidney has been greatly advanced 
by the application of these methods. 
In order to be certain that a substance is reabsorbed or excreted by 
the tubules, it is necessary to compare its clearance to that of a substance 
excreted only by the glomeruli. In man, inulin is ordinarily used as the 
reference substance (204). The suitability of inulin for this purpose is 
reviewed by Smith (202, p. 73). In man creatinine is to a small extent ex-
creted by the tubules, so that is is not suitable as a measure of glomerular 
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filtration, though it is suitable in some animals, notably the dog. Clear-
ance ratios are often expressed relative to the simultaneous inulin (or 
creatinine) clearance. Thus the PAH/inulin clearance is greater than one, 
indicating tubular excretion. Ratios less than one indicate reabsorption. 
With substances bound by protein, careful account must be taken of this bind-
ing in order to assess the extent of glomerular filtration. 
Substances freely excreted by the tubules are almost entirely cleared 
from the blood in one pass through the kidney provided the excretion mecha-
nism is not saturated by too high a plasma level. Under these conditions 
(below complete saturation) the clearance of the substance represents renal 
plasma flow. When the tubules are saturated, the Tm for the excreted com-
pound may be measured; this is the maximum rate at which the substance is 
excreted and is a measure of the total tubular function. 
A number of organic iodine compounds which had come into use as uro-
graphic agents were found to be excreted by the kidney tubules. These com-
pounds had been selected empirically from many candidate substances to give 
dense radiograms. Diodrast, Iopax and Hippuran (o-iodohippurate) were well 
excreted, and Smith (204) investigated these compounds and selected Diodrast 
for measurements of renal plasma flow and Tm-Diodrast. A more readily 
determinable substance than Diodrast, however, was sought. Phenol red clear-
ance is markedly depressed by Diodrast or by Hippuran (204), and hippurate 
itself depresses phenol red clearance {203). Smith and co-workers, guess-
ing that these inhibitory effects indicated that these substances competed 
for the same excretory mechanism, tested a series of substances related to 
hippuric acid for tubular excretion {203, 79). Several of these were excre-
ted as efficiently as Diodrast. PAH (p-amino hippuric acid) was selected 
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from the standpoint of clearance, ease of determination and other considera-
tions. PAH has replaced Diodrast for these measurements. 
The following acids all had the same clearance as Diodrast, within 
experimental error: m- and p-hydroxyhippuric, m- and p-aminohippuric, 
Hippuran (o-iodohippuric), p-acetylaminohippuric, 2-pyridone-1-acetic acid 
and cinnamoylglycine. The following acids showed a high clearance, but 
distinctly lower than the above group: o-hydroxyhippuric, Iopax, p-amino-
phenaceturic and phenol red. No simple relationship between structure and 
tubular excretion was seen. The acidic strength of these acids is not im-
portant to tubular excretion; the clearance of phenol red (pK: 7.9) com-
pares favorably with that of Iopax (pK = 2.99). In addition, the iodine of 
urographic agents, although of prime importance in determining radio-opacity, 
is essentially unrelated to tubular excretion, since 2-pyridone-1-acetic 
acid (the nucleus of Iopax) shows the same high clearance as Diodrast 
(higher than Iopax itself). 
3. In vitro cultures of renal tubules 
Chambers and Kempton (41, 40) showed that the tubules of the 
chick mesonephros could be teased out by micromanipulation and cultured in 
special media. During the first few hours of incubation the tubule fragments 
close at the ends and gradually distend with fluid to form a cyst. These 
isolated tubules will concentrate phenol red within their lumina to a high 
degree. Metanephric tubules from a J~ month human fetus were shown to be-
have similarly (37). This concentration of dyes was shown only by the proxi-
mal segments of the tubules. Transport was halted by lowered temperature, 
anoxia and certain metabolic poisons (cyanide, iodoacetate). Acidification 
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of the external medium with co2 did not interrupt phenol red transport. 
The cyst fluid containing phenol red (pK = 7.9) may be red or yellow; from 
this and other considerations it is not readily discerned whether it is the 
yellow or red form (or both) which is transported. 
Such isolated tubule cultures are readily used for studies of trans-
port of dyes and the effects of various external agents, because the excre-
tion process may be directly visualized. Forster and associates (81, 83, 
225, 82) have extensively used the easily separated tubules of various fishes 
(flounder, sculpin, trout). The tubules are readily kept viable in a simple 
Ringerts medium by oxygenation. This type of system has enabled detailed 
studies to be made of ionic and osmotic effects, temperature effects, narco-
sis, anoxia, competitive phenomena, etc. Several of these studies will be 
discussed later in more detail. 
4. Renal tissue slice techniques 
Forster and associates (81, 82) also introduced the use of 
tissue slices of the kidneys of the frog and the dogfish. These may be main-
tained in an oxygenated medium, much as with isolated tubule preparations. 
Mammalian kidney cortex slices have also been used extensively in studies of 
the metabolic factors involved in transport. Several of these studies will 
be discussed. Tubular excretion results in accumulation of the excreted sub-
stance in the slice. The concentration of the substance is determined in the 
slice and in the external medium at the end of iacubation and expressed as a 
slice/medium (S/M) ratio. By carrying out the incubation in a Warburg appa-
ratus, simultaneous measurement of oxygen consumption may be made. 
This method is well suited to the types of studies made with isolated 
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tubule preparations, but is more readily applied to substances, like PAH, 
which are not dyes and to the use of a wider variety of species, particularly 
mammals. Several studies which will be discussed later were made by this 
method. 
Numerous other methods have been used in studying tubular excretion. 
Certain of these will be briefly mentioned later. 
c. The acids excreted and their interactions 
The list of organic acids excreted by the renal tubules by this mecha-
nism is quite extensive. That the mechanism for all of them is the same has 
been shown in several ways, but the most extensive evidence is based on the 
intimate manner in which the various substances compete with each other for 
excretion under conditions where other renal functions (for example, glucose 
reabsorption) are unaffected. 
Taken as a group these substances have a low order of toxicity. Be-
fore the development of other methods of conserving penicillin by interfering 
with its excretion, PAH was administered intravenously in dosages as high as 
100 to 200 grams per day. Even at this tremendous dosage PAH did not inter-
fere with other clinically measurable renal functions (19). In radiographic 
procedures for visualizing the aorta, coronary vessels, etc., very large 
dosages of certain urographic agents may be used: as much as 50 ml. of a 
50 to 90 per cent solution (25 to 45 grams) may be administered intravenously 
to man within two seconds or less (109, 119). The low toxicity of many of 
these substances lends credence to the concept that their observed inter-
ference with the tubular excretion of related compounds is a specific effect, 
attributable to involvement in the same mechanism. This is particularly so 
when the blocking compound itself can be shown to be excreted by the tubules. 
13. 
As already mentioned (p. 10), Smith tested a variety of compounds for 
their suitability in clearance measurements. Because of the depression of 
phenol red Tm by Diodrast, Hippuran or hippurate, several compounds related 
to hippurate were tested and shown to have high clearances. These were all 
glycine conjugates of substituted benzoic acids, phenylacetic acid or cinnamic 
acid. The presence or position of substituted groups on the benzoic acid did 
not prevent the excretion as long as the carboxyl of glycine was available. 
This suggests that this mechanism may bring about the excretion of glycine 
conjugates in general. The acids related to Diodrast (Iopax and 2-pyridone-
N-acetic acid) also had high clearances. 
Sperber (209, 210, 212) has demonstrated tubular excretion of a number 
of substances by the chicken. Because the renal portal circulation has a 
unilateral distribution, evidence for tubular excretion may be obtained by 
injection into one leg vein and collection of urine from each ureter. The 
substance excreted on the injected side, in excess of that excreted by the 
other side, represents tubular excretion. By this method he demonstrated 
that hippuric acid and menthyl-glucuronide were excreted by the tubules and 
that hippurate depressed menthyl-glucuronide or FSP excretion. Phenyl-
glucuronide and probably resorcinyl-glucuronide were also excreted. Free 
phenols or glucuronic acid itself were not excreted. Another conjugation 
product of phenol, phenyl sulfate, was excreted. Whereas benzoic acid and 
p-amino benzoic acid were not excreted, p-acetylaminobenzoic acid was. 
Sperber emphasized that many of the substances excreted by the tubules are 
products of important detoxication reactions. Note that although the chicken 
ordinarily conjugates benzoic acid with ornithine to give ornithuric acid, 
it excretes either ornithuric acid or the glycine conjugate of benzoic acid 
(hippuric). 
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Sperber verified the excretion of phenyl-glucuronide and of phenyl 
sulfate in the goat by clearance measurements. He also shown (211) that 
the chicken excretes several other sulfate esters: resorcinol sulfate, 
resorcinol di-sulfate, hydroquinone sulfate and hydroquinone di-sulfate. 
Hippuric acid decreased the excretion of these substances. This is in con-
trast to the findings of Gi l lissen and co-workers (84), who reported that 
phenyl sulfate is characterized by filtration and reabsorption in the cat and 
dog. The question of the tubular excretion of phenyl sulfate is apparently 
not fully resolved. 
Salicylic acid, having a phenolic group and a carboxyl group, forms 
in the body both phenolic and acyl glucuronides. Both types of conjugate 
have been shown by Schachter and Manis (181) to be excreted by the tubules 
in man. Salicylurate, the glycine conjugate, also has a high clearance. 
Sperber (213) later studied the tubular excretion of a series of 
sulfonphthaleins in the chicken. These compounds were all substituted deri-
vatives of phenol red. They were all excreted by the tubules of the chicken, 
exhibiting Tm's of from 3 micromoles/minute with phenol red to 0.03 micro-
moles/minute with bromcresol purple or bromcresol green. These dyes were 
found to compete with each other and, in general, those which were excreted 
at the highest rates were the poorest competitors. It is seen from this 
that competition is not necessarily directly related to efficiency of ex-
cretion by the same mechanism; in these cases it seems to be related to an 
affinity for some component of the system. Bromcresol green also inhibited 
the excretion of PAR, Carinamide and menthyl-glucuronide. From other work 
it would seem that some compounds which have high clearances (e.g., Diodrast) 
can also be fairly effective competitors. These results with the sulfonphtha-
leins in the chicken were remarkably well confirmed by Forster, Sperber and 
15. 
Taggart (82), using isolated flounder tubules and dogfish kidney slices. 
The dyes arranged themselves in the same order of excretion efficiency and 
exhibited the same reciprocal relationship between excretion and competition. 
Bromcresol green completely inhibited PAH uptake by dogfish kidney slices. 
Phenol red inhibited PAR uptake only about 50 per cent when the dye/PAR 
ratio was 8 times greater. Neither substance had a significant effect upon 
respiration of the slices. That the inhibition does not depend upon a toxic 
action on the flounder tubules is shown by the ready reversal of inhibition 
when the tubules are removed to an inhibitor-free medium. 
Most, or possibly all, of the urographic agents are excreted by the 
tubules. Smith and Ranges {206) showed that Diodrast, Hippuran and Iopax 
have high clearances in man and that Neo-iopax and Skiodan are excreted by 
the tubules to a lesser extent. These substances all depressed phenol red 
clearance. Skiodan (iodomethyl sulfonate) seems to be excreted to a rather 
small extent, however. With the exception of Skiodan, the urographic (and 
cholecystographic) agents are all carboxylic acids. 
The development of these agents has taken place without regard to 
demonstration of tubular excretion per se. They have been selected primarily 
on the basis of low toxicity and high density of shadow. The early selection 
of compounds on this basis invariably resulted in the choice of compounds ex-
creted by the tubules. It seems reasonable to expect that this is still true. 
Some of the newer compounds have strikingly low toxicity and permit much 
better visualization. Interesting reviews of the development of these com-
pounds, studies of changes in nature or position of substituent groups and 
references to more specific studies are given in the following papers (234, 
5, 109). 
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Knoefel and Huang (115) recently investigated the renal excretion by 
dogs of a series of variously substituted benzoic acids. Of the fourteen 
compounds tested, only four were excreted by the tubules. The others were 
in part reabsorbed. X-ray visualization of the urinary tract was achieved 
only with the four excreted by the tubules. The three which gave the best 
visualization were excreted to a greater extent by the tubules, and these 
three compounds were the new urographic agents: urokon, Miokon and Reno-
grafin (Renografin is the methylglucamine salt and Hypaque the sodium salt 
of the same acid). These investigators also found that the renal slice method 
is not reliable in the study of tubular excretion of some compounds; in 
some cases the uptake seems to be related to protein binding rather than 
cellular transport. 
Penicillin is excreted by the tubules in man, and Rammelkamp and 
Bradley showed that the tubular excretion is depressed by Diodrast (161). 
Beyer and co-workers recommended simultaneous administration of PAR to reduce 
the rate of penicillin excretion (21). 
The drugs Carinamide (18) and Benemid (19) were later introduced to 
inhibit the tubular excretion of penicillin. These acids, apparently re-
fractory to excretion themselves, are considered to block excretion by an 
affinity for some component of the system. They may act similarly to brom-
cresol green in this respect. The excretion of Carinamide is somewhat in 
question and complicated by its metabolism; Sperber (213), however, noted 
considerable excretion of Carinamide by the chicken. Beyer (19) discusses 
these drugs in some detail. Benemid itself is reabsorbed. 
These compounds also block excretion of PAH or phenol red. Their 
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interference with penicillin transport is not dependent upon a toxic effect, 
as shown by the ready reversibility as the plasma concentration of the in-
hibitor drops. In a series of compounds related to Carinamide, the sup-
pression of penicillin clearance varied independently of toxicity (18, 19). 
Beyer (19) has shown that these drugs also block the conjugation of 
PAB (p-~~no benzoic acid) with glycine to give PAR. This led to speculation 
that the excretion of PAH and the reabsorption of PAB involved such conju-
gation reactions which, in turn, were inhibited by Carinamide and Benemid. 
As a test of the possibility that the excretion of PAR involves, 
first, the hydrolysis of PAH to PAB and glycine and subsequent reconjugation, 
Taggart (220) administered PAH labeled with c14 in the carboxyl group to a 
dog by slow intravenous infusion. In the event that the excretion involved 
such hydrolysis and reconjugation, the carboxyl label would be expected to 
be diluted by the incorporation of unlabeled endogenous glycine. The speci-
fie activities of the original PAR and the PAH derived from the urine were, 
however, found to be identical. 
In studies of the conjugation of benzoate with glycine to give hippuric 
acid (analogous to conjugation of PAB with glycine to give PAH), Schachter 
and Taggart (183) showed that Carinamide and Benemid did not interfere with 
the enzyme mediated reaction between benzoyl-coenzyme A and glycine to give 
hippurate. The enzyme used (glycine N- acylase) was derived f.rom mitochon-
of hippurate ~thesis 
dria of pig kidney cortex. It was concluded that the inhibitio~by these 
drugs must be due to an interference with the reactions leading to benzoyl-
coenzyme A (benzoate activation) rather than with the conjugation reaction 
itself. They observed that Benemid and Carinamide likewise interfere with 
the ATP-supported activation of acetate. c-The writer of this thesis has 
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recently observed an inhibition of sulfate activation in lamb liver prepara-
tions by Benemid and Carinamide.J It thus appears that these compounds in-
hibit a variety of acid activation reactions and that their inhibition of 
the tubular transport of acids may be related to this action. Benemid is 
used in the treatment of gout to reduce the reabsorption of uric acid; this 
action would appear to be unrelated to the actions discussed above. The two 
mechanisms of action may be independent. 
Schachter (178) has recently shown that Benemid, which has a prolonged 
action, is excreted principally in the urine. About 60 per cent is recovered 
in two days and 80 per cent in four days, when administered to man. Of the 
recovered drug, approximately 80 per cent is the acyl glucuronide of the 
Benemid. 
Several other substances may be excreted by the renal tubules. For 
example, several substances excreted predominantly by the liver may appear 
in part in the urine. The cholecystographic agents Teridax and Orabilex 
are excreted predominantly in urine {6). Whether the excretion is in part 
tubular, is not stated. It seems probable that they are excreted by the 
tubules, since the kidneys compete so well with the liver, which excretes 
them rapidly. 
The bulk of evidence seems to indicate that this transport mechanism 
is specific for carboxylic and sulfonic acids (probably including sulfate 
esters). However, there is some evidence that a few other substances should 
be included. 
PAH-hydroxamate (in which the carboxyl of PAH is not free, but is 
combined with hydroxylamine) has been reported to have a high clearance. A 
re-examination of this problem by Taggart and by Forster and Copenhaver has 
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indicated that it is not excreted by the tubules - the true clearance being 
close to that of creatinine in dogs (200). Taggart (223) later stated that 
this substance had a clearance below that of creatinine. 
The sulfonamides in general seem to be reabsorbed by the tubules, 
whereas the acetylated derivatives are frequently excreted by the tubules 
(201). In acetylsulfanilamide, for example, the sulfonic group and the 
carboxyl of the acetate are both in amide linkage, so that the compound does 
not have a free carboxyl or sulfonyl group. The studies of renal excretion 
of these compounds show considerable variation among different sulfonamides 
and is complicated by protein binding and metabolism of the drugs. The tubu-
lar excretion of these compounds may be by a different mechanism, although 
Lundquist has noted a depression by Hippuran on the gross sulfathiazole or 
sulfamethylthiodiazole clearances (134). Smith (201, p. 214) states that 
multiple systems of tubular excretion may be involved in the excretion of 
some of these compounds and that the acidification of the urine, which occurs 
when Hippuran is administered, may influence sulfonamide excretion. Smith 
(201, pp. 210-15) discusses in some detail the excretion of these substances. 
Beyer (20) has recently studied the excretion of the carbonic anhydrase 
inhibitor, Ghlorothiazide. This compound, which has no free sulfonic or 
Chlorothiazide 
(6-chloro-7-sulfamyl-1,2,4-
benz~thiadiazine-1,1-dioxide) 
carboxylic group, has about the same clearance as PAH, even at fairly high 
plasma concentrations. This is unusual for a compound that is bound to 
plasma protein to the extent of about 50 per cent at these plasma concentra-
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tions. The material excreted was extracted from urine, recrystallized and 
shown to be identical with authentic Chlorothiazide. Its excretion is in-
hibited by Benemid, which indicates a mechanism common to PAR and related 
substances. The dog also eliminates substantial amounts of Chlorothiazide 
in bile. Taggart (224) has studied the accumulation of this compound by 
kidney slices and also considers the evidence quite convincing that a common 
mechanism with PAR is involved. 
Another group of substances is also known to be actively excreted by 
the kidney tubules. In this case, however, a mechanism independent of that 
for PAR is indicated by considerable evidence. Sperber (212) first noted 
that N-methylnicotinamide, piperidine, guanidine and methylguanidine were 
excreted by the tubules of the chicken. Large doses of hippurate or Diodrast 
did not influence the excretion of these bases. The quaternary base, tetra-
ethyl-ammonium (TEA), shows the same excretory characteristics (163, 77, 89). 
The basic cyanine dye (No. 863) is a very strong inhibitor of the tubular 
excretion of these bases, but this dye or the bases themselves are without 
effect on PAR excretion (158). A recent review by Lotspeich (132) discusses 
in more detail the excretion of these bases. 
D. The enzymatic nature of this excretion mechanism. 
In a review published in 1939, Shannon (197) very clearly delineated 
many of the factors on which an ultimate understanding of this excretion 
mechanism must be based. These principles appear to be no less valid today, 
and it seems apt to quote them here as a basis for further discussion. His 
analysis was intended to apply with equal validity to certain cases of tubu-
lar reabsorption. 
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ON THE MECHANISM OF TUBULAR EXCRETION 
In seeking the physiological basis for these processes 
one is led to the following considerations, which are presumed 
to apply to both the glomerular and aglomerular kidney: 
1. The cellular processes responsible for the transfer 
of a solute from the blood to urine, or vice versa, are 
orderly ones which proceed in accordance with the principles 
of thermodynamics and the kinetics of chemical reactions, 
the direction of the transfer being determined by the organi-
zation of the tubule cells. For convenience the sequence of 
events which results in such transfer will be designated the 
mechanism of tubular excretion or reabsorption, or, more 
briefly, the mechanism of transfer. By definition this term 
excludes all extra-cellular processes, such as diffusion or 
chemical reaction in the peritubular interstitial fluid and 
urine. 
2. Where the mechanism of transfer increases the free 
energy of the system, this energy is presumed to be made 
available entirely by local cellular metabolism. To what 
extent the energy expenditure is proportional to the quantity 
of solute transferred, whether this energy may be diverted 
into some operation in the absence of the solute, whether 
it is derived from processes that proceed wholly independent 
of the mechanism of transfer, or whether it is liberated in 
consequence of the presence of the solute, cannot be ascer-
tained. ( More recent work would make it possible to be more 
specific about these points J 
3. In some of the reacti ons involved in the mechanism 
of transfer, the transferred solute as such, or in combina-
tion, will be one of the reactants. Other reactions may not 
be so characterized (e.g., the energizing reactions). Each 
of the reactions in the former group may be said to be made 
up of two reactants or elements, the substance being trans-
ferred and the cellular element. All such cellular elements 
may be designated as the cellular component of the system 
and the substance transferred as the exogenous component. 
4. It may safely be inferred that the cellular compo-
nent is a more or less stable feature of the organization of 
the cell and does not arise de ~ on the presentation to 
the cell of the exogenous component of the system. 
5. Except where there is evidence to the cont r ary 
it is assumed that a cellular component of any system is' to 
some degree specific with respect to the solute transferred• 
and that the mechanism of transfer is identical in all spe-' 
cies in which the process of transfer is demonstrable. 
22. 
6. A cellular component may be common to the transfer 
of more than one substance. The extent to which more than 
one substance shares a cellular component is, theoretically 
at least, variable. The cellular component in its entirety, 
or only certain of its elements, may be common to the reac-
tions of transfer of the two substances. 
7. The mechanism of transfer is limited in respect to 
the quantity of any one solute which it can handle per unit 
time, and when two solutes are transferred simultaneously by 
a common mechanism, one will displace the other to a greater 
or less degree dependent upon their respective affinities for 
the common elements in each of the cellular components. 
8. A primary determinant in the rate of transfer of a 
substance, whether it occupies the cellular component alone 
or is, with another substance, in simultaneous competition 
for it, is the concentration of that solute in the peritubular 
interstitial fluid in the case of an excreted substance, and 
in the tubular urine in the case of a reabsorbed substance. 
In both cases the concentration in the fluid of deposition 
must also be considered a potential determinant limiting the 
rate of transfer, which may or may not be practically signi-
ficant under physiological conditions. 
9. The non-specific characteristics such as lipoid vs. 
water solubility and molecular volume are of no demonstrable 
importance in determining the rate of cellular transport 
unless the substance is in a colloid state or some molecular 
aggregate which makes it unavailable for transfer by the 
cellular mechanism. 
Shannon discusses the evidence for each of these postulates and de-
rives a mathematical description, which is in accord with experimental curves 
of the relationship between amount of solute transferred and plasma concentra-
tion (for the glomerular kidney). 
He assumes that, in the process of transfer, the solute {A) enters 
into a reversible combination with some intracellular component (B) and that 
the decomposition of this complex (AB) limits the rate at which the solvent 
is transported into the tubule. The sequence of reactions is represented as 
follows, 
A-/-B--~ AB --')~ Ts -/- B 
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where A is the solute on the proximal side of the reaction (in the inter-
stitial fluid at the capillary border of the cells); B is the intracellular 
component, and Ts is the solute added to the tubular urine. In order that a 
maximum rate be established the second reaction must become the limiting 
factor, rather than the rate of attainment of equilibri um in the first reac-
tion. The observation that the excretion of these substances becomes limited 
by a maximal rate (Tm) indicates that the second reaction above becomes the 
rate limiting step and is a first order process depending upon the intracellu-
lar concentration of AB. AB is, in turn, limited by available intracellular 
component B. Under conditions when the first reaction is limiting (at 
plasma concentrations significantly below Tm levels) the rate of excretion 
is proportional to the concentration of the solute A. The processes whereby 
energy is made available to the system are not considered, but they are assumed 
not to be rate limiting. Shannon therefore writes the equilibrium expression 
of the first reaction: 
K : i!1J.!U_ 
--u:BT 
By appropriate substitutions the following equation is arrived at: 
K : (a - Ts/V) x (Tm - Ts) 
Ts 
Where K : equilibrium constant = i!1J.!U_ 
-~ABT 
a = arterial plasma concentration of the 
solute 
V = plasma flow per unit time 
Ts = observed rate of excretion 
Tm = maximum rate of excretion 
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These factors, with the exception of K, are determinable by clearance methods, 
and the value of K may be calculated. With suitable modifications, the ex-
pression is also applicable to tubular reabsorption. Shannon draws a curve 
on the basis of this equation showing the relationship between plasma concen-
tration of phenol red and the rate of its excretion. A very close fit with 
the experimental points is obtained in substantiation of the basic assumptions. 
This was done for several other substances which are actively excreted or re-
absorbed. In the application of this expression to a system showing the de-
pression of phenol red excretion by Diodrast or Hippuran, the agreement was 
close enough to indicate tentatively that these compounds compete for a 
common B substance. The complete derivation of this expression as given by 
Shannon is included in Appendix III. 
From considerations to follow it is fairly well established that this 
excretion process if ATP-supported and that a high-energy intermediate is 
indicated. Hence it might seem reasonable to suppose that ATP {or something 
more or less equivalent) is a reactant and could correspond to Shannonts 
cellular element, B. However, this view is not compatible with the observa-
tion that these substances, even when being excreted at Tm levels, do not 
affect other cellular functions. The assumptions made in deriving the equa-
tions imply that at Tm levels all the ATP would be occupied with the excretion 
process; this would be expected to affect other ATP-dependent processes, 
such as glucose reabsorption. Hence it was of interest to the author to con-
sider whether these expressions are compatible with the assumption that 
Shannon•s cellular element, B, is an enz.yme (or a sequence of enz.ymes). Some 
of the assumptions made by Shannon in deriving this equation resemble those 
in deriving the equation of Michaelis and Menten (147). Ts, the observed 
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rate of excretion, may be taken as equivalent to the reaction velocity in 
considering the process as an enzymic reaction. The term (a - Ts/V) was 
used by Shannon to represent (A), the equilibrium concentration of the trans-
ported sol ute at the site of the reaction. This term is an estimate of the 
concentration of the solute in venous blood leaving the secretory system; 
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(a - Ts/V) is therefore taken to be a corrected estimate of "substrate con-
centration". The reciprocals of Ts and of (a- Ts/V} plotted against each 
other according to Lineweaver and Burk (125) give an exact straight line, and 
Shannon's equation has the same form as the Michaelis~enten equation, which 
describes enzymic action. The proofs of these assertions are given in Appen-
dix III. Accordingly the equation of Shannon, which describes these excre-
tory processes well, is wholly compatible with an enzymic interpretation in 
which 11cellular element, B, which is present in a constant but limited amount", 
may be considered to be an enzyme. In this view, the maximum rate of excre-
tion is determined by the amount of this enzyme available. Competition for 
excretion may accordingly be treated by the methods for competitive inhibition. 
Wilbrandt (239) also has recently shown that, by modification of the 
Michaelis-Menten equation, transport curves may be drawn having the general 
form of tubular reabsorption or excretion curves. The rapidity with which 
various substances approach and plateau at their Tm levels is shown to be 
related to the Km (Michaelis-Menten constant}, that is, to the enzyme-
substrate affinity. 
Puck, Wasserman and Fishman (160) used Forster 1s technique for isolated 
flounder tubules to study the effects of various inorganic ions in the sus-
pending medium. Under normal conditions of excretion intracellular accumulation 
does not occur; the intracellular concentration appears similar to that of 
the medium, the concentration gradient being set up at the luminal border. 
In a high calcium, low potassium medium phenol red was excreted into the 
lumen in high concentration. In a high potassium, no calcium medium, however, 
the phenol red accumulated within the tubule cells themselves to high con-
centrations. In the absence of calcium, the dye was taken up by the cells 
in proportion to the potassium in the medium, whereas the absence of potas-
sium prevented accumulation in cells or lumen. These workers proposed that 
a two-step mechanism was indicated - a potassium requiring step by which 
phenol red is brought into the cell and a calcium requiring step by which 
phenol red passes into the tubular lumen. PAH or Diodrast inhibited either 
type of accumulation, which suggests that these substances compete at the 
first step (or both steps) with phenol red. 
Taggart, Silverman and Trayner (226) similarly studied the effects 
of various ions on the accumulation of PAH in slices of rabbit kidney cortex. 
Potassium had a similar stimulating effect on transport, but optimal accumu-
lation occurred only under conditions which maintained normal Na/K balance 
in the tissue slices. Calcium had only a slight, though positive, effect 
on PAH accumulation. The various inorganic anions tested seemed to arrange 
themselves in a reverse lyotropic series in terms of their effectiveness in 
replacing chloride for the support of PAH accumulation. From these experi-
ments and those of Puck et al . , described above, it is difficult to ascer-
tain whether these effects of potassium and calcium are mediated directly 
{as, for example, by being specifically required by the transport enz.ymes) 
or by an indirect means. In the kidney slices, elevation of the tissue 
potassium to values above normal resulted in both decreased PAH accumulation 
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and respiration. 
Puck et al. {160} observed phenol red concentrations within the 
lumina of the flounder tubules as high as 4000 to 6000 times that of the ex-
ternal medium. With higher external phenol red concentrations, such high 
gradients were not obtained. This is possibly due to an energy limitation 
s i nce the tubules are maintained in saline media containing no nutrient; 
however, it seems possible that the tubular luminal concentration itself 
may partially limit the process. Shannon pointed out, in the eighth postu-
late quoted above {p. 23), that the concentration in the fluid of deposition 
must be considered a possible limiting factor under some conditions. Puck 
et al. discuss these interpretations. Smith (202, p. 68) mentions the 
possibility that this apparent saturation effect on the system may be related 
to self-depression of the Tm of PAH observed by Eggleton and Habib (71) in 
the cat and by Schachter and Freinkel (180) in the dog. When the plasma 
concentration of PAH is raised to very high levels in these animals the tubu-
lar excretion may drop to very low levels, indicating a functional blockade. 
This overloading effect is immediately reversible and represents no cellular 
injury. 
It has been mentioned that, under optimal conditions, Puck et al. 
observed luminal concentrations of phenol red as high as 4000 to 6000 times 
that of the external medium. The authors point out that the estimates of 
luminal concentration, while subject to relatively large errors, are cer-
tainly of this order. Considering the system as a concentration cell they 
calculate the free energy change associated with the process: 
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/l F - + n RT ln _a_ -
a' 
A F :: -1- n X 1.99 X 301 X 2.30 log 4000 
1 
A F - 1- n x 5000 calories/mol 
at temperature - 28° c. 
Thus, taking n to be one, an energy requirement of about 5 Kilocalories per 
mol is necessary to establish this gradient. It should be pointed out that 
the maximmn attained gradient is a measure of the minimum requirement. This 
requirement may be compared to a yield of perhaps 8 Kilocalories/mol from 
the hydrolysis of ATP (165). The excretion of these compounds is seen to 
be, from these considerations, a process requiring considerable input of 
energy (on a molar basis). It should be kept in mind, however, that this 
represents a small fraction of the total work required of the kidney. Even 
when one of these substances is being excreted at Tm levels, the capacity 
of the kidney to perform other functions depending on tubular metabolism is 
not impaired. 
It is difficult to restrain speculation about the nature of the dye 
accumulating within the tubule cells in the low calcium medium. If this 
accumulated dye is indeed the 11 natural11 intracellular intermediate involved 
in the normal excretion process, some deductions may be made about its nature. 
Puck et al. added enough bicarbonate to their medium to keep the phenol red 
principally in the red (alkaline) phase. The pK of this indicator is 7.9. 
The substance they observed accumulating within the cells was red. Cameron 
and Chambers (37) also noted some intracellular accumulation in their similar 
studies with human embryo tubules, but, in this case, the phenol red was 
yellow. The intracellular substance can apparently undergo the typical pH 
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dependent color change of phenol red itself. This indicates that neither 
of the two phenolic groups of phenol red is involved in a chemical union 
with another substance. The only other reactive group of phenol red is its 
sulfonic acid group. The color changes of phthaleins and related substances 
involve configurational changes in the two phenolic rings; neither phenol-
phthalein diphosphate nor phenolphthalein monoglucuronide (derivatives 
which bind both or one of the phenolic groups) gives a red color with alkali 
(110, 80). Since ?uck and co-workers found that PAH or Diodrast would inhi-
bit this intracellular accumulation, it is indicated that the phenol red in 
entering the cell has been subjected to the Diodrast inhibitable process 
which is characteristic of this group of substances. A chemical reaction 
has presumably taken place involving the entrance of phenol red into the cell. 
If the accumulated intracellular substance is phenol red itself, it must have 
entered into another reaction regenerating free phenol red. If this is the 
case, the border of the cell opposite to the lumen, where the concentration 
gradient is produced in this case, must be permeable to free phenol red in 
only one direction. In normal transport the one-way property appears to 
apply to the luminal border. 
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In a high potassium, no calcium medium, Puck and co-workers (160) 
observed intracellular concentrations estimated to be as high as 2000 times 
external. This observation is difficult to reconcile with a high energy in-
termediate in this excretion process. It will for the present be assumed that 
the process is ATP supported and that the intracellular intermediate is, in 
this case, a compound of high group potential - comparable to an acyl-
coenzyme A (acyl-GoA) compound or to active sulfate (PAPS). The overall 
equilibrium constants for the synthesis of these substances are of the order 
of 2.7 for acyl-CoA and 1 for PAPS (169, 127, 136). If a phenol red inter-
mediate of this type could be considered comparable, it is not readily seen 
how an intracellular concentration of 2000 times the external concentration 
is possible. These equilibria, of course, are subject to many unpredictable 
influences in the cell. The assumption that the intracellular intermediate 
in this excretion process is a compound of high group potential is therefore 
not without its hazards, but, at the same time, the demonstrated potential 
of the excretion process seems to indicate a mechanism of this type. These 
discussions do not allow a definite conclusion about the nature of the intra-
cellular intermediate in phenol red excretion, but it is hoped that they will 
help delineate the difficulties of the problem. 
It should be mentioned that Brauer and Pessotti (32) have shown that 
liver slices will take up bromsulfalein (BSP) so that the concentration of 
the dye in the slice reaches 20 to 30 times that in the external medium. 
The uptake in this case, however, is apparently due to binding of the dye by 
tissue proteins. Knoefel and Huang (115) have observed a similar effect in 
kidney slices with certain iodinated benzoic acid derivatives. Protein 
binding, however, does not appear to account for the much higher intracellular 
accumulations of PSP in flounder tubules observed by Puck and co-workers (160) 
in a low calcium medium. 
Another experimental approach to the nature of the intracellular 
intermediate in PAH excretion has been made by Chinard (43). Following an 
instantaneous injection of PAH along with substances excreted by the glomeruli 
alone, closely timed samples of urine were taken. This allowed an estimate 
of the delay time associated with the diffusion of PAH across the tubular 
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cell. Chinard estimates this delay as about 70 seconds for PAH. Hanzon 
(97), by direct observation under the fluorescence microscope, noted in 
the rat liver a transit time of about 50 seconds (from sinusoid to bile 
capillary) for the dye, fluorescein. Fluorescein is actively excreted by 
the liver. The situations are, of course, quite different, but the general 
agreement in transit time indicates that Chinardts estimate is of the right 
order of magnitude. Chinard assumes this delay time to represent the time 
required for diffusion of the intracellular intermediate across the cell. 
Measurement of distance across the cell and an assumed value for viscosity 
of the cell contents, allows the diffusion coefficient to be determined. 
In turn, an estimate of 7 million was arrived at for the molecular weight 
of the diffusing particle. Chinard points out that the viscosity of the cell 
contents cannot be accurately estimated, and it has an inordinately large 
effect (inversely as the cube) upon the calculation of the molecular weight. 
It should be further pointed out that the time measured was the time re-
quired to initiate transport, and this may be very different from diffusion 
time under steady-state conditions. If it is assumed that chemical reactions 
are involved in PAH excretion, there must be at least two sequential reactions, 
so that the initiation of excretion must certainly be delayed (to a wholly 
unknown extent) by the build-up of intermediates upon which subsequent en-
zymes can act. Chinard mentions, but does not discuss, this aspect. His 
estimate of the molecular weight may quite properly be accepted as an 
approximate upper limit for this value. It should be kept in mind that the 
intracellular intermediate could well be a small molecule (or more properly 
regarded as such) which is extensively protein-bound and hence diffuses as 
a macromolecule. 
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A long series of papers by Taggart and his associates has provided a 
much more specific insight into the nature of the reactions involved in the 
transport of these compounds. 
Taggart and Forster (225, 220) studied the effects of a series of 
nitrophenols related to 2,4-dinitrophenol on the accumulation of phenol red 
in isolated flounder tubules. The gradation of effects on phenol red trans-
port by this series of nitrophenols corresponded closely to uncoupling ef-
fect on oxidative phosphorylation of rabbit kidney. These nitrophenols were 
shown to have similar effects upon the respiration of crude minces of floun-
der kidney and of rabbit kidney. Mudge and Taggart (150) confirmed the 
effect of 2,4-dinitrophenol upon this transport system by clearance tech-
niques in the intact dog. Doses of 2,4-dinitrophenol which markedly d~ 
pressed clearance of PAH, Diodrast or phenol red had no significant effect 
on renal hemodynamics. The effect on the clearance of these substances was 
prompt and sustained, whereas no depressant action on maximal rates of glu-
cose or glycine reabsorption were observed at the same dosage. Dinitro-
phenol and related compounds, while stimulating respiration, depress the 
yield of high energy phosphate from oxidative phosphorylation (131, 53), 
so that these experiments indicate that the tubular transport of these acids 
is supported by phosphate bond energy. This conclusion is in accord with 
many other observations. Isolated tubule preparations or kidney slices, 
for example, quickly lose their capacity to transport these substances when 
deprived of oxygen; transport is readily blocked by cyanide or iodoacetate 
(83, 52, 41). Isolated flounder tubules show an irreversible loss of capa-
city to transport phenol red at high temperatures and a reversible loss of 
transport capacity at low temperatures (83, 160), indicating the enzymic 
character of the transport. 
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Beyer, Painter and Wiebelhaus (20a) studied different types of in-
hibitors of phenol red excretion using kidney slices of frogs, guinea pigs, 
rabbits, mice and rats. Tubular excretion of the dye was determined by 
microscopic examination of kidney slices. Of the mammals, the guinea pig 
was the most suitable for study by this method; the rat was the most diffi-
cult. Phenylhydrazine, an inhibitor of oxidases, stopped phenol red excre-
tion. Irreversible interference with excretion was produced by cyanide 
{an inhibitor of cytochromes), and by mercuric ion or quinone (inhibitors 
of sulfhydryl-containing dehydrogenases). Uncoupling of oxidation and 
phosphorylation by 2,4-dinitrophenol, produced a reversible inhibition of 
transport. Phlorizin, an inhibitor of phosphorylation mechanisms, also 
produced a reversible inhibition of transport. Carinamide reversibly inhiw 
bited excretion of phenol red; the action of Carinamide was apparently that 
of a competitive inhibitor of transport. 
Cross and Taggart (52) made a detailed study of the effects of several 
substrates upon PAH accumulation in rabbit kidney slices. Acetate was found 
to have a striking and consistent effect in stimulating PAH accumulation. 
Lactate and pyruvate also produced a consistent increase. Acetate was al-
ways more effective than pyruvate, and pyruvate more effective than lactate. 
These workers felt the effects of pyruvate and lactate were in accord with 
their efficiency as precursors of acetate. or other potential acetate pre-
cursors, acetylglycine had a definite stimulatory effect; ethanol, acetal-
dehyde and diacetyl were without effect. Minimal and less reproducible 
stimulatory effects were given by glucose, hexose diphosphate, propionate, 
butyrate, isobutyrate and acetoacetate. Several Krebsl cycle intermediates 
were tested as substrates: ~-ketoglutarate, succinate, fumarate and malate 
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were inhibitory to transport at 0.01 M, whereas oxaloacetate was stimulatory. 
The authors point out that the stimulatory effect of oxaloacetate may be due 
to decarboxylation to pyruvate. The inhibitory effect of these Krebsr cycle 
intermediates has remained unexplained. It seems quite anomalous in view 
of the known dependence of the transport process upon oxidative phosphoryla-
tion. This author would like to point out that if ~-ketoglutarate, succi-
nate, fumarate and malate were acting only in their characteristic roles as 
Krebsf cycle intermediates, they should have the same effect as oxaloacetate, 
of which they are precursors. Their inhibitory action would appear to be 
due to some other relatively specific effect on the transport reactions. 
Cross and Taggart also found the longer fatty acids to be inhibitory 
to PAH accumulation in the rabbit kidney slices. Glycine, alanine, gluta-
mate and formate also inhibit. The following substances were without effect -
coenzyme A, coenzymes I and II, diphosphothiamine, flavine adenine nucleo-
tide, cytochrome c, pyridoxal phosphate and 5t-adenylic acid. 
Kidney slices of the rat, guinea pig and pigeon, as well as those of 
the rabbit, accumulate PAH under the conditions described. In the guinea 
pig, some indication for acetylation of the p-amino group of PAH was found. 
The clearances of PAH and p-acetylaminohippurate (PAAH) have been shown to 
be identical in the dog (203). Cross and Taggart (52) found the stimulatory 
effect of acetate in kidney slices to be almost as great with PAAH as with 
PAH. They conclude the stimulatory effect of acetate is not likely related 
to p-acetylation of PAH, since either PAH or PAAH is excreted and in both 
cases acetate is stimulatory. 
Mudge and Taggart (151) showed that acetate produced a prompt and 
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consistent increase in the Tm of PAH in the intact dog. Acetate similarly 
stimulated PAAH excretion, but somewhat less. No significant effect on 
glucose Tm was noted at the dosage of acetate used. Lactate stimulated PAH 
excretion somewhat less than acetate; succinate and fumarate depressed 
excretion. The stimulatory effect of acetate (8) and of lactate (143) on 
PAH transport has also been demonstrated in man. 
The stimulatory effect of acetate was considered to be fairly speci-
fic for the excretion mechanism. Stimulation of respiration in slices 
occurred with acetate, but its effect on transport was more pronounced. 
Several of the substrates which stimulated respiration did not stimulate 
transport. 
Schachter and Freinkel (180) also noted a remarkable effect of ace-
tate in reversing the self-depression of Tm observed in dogs given a heavy 
overload of PAH. 
Cohen and McGilvery (46), using slices and homogenates of rat liver, 
studied the conjugation of p-aminobenzoate (PAB) with glycine to give PAH. 
They showed the dependence of this conjugation upon oxidative metabolism 
and, in an anaerobic system, upon ATP. Chantrenne (42) showed that the 
same system also would conjugate benzoic acid with glycine to give hippuric 
acid. In a soluble enzyme system from rat liver, he was able to demonstrate 
a dependence upon coenzyme A. Schachter and Taggart (183, 184, 185) iso-
lated an analogous soluble enzyme system from hog kidney cortex which demon-
strated the same dependence upon coenz.yme A for hippurate synthesis. They 
showed that synthetic benzoyl-coenzyme A would completely replace the addi-
tions of ATP, benzoate and coenzyme A in the system. This revealed that 
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hippurate synthesis involved the activation of benzoate to give the benzoyl-
thioester of coenz.yme A, followed by condensation of this intermediate with 
glycine. Further studies were made on this system with a soluble preparation 
from beef liver mitochondria. The enzyme, glycine N-acylase, which cata-
lyses the condensation of glycine with the thioester of benzoic acid, was 
completely specific for glycine but capable of forming glycine conjugates 
of a variety of acids: benzoic, p-amino benzoic, acetic, numerous fatty 
acids and other aromatic acids related to benzoic. 
Schachter and Taggart (183) further observed that Carinamide and 
Benemid did not inhibit the glycine N-acylase reaction, although these 
drugs were known to block the overall synthesis of hippurate from benzoate 
and glycine (19). It was concluded that these compounds must block benzoate 
activation. Schachter and Taggart also observed that these compounds blocked 
acetate activation. 
Further studies of the glycine N-acylase reaction resulted in a re-
markable explanation of the stimulatory and inhibitory effects of several 
of the substrates studied by Cross and Taggart (52). Schachter, Manis and 
Taggart (182) showed that respiring rabbit kidney cortex slices were capable 
of synthesizing the aliphatic acyl-glycines of fatty acids from c2 to c12• 
The greatest rates of synthesis were obtained with the c7 and c9 fatty 
acids. Kidney slices from various species were examined for glycine conj~ 
gation of PAB to give the representative acyl-glycine, PAH. Positive re-
sults were obtained with kidney slices from the rabbit, dog, pig, rat, 
guinea pig and pigeon. No PAH synthesis was detected with slices from the 
chicken, turkey, goose, duck or dogfish. 
Since various acyl-glycines such as hippurate, PAH and cinnamoyl• 
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glYcine are excreted by the kidney tubules, some of these aliphatic acyl-
glycines were tested with rabbit kidney slices. It was found that accumu-
lation occurred with the compounds tested and that acetate stimulated the 
accumulation, as it does with PAH. A hippuricase-like enz.y.me in the slices 
made it impractical to test more than a few of the acyl-glycines for accu-
mulation in this manner. 
A study was then made of the capability of these fatty acyl-glycines 
to inhibit the uptake of PAH by the rabbit kidney slices. Acetyl-glycine 
did not inhibit PAH accumulation, but increasing inhibition was noted with 
the glycine conjugates of fatty acids of longer chain length. Propionyl-
and butyryl-glycines were only slightly inhibitory, while the glycine co~ 
jugates of fatty acids from c5 to c8 were nearly as inhibitory to PAH 
accumulation as was hippuric acid (benzoyl-glycine). 
The inhibitory effects by fatty acids of intermediate chain length 
upon PAH transport, therefore, seems to depend upon their forming glycine 
conjugates which compete for transport. If it is assumed that the transport 
mechanism is subject to continuous inhibition by this means {from endogenous 
fatty acids of fat metabolism), the stimulatory effect of acetate can also 
be explained from the observations outlined. The abundance of acetate is 
presumed by these workers to bring about synthesis of acetyl-glYcine at 
the expense of the other acyl-glycines which are competitive in the excre-
tion mechanism. Acetyl-glycine does not inhibit transport. The net effect 
of acetate is therefore one of removing an endogenous inhibition. These 
workers demonstrated that the enhancing effect of acetate on PAR uptake by 
kidney slices occurred only in those animals in which glycine conjugation 
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was also demonstrable in kidney slices. Thus, the dog, rabbit, pigeon and 
guinea pig demonstrate glycine conjugation and also an enhancing effect 
upon transport by acetate. In the chicken, turkey, duck and goose (which 
are ornithine conjugators), acetate is without effect. In the dogfish, 
acetate is inhibitory to transport, and the formation of glycine conjugates 
did not occur in kidney slices. Note that one bird, the pigeon, is included 
among those in which acetate has an enhancing effect; kidney slices of the 
pigeon, however, formed glycine conjugates. Although the enhancement effect 
of acetate occurs only in those species capable of glycine conjugation, the 
reverse is apparently not necessarily the case. The rat can form glycine 
conjugates, although acetate has no effect on transport in this animal. 
Rabbit kidney slices are also capable of forming alanine conjugates 
with L-alanine, but not with D-alanine. L-alanine conjugates compete for 
PAH transport and L-alanine is inhibitory to transport in the rabbit. D-
alanine, on the other hand, is stimulatory to transport, presumably because 
of conversion to pyruvate by the D-amino acid oxidase of kidney. Although 
the conjugating system shows this specificity between D- and L-alanine, the 
excretion mechanism itself does not discriminate between synthetically pre-
pared p-aminobenzoyl-1-alanine and p-aminobenzoyl-D-alanine. Either is 
accumulated by rabbit kidney slices to an equal extent, and the excretion 
of either is stimulated equally by acetate. Kidney slices of the guinea 
pig or rat do not form alanine conjugates, and in these species L-alanine 
has no effect upon PAH transport. 
These investigations seem to account rather well for the unusual 
effects of a number of substrates upon PAH transport, although these co~ 
elusions have been challenged by White (237). White used Pentothal, which 
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is sodium 5-ethyl-5-(1 methylbutyl)-2-thiobarbiturate, as an inhibitor or 
PAH accumulation in rabbit renal slices. Pentothal, a sulfhydryl compound, 
was assumed to be acting as an inhibitor or coenz,rme A (137). The pertinent 
data are given in Table 3 on p. 52 or Whitets article. The effect or dif-
ferent concentrations or Pentothal was first determined (Experiments 232 
and 233). At 0.625 mM/L, Pentothal inhibited the PAH slice/medium (S/M) 
ratio to 17.7% and 19.3%, respectively, of the control. At this concentra-
tion respiration is not depressed, as it is at higher concentrations or 
Pentothal. A Pentothal concentration or 0.625 mM/L was therefore chosen 
for the subsequent experiments, since it markedly depressed PAH uptake with-
out depressing respiration. In experiments 257 and 258, White showed that 
acetate stimulated the S/M ratio of PAH to 229.6% and 192.7%, respectively, 
or the control; when acetate and Pentothal were both added to the medium 
the S/M ratio or PAH was 90.1% and 94.5%, respectively. From this White 
asserted, "Table 3 demonstrates the well-known stimulatory effect of acetate 
(10 mM/L) on the uptake or PAH by rabbit renal slices (approximately 200% 
of control value). Pentothal (0.625 mM/L) completely inhibits the stimula-
tory effect or acetate on uptake. 11 
The conclusion that 11pentothal completely inhibits the stimulatory 
effect of acetate on uptake" appears to the author unwarranted, since White 
apparently did not run a simultaneous control with Pentothal alone. The 
stimulatory effect of acetate in the presence of Pentothal would more 
properly be ascertained from comparison between vessels containing acetate 
~ Pentothal with vessels containing Pentothal alone. It anything, the 
data ot White indicate quite the opposite or what is asserted. In the 
first experiments (#232 and #233), the effects of varying concentrations 
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of Pentothal were measured. As already mentioned, Pentothal alone, at the 
same concentration as was employed in all the cases cited here, depressed 
the S/M ratio to 1?.7% and 19.3% (average= 18.5%) of the control. To 
the extent that these values (from different experiments) can be considered 
to apply to the later experiments in which acetate ~ Pentothal were used, 
we may calculate the stimulatory effect of acetate in the presence of 
Pentothal. 
Exp. 257: 
s 
= 
90.1 
-
4.9 
-18.5 
Exp. 258: 
s 
- ~ - 5.1 
-
... 
II 18.5 
It follows that Pentothal indeed does not completely inhibit the 
stimulatory effect of acetate on uptake, since acetate appears to stimulate 
the S/M ratio of PAH by a factor of about 5 in the presence of Pentothal. 
In the absence of Pentothal, as White pointed out, this ratio is increased 
by a factor of 2 by acetate. 
The data of Whitets Table 3 were considered to argue against Taggart's 
explanation of the effect of acetate as follows. Taggart (182) suggested 
that PAH transport was under constant inhibition by fatty acyl~glycines 
(06 - Clo) from endogenous fatty acids and that acetate removed this inhi-
bition by overwhelming the glycine conjugation system with acetate. Acetyl-
glycine does not inhibit transport. White states: 
If this thesis is correct, the inhibition of coenzyme A 
should increase the uptake of PAH by decreasing the production 
of the inhibitory acylglycines (06 - c10). To the extent that 
Pentothal functions as an inhibitor of coenzyme A in the renal 
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slices, the present demonstration that the uptake of PAH is 
depressed by the compound is not consistent with the hypothesis 
of continuous inhibition of PAH transport by acylglycines. 
The inhibition by Pentothal of the stimulatory effect of ace-
tate on the uptake of PAH suggests that Pentothal does, indeed, 
inhibit coenz.yme A in the renal slices. 
Since Pentothal apparently does not inhibit the stimulatory effect 
of acetate, the evidence does not warrant the conclusion that Pentothal 
is acting as a coenzyme A antagonist. The effect of Pentothal on transport 
is, therefore, as yet unexplained. Taggart's conclusions about the effects 
of fatty acids and acetic acid upon transport, from the evidence presently 
available, seem to be sound. 
Taggart {223) has recently extended the studies of PAH transport in 
such a way as to delineate further the type of mechanism to be considered. 
He points out that the compounds known to share this pathway are all acids, 
either carboxylic acids or derivatives of sulfuric acid (phenolsulfonphtha-
lein dyes, ethereal sulfates), suggesting that the ionic group (.-coo- or 
-- so3-) is the primary site or attachment between the transported com-
pound and "carrier 11 • 
He summarizes clearance studies of compounds in which various possi-
ble reacting groups of PAH are substituted. The following compounds all 
have high clearances in the dog: PAH, p-acetylaminohippurate (in which the 
amine group is changed), p-aminobenzoylsarcosine (which has a methyl group 
on the amide N), p-acetylaminobenzoylsarcosine (substitutions on both amine 
and amide Nfs). No compound with an altered amide carboBfl has been tested. 
However, if a substitution is made on the carboxyl group, the compound is 
not excreted by the tubules. Taggart finds a clearance below that of 
creatinine for such a compound, PAH-hydroxamate. 
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To obtain information about the nature of the bond between the 
carboxyl group and the "carrier", PAR labeled in the carboxyl group with 
18 0 was used. The two oxygens of the carboxyl group are equivalent. This 
PAH was injected directly into the renal vein of a dog and collected from 
the ureter on the same side. The injection was slow, to ensure nearly 
complete extraction in one pass, and under the conditions employed approxi-
mately 2/3 of the PAH collected was excreted by the tubules and 1/3 by the 
glomeruli. The total recovery of PAH was 88 per cent of that injected. 
The o18 in the original PAH and in the PAH which had passed through the 
kidney was determined. I t was found that the transport of PAH across the 
renal tubule did not result in any appreciable loss of o18 from the car-
boxyl group. 
This seems primarily to exclude certain types of chemical reaction 
into which the carboxyl group may have entered during transport. Taggart 
points out that neither an amide (--CO-NHR) nor thiol ester (--CO.SR) 
linkage can be involved, since formation of either entails the loss of 
carboxyl oxygen (1/2 of it). An ester of the type (-CO-O-CH2R) appears 
improbable, for, as KOshland (116) points out, the acyl-oxygen bond (-Qo-o-) 
is much more susceptible to hydrolytic cleavage than is the oxygen-methylene 
An acyl-phosphoric acid anhydride (--C0-0-P03R) is a possibility 
considered by Taggart. Its formation and cleavage would have to occur in 
such a way as not to remove one of the oxygens from the carboxyl. The 
dependence or PAH transport on ATP suggests the occurrence in transport 
or an acyl-adenylate, as Taggart points out. Taggart suggests also that 
an ion-exchange mechanism is consistent with the ol8 data. This, however, 
is more difficult to reconcile with other factors. 
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A more recent study by Kellerman (112) has further investigated the 
possible involvement of an adenylate derivative in the transport of PAH. 
Synthetic benzoyl- and hippuryl-adenylates were prepared, and their hydro-
lysis by fractions from pig kidney mitochondria was studied. All the 
various fractions rapidly hydrolyzed these compounds. When these 
substances were enzymatically hydrolyzed in water enriched with o18, it 
18 
was found that the 0 from the water was incorporated into the adenylic 
acid formed rather than into the benzoic or hippuric acid. The opposite 
result was obtained when benzoyl-adenylate was hydrolyzed by alkali. This 
demonstrates that in the enz.ymatic hydrolysis of these adenylates the 0-P 
bond, rather than the C-0 bond, of the adenylate was split by water. It 
would thus appear that an acyl-adenylate intermediate is compatible with 
Taggartts observation (223) that PAH passes through the kidney tubule cell 
without losing oxygen from its carboxyl group. This experiment of Kellermanfs 
indicates that an acyl-adenylate may be enzymatically split, leaving the 
oxygens of the carboxyl group intact. Kellerman points out that the ex~ 
periments of Boyer, Koeppe and Luchsinger (25) indicate that an acyl~adeny-
late may be formed enzymatically with the acyl oxygen being incorporated 
into the intermediate. Boyer, Koeppe and Luchsinger found that o18 from 
the carboxyl of acetate is transferred to adenylic acid (and must therefore 
have been present in the intermediate acetyl-adenylate) in the enzymatic 
synthesis of acetyl-coenzyme A. Bernlohr and Webster (15) have more re-
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cently shown that 0 from the carboxyl of tryptophan or alanine is similar-
ly transferred to adenylic acid in amino acid activation. Note that the 
linking oxygen of the acyl-adenylate goes to adenylic acid when split by 
hydroxylamine (Bernlohr and Webster) or by coenz.yme A {Boyer, Koeppe and 
~. 
Luchsinger) but this oxygen may go to the. carboxyl group when split 
enz.ymatically by water (Kellerman). 
Kellerman (112) also investigated the enz.yme, octanoic thiokinase 
(fatty acid activation enzyme for fatty acids of intermediate chain length) 
(136), for its direct involvement in this transport mechanism. This enz.yme 
is known to be indirectly involved in PAR transport, since it activates the 
fatty acids in the formation of acyl-glycines which inhibit PAH transport 
(182). In addition to activating fatty acids, this enzyme was known to 
activate certain aromatic acids: PAB or benzoic (183, 184, 182, 136). 
This suggests a wider substrate specificity, and it is reasonable to sus-
pect that it might also activate the acids transported by the kidney. Puri-
fied octanoic thiokinase, however, showed no significant activity with trans-
ported substances (PAR and resorcinol disulfate) and very slight activity 
with Benemid or Garinamide. The assay used by Kellerman was of the first 
reaction in the activation scheme for fatty acids, by which the acid splits 
ATP to give an acyl-adenylate (acyl-AMP) and pyrophosphate (PP). 
acid -/- ATP ---'..::L acyl. AMP + PP 
Thus his assay method excludes the possibility that this enzyme forms either 
an acyl-adenylate or a coenz.yme A thioester of PAH. The formation of a co-
enzyme A thioester would involve an acyl-adenylate intermediate. 
acyl. AMP -/- GoA acyl. GoA -/- AMP 
' 
Kellerman's findings indicate that an acyl-adenylate could fulfill the re-
quirements of what is known about PAH transport, but octanoic thiokinase is 
45. 
not the enzyme directly involved. 
Various aspects of this work by Taggart and his associates is 
discussed in the following reviews (219, 220, 221, 222, 224). 
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III 
THE NATURE OF BILIARY EXCRETION 
A. Active excretion by the liver 
Blood is supplied to the liver from two sources, the portal vein 
and the hepatic artery. The active metabolism of the liver is dependent 
upon the oxygenated blood supply from the hepatic artery. Within the 
liver, blood from both these sources empties into the sinusoids which 
surround the parenchymal cells of the liver. Within the sinusoids, blood 
flows from the periphery of the hepatic lobules to the central vein of the 
lobule. From these central veins, the blood is collected into the hepatic 
vein, which drains the liver. Blood within the sinusoids surrounds the 
polygonal cells of the liver. These polygonal cells are radially arranged 
in cords within the lobule, and, between the paired rows of polygonal cells 
within a cord, run very small canals, the bile canaliculi. Bile is formed 
by the polygonal cells of the liver and drains by way of these fine canali-
culi into the bile duct system. The sinusoids are wholly lined by a squa-
mous endothelium, so that the polygonal cells are more properly considered 
to be bathed in an interstitial fluid, rather than in blood itself. The 
bile canaliculi themselves have no lining other than the cuticular borders 
of the polygonal cells between which they lie. 
Bile is considered by some workers to be formed by a process of 
filtration and secretion quite analogous to urine formation. Selective 
reabsorption plays a lesser role, however. Cook, Lawler, Calvin and Green 
(48), for example, measured the hepatic clearance of a number of substances. 
Many of these had clearances similar to the clearance of water, and appeared 
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in bile in concentrations not greatly different from their concentration 
in plasma. They considered these substances to be cleared primarily by 
a filtration process through the polygonal cells. Plasma and bile also 
have comparable osmotic pressures. Certain other substances had consider-
ably higher clearances and were considered to be actively excreted by the 
polygonal cells. The following table, adapted from their paper, will 
amplify this concept. Each value is an average of many determinations. 
Hepatic Excretion in the Dog 
Clearance Bile cone. Rate of excretion 
(m.l/min.) Plasma cone. (liM/min/Kg X 10""5) 
e alculated fro~ 
data given 
Water 0.0055 
-Inulin 0.0014 0.47 0.14 
Cholesterol 0.0169 0.57 ~.6 
Cl- 0.0028 0.49 39 
Glucose o. 0035 1.36 6.7 
~aj- 0.0065 1.23 116 0.0097 1.93 3.1 
Creatinine o. 0137 2.12 1.8 
PAH 0.176 1~.7 13 
Bilirubin 1.61 235 2.9 
BSP 1.48 93.3 12 
Penicillin 0.131 9.2 O.!t;5 
Aureomycin 0.031 1.9 0.49 
Dihydrostreptomycin 0.0010 0.5 0.02 
Chloro!!!,Ycetin 0.0079.. 3.1 0108 
Terram;rcin 0.04.0 ~.6 0115 
In general, it appears that BSP (bromsulphalein) and bilirubin are 
cleared at high rates. Penicillin and PAH are cleared at moderate rates. 
The active excretion of some of the other substances, such as terramycin 
or aureomycin is of a rather low order. These clearances are determined in 
an analogous way to renal clearances, but the measurements are considerably 
more difficult to make. Hepatic bile must be obtained by cannula. In 
animals having a gall bladder, the cystic duct must be clamped so that the 
concentrating effect of the gall bladder does not distort the results. Two 
factors in particular reduce the accuracy, the low volume of flow (1/30 
that of urine) and the chromogens in bile. Another method for determining 
a fractional hepatic clearance, based only on measurement of the disappear-
ance from blood, has recently been proposed by Lewis (124). 
Cook, Lawler and Green (49) noted that two hydrocholeretics, de-
hydrocholic acid and ~-(2,4-dimethyl-5-cyclohexyl-benzoyl) propionic acid, 
increased the excretion of substances considered to be primarily filtered 
(water, Na~ ~' Cl- and creatinine), whereas the excretion of BSP, PAH 
and penicillin was not increased. This supports the concept of filtration 
and active excretion in the production of bile; they also concluded that 
the primary mechanism affected in hydrocholeresis is filtration. 
Brauer (29) criticizes the drawing of a sharp distinction between 
filtered and excreted substances in bile, since, as he points out, a more or 
less continuous series of clearances is shown by the data of Cook et al. 
(table on p. 48). Brauer considers filtration ruled out as a major mecha-
nism in bile formation by data concerning the relations between bile flow, 
bile secretion pressure and blood pressure delivered to the liver. Factors 
affecting the pressure in the sinusoids do not affect bile flow. For 
example, deflection of portal blood from the liver (157) or significant 
changes in intra-abdominal pressure (156) do not affect bile flow. A 
filtration mechanism is not consistent with the observation that bile secre-
tion pressures are higher than perfusion pressures in the isolated rat liver; 
and bile flow is independent of blood flow at physiological perfusion 
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pressures (31). Bile flow is rapidly depressed by hypoxia of short dura-
tion {96, pp. 206-15). Brauer concludes from such considerations that 
"transfer of water and nonconcentrated electrolytes, as well as that of 
substances secreted against concentration gradients into bile, represents 
active transport, dependent upon metabolic energy derived apparently from 
aerobic metabolism." 
The mechanics of bile production is in some respects similar to that 
of urine production in the aglomerular kidney. In either case a lining of 
metabolically active cells excretes into a tubule closed at one end. The 
glomeruli in the glomerular kidney, of course, make a considerable dif-
ference in the capacity of the kidney to excrete substances not handled by 
a specific active excretion process. In the liver where the situation is 
not complicated by the passage through the 11 tubules 11 of large amounts of 
filtered fluid, it is probably safe to assume that substances occurring in 
concentrations moderately or considerably above filterable concentrations 
in plasma are actively excreted. Whether this active excretion is brought 
about by the process under consideration for certain organic acids, must 
be decided from chemical structure of the compounds, competition for 
excretion, etc. 
In passing from sinusoid to bile canaliculus, or, in the kidney, 
from capillary to tubule lumen, requires that the transported substance 
pass through the endothelial lining of the sinusoid or capillary in addition 
to the polygonal or renal tubular cell. Hanzon (96, pp. 167-9), by fluo-
rescence microscopy, observed the rapid transfer of fluorescein through 
the endothelial membrane in the liver without any concentrating effect. 
From numerous observations he concluded that this membrane is readily 
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permeable to these substances in both directions by passive diffusion. In 
the kidney, where the situation may be considered similar, the ready dif-
fusibility through an endothelial membrane may be seen in the glomerular 
formation of an ultrafiltrate containing the non-protein bound crystalloids. 
The character of lymph throughout the body also illustrates this. The 
f l uid upon which the polygonal cell of the liver or the renal tubular 
cell operate in transferring substances through into bile or urine is, 
therefore, an ultrafiltrate of blood. With a highly protein.bound sub-
stance like phenol red, this intracellular fluid will contain only a small 
fraction of the dye. In a single pass through the kidney most of the phenol 
red is removed from the blood. Thus, the protein-binding equilibrium must 
be very readily and rapidly reversed when the equilibrium is disturbed by 
removal of the unbound fraction. 
The nature of the process by which these transported substances 
first enter the polygonal or renal tubular cell is an important aspect of 
their transport. Considerable evidence indicates that a free diffusion is 
responsible. Beyer (19), for example, noted that when the active process 
was fully inhibited by Benemid or Carinamide, PAH accumulated in kidney 
slices to give a slice/medium ratio of 1.0. This indicates that the cell 
membrane is freely permeable to PAH, and that the active step of the process 
is distinct from this diffusion into the cell. Brauer {29) considers free 
diffusion to be the basic mechanism for initial uptake of BSP by the liver. 
Hanzon (96, pp. 112-22) noted fluorescein concentrations within rat liver 
polygonal cells to be somewhat higher than within the sinusoids. This 
effect was much more pronounced when the liver was perfused with a protein-
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free solution containing fluorescein than when blood was circulating through 
the organ. Brauer and Pessotti (32) observed, with liver slices, that BSP 
was passively absorbed by liver tissue. Both BSP and fluorescein are 
strongly bound by plasma and liver proteins. Brauerts data indicate that 
liver slices can absorb BSP to give slice concentrations of the order of 
20 to 30 times that of a protein-free incubation medium. Intracellular 
accumulation of BSP was less when protein was added to the incubation medium, 
reducing the concentration of diffusible BSP. In another view, protein in 
the external medium competes with intracellular proteins for the BSP. 
Similar effects were observed with perfused liver. The intracellular 
accumulation of fluorescein, when the liver is perfused with a protein-free 
solution, therefore, is probably attributable mostly to protein binding of 
the fluorescein. Hanzon (96) discusses this possibility and also the possi-
bility that concentration gradients at both borders of the polygonal cell 
represent two active steps. 
With kidney slices it has been possible to work out many of the dew 
tails of the active phase of PAH excretion, as previously discussed. The 
relatively small amount of work which has been done using liver slices, 
however, has not enabled study of the active phase of excretion. As men-
tioned in the last paragraph, Brauer and Pessotti (32) found that rat liver 
slices took up BSP rapidly when suspended in an isotonic, oxygenated, pro-
tein-free medium containing BSP. For example, 0.15 g of tissue took up 
about 67 per cent of the BSP in 2 ml. of incubation solution containing 
50 mg./L. of BSP. It may be estimated from this that a slice/medium ratio 
of about 25 was attained. In sharp contrast to the results obtained with 
PAH in the kidney, however, this uptake of BSP was not inhibited by incubation 
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under pure nitrogen, by cyanide (0.08 M), by mercuric ion (0.001 M) or by 
fluoride (0. 05 M). Dye uptake was reduced by small amounts of albumin in 
the external medium; uptake was much lower with protein concentrations 
comparable to plasma. Detailed studies indicated the uptake to be due to 
passive diffusion, the intracellular proteins binding the dye. The BSP 
taken up by the slice is 90 per cent to 98 per cent recoverable and is 
chromatographically indistinguishable from BSP. This passive uptake of 
a substance which is bound to protein as extensively as is BSP, masks the 
active excretion process which is undoubtedly also going on in the slice. 
PAH is bound to a very small extent by protein, and its uptake in kidney 
slices is, therefore, essentially dependent upon active transport. Brauer 
also found that phenolphthalein and phenol-tetrabromphthalein (also ex-
creted by the liver and also largely bound by protein) are taken up by 
liver slices in a manner analogous to BSP. Phenolsulfonphthalein was taken 
up to a lesser extent. Under the conditions these dyes were used (0.01% 
albumin), less than 10 per cent of BSP is dialyzable and more than 80 per 
cent of PSP is dialyzable. By perfusion studies, considerable amounts of 
BSP were found to be taken up by other tissues. Knoefel and Huang (115) 
found that the uptake of certain acids by kidney slices depended primarily 
on protein binding. 
The rate of disappearance of BSP from blood is faster than its 
secretion in bile (38, 246, 39). Hanzon (96, pp. 121-2) observed a very 
rapid disappearance of fluorescein from the blood, with considerable lag 
before maximum excretion rates in bile were produced. The high rate of 
biliary excretion persisted for some time. The uptake phase and the excre-
tion phase are to some extent separable processes with these strongly 
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protein-bound substances. The rapid fall of plasma level is apparently due 
to this diffusion into liver and other tissues. As it is excreted by the 
liver, more dye returns from extra-hepatic reservoirs to maintain the high 
excretion rate. In the BSP test of liver function, however, the blood level 
does not drop to the required extent unless the dye is efficiently removed 
into bile. 
H6ber (107) made extensive studies of active transport with dyes. 
Reviewing his experiences with acidic dyes, he emphasized the importance of 
a bipolar structure in the transported substances ... one end of the molecule 
being predominantly organophilic and the other hydrophilic. The positions 
of sulfonic acid groups in the dyes and the resulting effect on transport 
was considered. He believed that the penetration into cells involved the 
orientation of these molecules at the cell membrane in a "Langmuir film" 
and that the active process necessarily occurred at the membrane (108), 
being supported by metabolic energy. Taggart (224) notes that in the series 
of aliphatic glycines he studied, transport did not become evident until 
the aliphatic chain was sufficiently long to give a more hydrophilic-
organophilic character to the molecule . It should be pointed out that 
some substances are actively excreted which have sulfonic or carbox,ylic 
groups symmetrically placed on the molecule, as for example, indigo carmine, 
Neo-iopax (a urographic agent) and Cholografin (a cholecystographic agent). 
Compounds like hippurate, p.aminohippurate or p-hydroxyhippurate all have 
high renal clearances but differ considerably in their hydrophilic-organo-
philic character. Orientation of the type described is undoubtedly involved 
in the penetration of these polar compounds through cell membranes. However, 
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the bipolar nature of these molecules alone does not seem to explain the 
specificity of the process of transport, although polarity may be associated 
with transport in specific series of compounds. 
Williams (240) discusses in detail a number of theories which have 
been proposed by maQY workers in explanation of detoxication phenomena. 
Many of the products of conjugation reactions are more readily excreted than 
the compounds conjugated. For examPle, phenyl sulfate is more readily ex-
creted than phenol itself; hippurate more readily than benzoate; phenyl 
glucuronide more readily than phenol. These conjugations often seem to 
result in compounds which are excreted by the kidney tubules or by the liver 
by the active processes which are the subject of this thesis. In explanation 
of the large body of facts known about these reactions, various workers have 
proposed that the aim of detoxication is: reduction of toxicity, increase 
of solubility, production of a compound which lowers the surface tension of 
water to a lesser degree than the original substances, conversion to a 
stronger and more excretable acid, etc. These various theories are examined 
by Williams, and he notes that exceptions to each of these rules occur. 
Some of these theories imply an intelligence on the part of the liver or 
kidney, which Williams is reluctant to admit. He considers that these de-
toxication systems are true physiological functions, in that they normally 
deal with endogenous substances, such as steroid hormones or with certain 
phenolic compounds absorbed from the intestine. The usefulness of these 
reactions is obvious, and this body of reactions is certainly of survival 
value to the organism. It should be pointed out that these detoxication 
and excretion mechanisms are, thereby, probably important evolutionary 
determinants, to which their widespread occurrence may be attributed. 
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Williams asserts that whether, or how, a foreign substance is "detoxified" 
is determined wholly by how well it fits, as a substrate, these existing 
enzymatic mechanisms of the body, rather than by whether a less toxic 
substance is produced, an increased surface tension results, etc. This 
same 11 lock and key" analogy would seem to apply with equal validity to the 
excretion phenomena under consideration. The distinction between conjuga-
tion and excretion will be discussed later . 
The 11 surface tension hypothesis", discussed by Williams and attributed 
to Berczeller (12), leads to a contradiction of the conclusions of H6ber 
(107) and Taggart (224) mentioned previously. Berczeller claimed that, 
during a conjugation process, a change in surface tension takes place so 
that the surface tension of a solution of the conjugate is nearer to that 
of water than the surface tension of a solution of the toxic or foreign body. 
Rose and Sherwin (170) investigated this concept and found many exceptions. 
A typical example which agrees with Berczeller's hypothesis is the conjuga-
tion of benzoic acid to produce hippuric acid. Hippuric acid does not lower 
the surface tension of water to a significant extent, whereas benzoic acid 
does. The advantage to be gained from this conjugation was therefore con-
sidered to result from the reduction of the tendency to accumulate at inter-
faces, where the compounds were considered to do most harm. The conjugate 
is also more readily excreted. In the series of acyl-glycines studied by 
Taggart (224.), lengthening of the aliphatic side chain resulted in compounds 
excreted by the PAR mechanism. A longer side chain increases the hydrophilic-
organophilic character of the molecule and presumably would enhance its sur-
face tension lowering effect. The fact that this increases their excretabi-
lity is the reverse of what Berczellerts hypothesis would imply. The surface 
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tensions measured by Berczeller were made with the acids themselves rather 
than the salts at physiological pH's, so that the significance of the 
measurements is difficult to assess. 
This hepatic excretion system is capable of producing high bile/ 
blood concentration gradients, analogous to the gradients produced by the 
renal tubule. Hanzon (96, p. 120) found that liver could concentrate 
fluorescein at least 500 times. Correction for protein-binding of fluo-
rescein in plasma would increase this value considerably. Brauer (28) 
states that the thermodynamic activity of BSP in the biliary tree is between 
1000 and 10,000 times as high as that presumably in "equilibrium with it11 
in the blood plasma. Gradients of 1000 or 10,000 indicate a process re-
quiring from 4.3 Keal/mol to 5.7 Keal/mol, assuming a temperature of about 
37°. 
An estimate of the activation energy for the excretion of fluorescein 
by the rat liver has been made by Hanzon (96, pp. 162-4). Measurements were 
made of the time required for fluorescein to pass from hepatic sinusoid to 
bile canaliculus at different temperatures in the living rat. The estimate 
of activation energy was then made graphically from the Arrhenius equation. 
A value of 24.7 Kcal/mol was arrived at for the activation energy. The 
Q10 was 3.75. The time required to initiate excretion across the polygonal 
cell was used for estimation of reaction rates. The question of whether 
this value may be taken as a true measure of reaction rate has already 
been discussed (pp. 31-2 ). 
It is generally accepted that bile is formed by the polygonal cells 
of the liver and excreted into the canaliculi, which drain into bile ducts. 
It is held by some investigators (Maegrai th and Andrews, for example) 
(135, 4) that bile is produced by the cells lining the bile ducts. They 
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consider that the bile canaliculi may perhaps serve a reservoir function, 
but that they do not join the bile ducts. The bile ducts have an epithe-
lium resembling that of renal tubules and have a rich vascular bed supplied 
by the hepatic artery. Andrews (4) has observed a faster clearance of BSP 
when injected into the hepatic artery than into the portal vein. These 
views have not been very generally accepted. Hanzon, for examPle, has been 
able to visualize the conjunction between canaliculi and bile duct in living 
rats during uranin excretion (4, in discussion; 96, p. 105). Brauer (4, 
in discussion) has observed more efficient clearance from portal injections 
of ESP than for hepatic artery injections, the opposite from that observed 
by Andrews. 
The Kupffer cells of the hepatic sinusoids have also been proposed 
as the cells which bring about the excretion of these substances. These 
phagocytic cells are known to take up India ink particles, colloidal dyes, 
etc. Cantarow and Wirts (39) noted an increased blood bilirubin level and 
a delayed BSP removal after India ink injection. They concluded that the 
reticulo-endothelial system plays an important part in removal of halo-
genated phthaleins from the blood stream. Mendeloff (145) and Hanzon (96), 
however, have emphasized that Rose Bengal or fluorescein may be observed 
only in the polygonal cells during excretion of these dyes; these dyes are 
not seen to be concentrated in the Kupffer cells or in the spleen. These 
effects of India ink can be reproduced by the particle-free suspension 
medium and may be attributable to a hepato-toxic effect (248, 29). Mendeloff, 
Kramer, Ingelfinger and Bradley {146) have extensively refuted the asser-
tions that the reticulo-endothelial system is principally involved in the 
excretion of these acid dyes. This subject is also reviewed by Cohen, 
Althausen, Uyeyama and Treager (44). 
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It seems safe to assume that bile is produced at the canaliculi, 
but the character of bile is probably altered to some extent in the bile 
ducts. The reabsorption of large amounts of water in the bile ducts seems 
unlikely because or the lack or special structures for filtration or a 
situation favorable to the production of large amounts of water in the liver. 
B. Conjugation reactions associated with excretion 
The bile acids (cholic acid, desoxycholic acid, etc.) are excreted 
in bile only after being first conjugated with taurine (2-aminoethanesul-
fonic acid) or with glycine {199). The enzymatic details of these conjuga-
tion reactions have been recently elucidated (199, 34, 73, 74, 75). Cholic 
acid, desoxycholic acid or lithocholic acid are activated as thioesters of 
coenzyme A for the conjugation process. The activating enzyme is present 
in liver microsomes. Separate enzymes then conjugate the activated bile 
acid with either taurine or glycine. These processes occur only in liver, 
and the occurrence of the two types of conjugate is variable in different 
animals. The rat, for example, conjugates bile acids primarily with taurine; 
the rabbit conjugates bile acids with glycine; in man both types occur (14). 
These bile salts are excreted in bile and almost wholly reabsorbed from the 
intestine and re-excreted in bile - an entero-hepatic circulation. 
These bile acid conjugates have either the free carboxyl group of 
glycine or the sulfonyl group of taurine. 
The question arises whether the bile acid conjugates, in the course 
of their entero-hepatic circulation, must be de-conjugated and re-conjugated 
when excreted. Sobotka (207, pp. 30 and 36) states that Weiss in 1884 (236), 
Prevost and Binet in 1888 (159), Winteler (quoted by Moore in 1898) {149), 
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Stadelmann in 1891 (214) and others have introduced glycocholic acid into 
the dogts intestine and recovered both glycocholic and taurocholic in the 
bile. The dog normally conjugates bile acids only with taurine. These 
experiments show several things: 1) the dog absorbs the conjugates as 
such from the intestine, at least in part; 2) although the dog does not 
form glycine conjugates, it can excrete them in bile; 3) at least in part, 
the conjugates are excreted without reconjugation; and 4) the conjugation 
is distinct from excretion. 
Sobotka (207) mentions that the reverse experiment, ingestion of 
taurocholic acid by the hog, which conjugates only with glycine, has not 
been attempted. Brauer (29) also states that: 
no experiments have yet been reported with doubly labeled 
taurocholate to establish whether this compound is broken 
up and resynthesized in transit through the liver. Theore-
tical interest attaches to this since, wherever detailed 
studies have been performed, substances concentrated in 
bile were found to be subject to 'detoxication' or trans-
formation reactions in passage through the liver •••••• 
BSP, bilirubin, bile acids. 
What Brauer seems to imply here is that the conjugation reactions may be 
a necessary part of the excretion mechanism or that the excretion is a 
conjugation reaction. The older work with glycocholic acid (207) indi-
cates that this is not necessarily the case. Some evidence, which will 
be discussed, also indicates that the conjugation of bilirubin or BSP is 
distinct from their excretion. In some cases a separation of conjugation 
and excretion may be geographic as well; benzoic acid is conjugated with 
glycine in the liver, but the resulting hippuric acid is excreted princi-
pally by the kidney. 
On the other hand, it is not wholly ruled out that some additional 
undetected conjugation may be the reaction by which all these compounds are 
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excreted. In defense of this possibility, the case of bilirubin is illu-
minating. Although it was known that bilirubin was excreted in bile in a 
changed form, it was many years before it was found that 11direct-reacting11 
bilirubin was a labile glucuronic acid conjugate. The possibility that a 
labile conjugate of this type could escape detection is not to be ignored. 
In fact, the writer of this thesis devoted a portion of the experimental 
work to follow to a partial test of this possibility. However, conjugates 
have, to some extent, been looked for with many of these excreted compounds. 
In some of the cases which will be mentioned, they seem to be excreted in 
part as conjugates. It seems unlikely, from the evidence at hand, that the 
reactions of excretion necessarily involve conjugation of this sort. 
Bilirubin is excreted by the liver as a di-glucuronide conjugate 
(227, 22, 187). The glucuronic acid is coupled to the propionic acid-
carboxyl groups of bilirubin, so that bilirubin glucuronide is an acyl 
glucuronide (ester glucuronide) (179). The carboxyl group of glucuronic 
acid itself is free as in other types of glucuronides. This conjugation 
takes place in the liver and involves, first, the formation of uridine-
diphosphate-glucuronic acid (UDPGA), followed by transfer of the glucuronic 
acid to an acceptor - in this case, bilirubin. This transferring enzyme, 
from the microsome fraction of liver, is apparently able to form phenolic 
glucuronides, alcoholic glucuronides, N-glucuronides or acyl-glucuronides, 
depending upon the aglycone presented (111, 7, 91). 
Several types of jaundice have been shown to be related to disorders 
in the conjugation or excretion systems of bilirubin (188). In Gilbert's 
disease (constitutional hyperbilirubinemia), a moderate jaundice is found. 
The increase in serum bilirubin is in the indirect-reacting fraction, al-
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though the disease seems not to be associated with a hemolytic process. 
The increased indirect-reacting bilirubin might be considered to be due to 
a reduced capacity to conjugate bilirubin; however, Schmid and Hammaker (190) 
were able to demonstrate no reduced capacity to form the glucuronide of 
N-acetyl-p-aminophenol. 
A similar, but more serious, congenital familial nonhemolytic jaundice 
has been described by Crigler and Najjar (51). In this syndrome the in-
direct serum bilirubin rises to high levels and is often associated with 
kernicterus. Most individuals with this disorder die in infancy. They 
demonstrate a normal liver histology; liver function tests, including BSP 
excretion, are normal. Clearance of administered bilirubin is markedly low. 
It is indicated that these patients cannot conjugate bilirubin with glue~ 
ronic acid. Glycine conjugation of other substances is normal. They can 
apparently excrete BSP and Cholografin {as indicated by normal visualization 
of the biliary tract in roentgenograms). There is also some indication of 
normal sulfate conjugation (188, p. 561). 
Schmid, Axelrod, Hammaker and Swarm (189) have studied an almost 
identical congenital syndrome in a strain of rats. These rats were shown 
to be incapable of conjugating bilirubin with glucuronic acid although normal 
amounts of UDPGA were present in their livers. Thus, the enzyme which was 
missing is shown to be the transferring enzyme. They also showed a marked-
ly low capacity to form other gluouronides - as with o-aminophenol, a-amino-
benzoic acid and menthol. Glycine conjugation of benzoic acid was normal. 
The rats showed a normal ability to excrete BSP and Cholografin. Paren-
terally administered bilirubin was not excreted, but bilirubin glucuronide 
itself was excreted, when given. These animals, therefore, were capable of 
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excreting bilirubin glucuronide, BSP and Cholografin, although they could 
not produce bilirubin glucuronide. This clearly shows that the conjugation 
and the excretion of bilirubin are separate processes, as was the case with 
the bile acids. The substrate for the excretion reaction is the glucuronide. 
This conclusion is supported by observations on a different type of 
familial nonhemolytic jaundice in which the elevated serum bilirubin is 
largely direct-reacting. These patients can apparently conjugate bilirubin 
but have a reduced capacity to excrete bilirubin glucuronide. Their capa-
city to excrete BSP and cholecystographic media is also reduced (186, 188). 
It thus appears that bilirubin conjugation and excretion are separable in 
the opposite sense to that observed in the Crigler-Najjar syndrome or in 
the rats. An indication that bilirubin glucuronide, BSP and cholecysto-
graphic media are excreted by the same mechanism is also shown by these ob-
servations. 
The excretion of BSP has been shown to be a complex process. As 
already discussed, this compound is taken up from blood much more rapidly 
than it is excreted in bile. This uptake by liver and other tissues is 
apparently due to protein binding. BSP also undergoes numerous metabolic 
transformations as well. Brauer, Pessotti and Krebs (33) administered s35_ 
labeled BSP to dogs and recovered it in bile. Higher concentrations of BSP 
in the bile were indicated by radioactivity measurement than by colorimetry. 
This would appear to indicate that the BSP is converted in part to colorless 
(or less colored) derivatives, presumably by blocking one of the phenolic 
groups. 
Krebs (117) and Grodsky, Carbone and Fanska (92) have found that, 
when chromatographically homogeneous BSP is administered, the biliary or 
urinary BSP is separable by chromatography into two to four separate components 
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distinct from BSP. In different animals the proportion of these various 
components varies, but the same metabolites seem to appear. In some animals, 
including man, rat and dog, unchanged BSP is only a minor component of the 
11biliary BSP11 • In the rat about 85 per cent of the BSP is converted to a 
different form; in man about 65 to 75 per cent is changed. Traces of these 
metabolites are also found in serum. The separation of these metabolites 
has been shown not to be dependent on protein association. They are pro-
duced in the liver as shown by perfusion through isolated cat liver. BSP 
added to bile, or incubated with bile, is not changed. 
The principal BSP metabolite in man is stable to hot acid or alkali 
(0.2 N) for one hour and is not hydrolyzed by! -glucuronidase. In 6 N HCl 
it hydrolyzes slowly at 120° giving a ninhydin positive substance as one of 
the products. 
Combes {47) has recently presented evidence that the principal BSP 
metabolite in the rat contains BSP, glutamic acid and glycine in equimolar 
amounts. 
By chromatographic separation and re-injection it has been shown which 
of these BSP metabolites are precursors of the others (117). The complete 
nature of these conjugates is, however, not yet elucidated. These compounds 
show the same color change with alkali and retain the same spectrophotometric 
characteristics as the parent compound. There is some loss in specific peak 
extinction coefficients. In the rat, this appears to account for the dis-
crepancy between radioactive and colorimetric measurements using s35_labeled 
BSP as observed by Brauer, Pessotti and Krebs (33) (see p. 63). 
Krebs (117) found that BSP itself was cleared from the blood of the 
rat faster than were any of its metabolites. This could be interpreted 
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either as a preferential excretion of BSP or as merely a more rapid uptake 
due to ~otein binding in tissues. That BSP is excreted preferentially is 
indicated, however, by an experiment of Brauer (JO). Ordinary BSP was in-
fused into a dog for two hours, the infusion stopped and the biliary ex-
cretion allowed to decay to a rather low level. At this point a small amount 
of s35_labeled BSP was injected. The unlabeled BSP in the bile continued 
to decrease without a break in the curve. The radioactive BSP, however, 
came out in the bile with a sharp concentration peak shortly after the in-
jection. This indicates that BSP itself is preferentially excreted relative 
to its conjugates, although the conjugates also seem to be excreted. It is 
therefore indicated that BSP conjugation and excretion are separate processes 
(as with bile acids and bilirubin). BSP conjugation apparently delays its 
excretion, and conjugation is not a necessary preliminary step to excretion, 
as it is with bile acids or bilirubin. 
The ~eferential excretion of 11fresh11 BSP seen by Brauer would not 
seem likely if the competition had been with the protein-bound BSP in the 
liver cell. A free association of this type would not have discriminated 
between new and old BSP. The competition would, therefore, appear to have 
been with conjugates which had accumulated because of their slower excretion. 
That these conjugates accumulate in this manner was shown by Krebs (117). 
After an injection of BSP, the fraction of conjugates in the blood plasma 
systematically increased with time, as the free BSP fell. 
Other compounds excreted by the liver are known to be excreted in 
part as conjugates. As far as is known, however, conjugation appears to 
have a minor role in the excretion of most of them. It is quite possible 
that conjugation reactions are involved considerably more than is realized 
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particularly with some of the phthaleins related to BSP. 
C. The acids excreted and their interactions 
Evidence that these compounds are all excreted by the same mechanism 
depends upon several factors. Chemical resemblance is often obvious. For 
example, it is easy to imagine that phenolphthalein and fluorescein are 
excreted by the same mechanism, since their chemical structures differ in 
only one detail - an oxygen bridge between the two phenolic rings. Many 
derivatives of these compounds are known to be excreted by the liver, for 
example, phenoltetrachlorphthalein, tetrabromphenolphthalein, tetraiodo-
phenolphthalein, phenoltetraiodophthalein, eosin, erythrosin, Rose Bengal, 
mercurochrome and BSP. The same mechanism that applies to phenolphthalein 
and fluorescein would be expected to apply to these compounds, although BSP 
has two sulfonic groups which are also potentially involved in the mechanism. 
Likewise the fact that the bile acids and bilirubin are excreted as conju-
gates of glycine, taurine or glucuronic acid makes other such conjugates 
suspect. 
Competition between compounds and between groups of compounds for ex-
cretion also reveals the identity of the underlying basic mechanisms. This 
evidence must be interpreted cautiously, however. For example, a compound 
which is highly protein-bound may be taken up in tissues so that its blood 
level drops rapidly. Injection of another substance, which also binds with 
protein, may compete with the first compound for protein-bound storage and 
induce an apparent delayed clearance of the first compound from blood by 
causing the first compound to be re-released into blood. This appears to 
play a part in some cases, and, for this reason, competition is less equi-
vocally shown if measurements are made of actual biliary output rather than 
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of disappearance from blood. 
Competition may also occur at the conjugation level. An alternate 
aglycone could compete with bilirubin for conjugation with glucuronic acid 
and thereby interfere with bilirubin excretion. The resulting conjugate, 
however, might very well also compete with bilirubin glucuronide for excretion. 
Substances which are excreted well are not necessarily good competi-
tors of excretion. This was well demonstrated with the series of sulfo~ 
phthaleins studied with renal tubules (pp. IS-1, ). Although the excretion 
of one compound may be markedly inhibited by another, the reverse may be 
difficult to demonstrate. 
The conjugation and excretion of bile acids has already been discussed 
{pp. 5 9-"); their interactions with other excreted substances will be con-
sidered here. Dehydrocholic acid (Decholin), which is a synthetic compound 
produced by oxidation of cholic acid, may also be considered to be a member 
of this group. !t is apparently not known if this substance is excreted as 
a glycine or a taurine conjugate, as are the other bile acids, but it appears 
probable. The natural bile acids or their conjugates are apparently not 
good excretory competitors. Cantarow and Wirts (39) noted no elevation of 
plasma bilirubin or delay in BSP excretion in bile when desoxycholate or 
whole dog bile (which would contain taurocholate among other things) were 
given to a dog. A marked choleresis was produced by the whole bile. Dehydro-
cholate (Decholin) is, however, a better competitor. These workers found 
that it produced a marked choleresis, increased serum bilirubin, delayed 
BSP removal from blood and reduced BSP excretion in bile. Mendeloff, Kramer, 
Ingelfinger and Bradley (146) found a markedly decreased rate of clearance 
of BSP from blood after dehydrocholate administration to man. Using large 
doses of cholate, Hanzon (96, pp. 126-55) found that this bile acid reduced 
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fluorescein excretion in bile and delayed its passage through the liver 
polygonal cell. The delay in the passage of fluorescein through the cell 
was evinced by less cholate and was related to dose of cholate. Cholate 
was likewise shown to lower the excretion of administered bilirubin as 
well as of endogenous bilirubin. The bilirubin measurements were made on 
bile and therefore represent bilirubin glucuronide. Fluorescein and bili-
rubin were similarly shown to depress the excretion of each other. 
Besides the glycine conjugates of bile acids, other glycine conjugates 
may be excreted in bile. Hippurate is excreted in part in bile (207, p. 100), 
as is PAR (see table on p. 48). 
As mentioned previously (j,p S~ the dog, which ordinarily excretes 
taurine-conjugated bile acids can excrete glycocholic acid. This is some 
indication that these sulfonic and carboxylic acids may be excreted by the 
same mechanism. 
Bilirubin is excreted as a glucuronide conjugate by the liver. Hanzon 
(96, pp. 126-55), as already mentioned, has shown that cholate depresses 
bilirubin excretion and that fluorescein and bilirubin mutually inhibit each 
other. 
In the type of familial nonhemolytic jaundice showing an increase in 
direct-reacting bilirubin in blood (discussed on p. '3 ), a reduced capacity 
to excrete bilirubin glucuronide is indicated. These patients, as noted, 
also demonstrate a reduced capacity to excrete BSP and cholecystographic media. 
Other glucuronic acid conjugates, such as menthol-, cresol- and 
camphor-glucuronides (207, p. 100) may appear in bile. 
In 1909, Abel and Rowntree (1) began an extensive investigation of 
phthalein derivatives and their pharmacological actions. They were looking 
for a 11 serviceable hypodermic purgative11 and, of many substances tested, 
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phenoltetrachlorphthalein best served the desired function. The excretion 
in bile and urine of this compound and of phenolphthalein was extensively 
studied in dogs. Given subcutaneously, these substances were excreted pri-
marily in bile; a small fraction of phenolphthalein appeared in urine. 
Of that excreted in bile, a portion is reabsorbed from the colon, establish-
ing an entero-hepatic circulation. That excreted in bile is partly in a 
conjugated form; free phenolphthalein appears first. More recent work (69, 
228) has indicated that the conjugate of phenolphthalein which occurs in 
urine of rabbits or guinea pigs is the monoglucuronide (phenolic). 
Abel and Rowntree (1) also investigated phenolsulfonphthalein. This 
substance was found to be excreted freely in bile as well as in urine. The 
biliary fraction is, however, reabsorbed and recirculated. Eventually this 
dye ends up almost wholly in urine, only traces occurring in feces. These 
studies led to the introduction of the PSP test for kidney function by 
Rowntree and Geraghty in 1910 (17~. 
The excretion of phenol-tetrachlorphthalein later came into use as a 
liver function test, and Rosenthal (171) introduced the method of determining 
liver excretion of this compound by its disappearance from blood. 
Rosenthal and White (173) in 1925 studied several groups of phthalein 
compounds for the purpose of finding compounds more suitable for liver func-
tion tests. A number of these compounds have come into use for various 
purposes. 
Group 1 - H ~gen on phthalic ring. Phenol-tetrachlorphthalein, 
phenol-tetraiodophthalein, phenol-tetrabromphthalein, orthocresol-
tetrachlorphthalein and di-bromcresol-tetrachlorphthalein ••••• 
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These compounds disappear from blood more rapidly than excreted. 
Taken up by liver and other tissues, though eventually excreted 
by liver. 
Group 2 - Sulfonated phthaleins. Bromsulfalein (BSP), chlorsulfalein, 
iodosulfalein, o-cresol-tetrachlorphthalein sulfonate ••••• Taken 
up primarily by liver and excreted. Not taken up to a large extent 
in animals with extirpated livers. 
Group 3 - Halogen on phenolic rings. Tetrabromphenolphthalein, 
tetraiodophenolphthalein..... These compounds are not very highly 
colored and readily decompose in alkali. (They are, however, 
excreted by liver and were the first successful cholecystographic 
agents). 
Group 4 - Fluorescein derivatives. Tetrachlorfluorescein, tetra-
iodotetrachlorfluorescein (Rose Bengal), hydroxymercurifluorescein 
and dibrom-oxymercurifluorescein (mercurochrome) ••••• Act as stains 
and extensively taken up by tissues. They noted that mercurochrome 
is concentrated 500 to 1000 times in bile and suggested that it 
showed some promise as a biliary antiseptic, particularly in the 
treatment of typhoid carriers. 
It can be seen that · excretion by the liver is characteristic of 
phenolphthalein or fluorescein derivatives of many different types. Rosen-
thal and White (172) introduced the BSP test in 1925. Hill and Scott (104), 
in the same year, proposed the use of mercurochrome as a biliary antiseptic; 
it is no longer so used because of its toxicity. 
In 1924, Graham and Cole (86) introduced tetrabromphenolphthalein 
for intravenous cholecystography. This compound "visualized" the gall bladder 
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in man and dog. The tetraiodophenolphthalein then available was apparently 
more toxic. Tetraiodophenolphthalein (Iodeikon), however, was soon intro-
duced for this purpose by Graham, Cole and Copher (87). This compound was 
suitable for either oral or intravenous administration. Its isomer, phenol-
tetraiodophthalein (Iso-iodeikon) was introduced later by Graham (85), for 
intravenous cholecystography and simultaneous liver function testing (the 
more intense color of this compound makes it suitable for quantitation in 
plasma). Despite shortcomings, these two compounds (tetraiodophenolphthalein 
and phenol-tetraiodophthalein) were the best available cholecystographic 
agents for about twenty years, and they established cholecystography as a 
practical procedure. Other iodine or bromine containing phthaleins, such 
as eosin, erythrosin or Rose Bengal, will produce cholecystograms but are 
not practical for this use (88, 94). 
Of compounds used for liver function tests, BSP and phenol• 
tetraiodophenolphthalein have already been discussed. Rose Bengal was also 
proposed for this purpose in 1924 by Delprat and co-workers (59, 60, 61). 
Rose Bengal is a generic name for several related dyes. Tetraiodo-tetrabrom-
and diiodo-tetrachlor-fluorescein were the Rose Bengals used in these studies. 
Tetraiodo-tetrachlor-fluorescein was later selected as the most suitable 
because of lesser elimination in urine (217). Brakefield and Schmidt (26) 
noted that fluorescein derivatives with four halogens, such as eosin or 
erythrosin, are eliminated in both bile and urine, whereas those with six 
or more halogens, such as Rose Bengal, are exclusively 11 cholotropic". 
There is a small amount of evidence that the urinary excretion of 
some of these phthaleins is a tubular function, as is the urinary excretion 
of the sulfonphthaleins. Blondheim (23) has shown that patients with im-
paired liver function may excrete in urine as much as 10 to 25 per cent of 
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an injected dose of ESP. Both urinary and hepatic excretion of this dye 
was reduced by Benemid. These observations indicate that BSP is excreted 
by the liver and kidney by similar mechanisms and that the renal tubules 
are involved in its urinary excretion. As a group, the phthaleins are 
strongly bound by plasma proteins, and glomerular filtration would there-
fore be slight. The occurrence of significant fractions of some of these 
dyes in urine, therefore, probably indicates tubular excretion. The speci-
ficities of these two organs for various excreted compounds show many 
differences, however. 
Another dye, azorubin s, was introduced for liver function testing 
by Tada and Nakashima in 1924 (218). This is a sulfonated azo dye, not a 
phthalein. It is mostly eliminated in bile, only small amounts occurring 
in urine. It was selected from a number of related compounds, many of which 
were excreted to a greater extent in urine. Although apparently well suited, 
azorubin s does not seem to have been used widely. 
131 Rose .Bengal labeled with I has recently come into use as a liver 
function testing agent. Using a collimated scintillation counter, the dis-
appearance from blood, accumulation in liver or excretion in bile of this 
dye may be continuously followed. These methods have been developed by 
Taplin and co-workers (229, 230, 231) and by others (144, 153). Radio-
active Diodrast has been similarly used in studies of kidney function. 
Diodrast, however, gives poor localization of the kidneys because a con-
siderable portion is excreted by the liver. Other labeled urographic agents, 
particularly Miokon and Hypaque, are more organ specific and allow better 
kidney localization (231, 245). 
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Mendeloff, Kramer, Ingelfinger and Bradley (146) found in man that 
BSP excretion was markedly reduced by dehydrocholate. However, BSP clear-
ance was not depressed by bilirubin, Rose Bengal or fluorescein. Rose Bengal 
removal, however, was depressed by BSP. Cohen, Giansiracusa and Althausen 
(45) also noted a marked inhibitory effect upon Rose Bengal excretion by BSP. 
Rose Bengal was shown to have a minor, but statistically significant, inhi-
bitory effect upon BSP extraction. In the radioactive Rose Bengal test for 
liver function, BSP has been shown to inhibit Rose Bengal removal. The 
sensitivity of the test in discriminating between normal and impaired liver 
function is increased by simultaneous injection of unlabeled BSP to "stress" 
the liver (230, 144, 231). In rabbits large amounts of pure bilirubin did 
not influence Rose Bengal-Il3l dynamics. 
It was previously noted (pp.~7-l) that Hanzon was able to show an 
inhibitory effect of cholate upon bilirubin or fluorescein excretion. Mutual 
inhibition between bilirubin and fluorescein was also observed. 
It was found by Cohen, Althausen, U,yeyama and Treager (44) that BSP 
excretion and galactose tolerance tests may be done simultaneously without 
mutual interference. They concluded that the excretory function of the liver 
is apparently functionally independent of the role of the liver in carbo-
hydrate metabolism, since dye excretion is unaffected by overload of the 
galactose metabolizing mechanism. 
The newer cholecystographic media have replaced the phthaleins for-
merly used. The newer compounds give better cholecystograms and are less 
toxic. Priodax (a substituted phenyl propionic acid) was introduced in 
about 1943. Priodax represented a considerable gain in efficiency since 
it gave better opacification (although it contained only 2 iodine atoms) 
than the tetraiodinated phthaleins previously used . Many series of compounds 
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related to Priodax were synthesized and tested. This led to the introduc-
tion of Telepaque, Teridax, Orabilex and other compounds which contain three 
iodine atoms. These compounds are all administered orally. Interesting 
accounts of the development of some of these compounds are given in the 
following references (234, 5, 76). About 50 per cent of Priodax administered 
appears in the urine, and 70 per cent of Orabilex does so. A new intravenous 
cholecystographic agent, Cholografin, has also been introduced. Chemically, 
it is a substituted benzoic acid, resembling the new urographic agents more 
than it resembles the other cholecystographic agents. Cholografin is, in 
fact, two Urokon molecules joined by a two carbon bridge. This is a strong 
indication of the similarity of mechanism between the hepatic and renal 
tubular excretion mechanisms. 
There does not seem to be much evidence available that these newer 
cholecystographic agents compete with the other compounds excreted by the 
liver. However, it seems quite reasonable to suspect that they are excreted 
by the same mechanism. They are all carboxylic acids. They are freely ex-
creted by the liver in high concentration, as evidenced by the fact that 
they are cholecystographic agents. It has already been mentioned (p.,~ ) 
that patients with one type of familial nonhemolytic jaundice appear to be 
capable of forming bilirubin glucuronide but cannot excrete it. These 
patients also show an impaired ability to excrete BSP and cholecystographic 
agents. 
Benemid has been shown to have an effect upon hepatic BSP excretion 
similar to its effect upon PAH excretion in the kidney. Blondheim (23), 
noting the similarity of the two processes, tested this known inhibitor of 
renal tubular excretion for its effect upon both hepatic and renal excretion 
of BSP. Retention of BSP was increased to a marked degree by Benemid both 
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in normal individuals and in a group of patients with abnormal retentions. 
The effect was shown to be due to blockage of hepatic excretion. The normal 
individuals did not pass in urine more than 2 per cent of an injected dose. 
In the patients with abnormal retentions, however, as much as 10-25 per cent 
of an injected dose appeared in urine, so that an effect of Benemid upon 
renal excretion of BSP could be tested in these individuals. It was found 
that Benemid markedly reduced renal excretion also. These data indicate, 
therefore, that BSP is excreted by the renal tubules, as well as by the 
liver, and that both processes are blocked by Benemid. Stone (216) con-
firmed the effect of Benemid on BSP excretion in the dog. Benemid slowed 
the clearance of the dye from blood and its rate of excretion in bile. 
Benemid was also noted to have a hydrocholeretic effect. 
Penicillin is also excreted in bile at a moderate concentration, as 
shown in the table on p. 48. 
Indigo carmine, a sulfonated indigo, is excreted by both the kidney 
and liver. Since it is readily excreted by the toadfish, an aglomerular 
fish, its renal excretion may be presumed to be tubular (141). It is also 
excreted by the liver and clearly outlines the bile passages (107, p. 606). 
As hy the kidney, certain organic bases are excreted by the liver. 
The mechanism may be related to the corresponding mechanism in the kidney. 
The quaternary ammonium compounds, Oxyphenonium (Antrenyl) and Benzomethamine, 
for example, seem to be excreted in bile freely as shown by Levine and Clark 
(120, 121). These substances are anticholinergics. Clearance measurements 
with Oxyphenonium indicate that it is also excreted to some extent by the 
renal tubules. 
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A CHEMICAL CLASSIFICATION OF THE COMPOUNDS EXCRETED 
BY THE KIDNEY OR THE LIVER 
The structural formulas or many of the compounds excreted by the 
systems considered in this study are given in this section. Other compounds, 
such as Carinamide or Benemid, which are related to the excreted compounds, 
are included in the classification. The list is not intended to be exhaus-
tive; certain groups of compounds will be represented by type examples. 
The excreted substances are classified into groups primarily on the basis 
or their chemical structures. The remarkable diversity of these substances 
may be seen by intercomparison of groups. With a few exceptions of somewhat 
questionable status, these compounds, however, contain sulfonyl, sulfate 
or carboxyl groups. 
The compounds excreted by the renal tubular and hepatic systems are 
classified together to emphasize the fact that, in spite of considerable 
chemical differences between groups, the same chemical classification applies 
with equal validity to the substances excreted by either organ. Most groups 
may be seen to contain compounds excreted by the liver and compounds excreted 
by the kidney. Many of the compounds are excreted to some extent by both 
organs. This classification has not been placed at an earlier point in 
this thesis, since some of these interrelationships may be more fully appre-
ciated after discussions of the nature of the individual systems. 
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A. Glycine conjugates 
0 
o- '' J.l C- N- C -C OOH H H 
Hippuric acid 
0 ~ t-C'- fJ-CHJ.-Cooll 
"==.T"H H 
Phenaceturic acid 
0 
NaN~~- N- c Hz.-CooH 
-'-=./ H 
p-aminohippuric acid (PAH) 
Cinnamoylglycine 
Hippuran is o-iodohippuric. An early urographic agent. 
Para-acetylamino-hippurate has a CH3-co-NH- group replacing 
the NH2- group of PAH 
These substances and several related aminohippurates and hydroxy-
hippurates are excreted by the kidney tubules, and some (e.g., hippurate, 
PAH) are excreted partly by the liver (p. 6t ). Taggart has shown that 
fatty acyl-glycine conjugates are accumulated in kidney slices (pp.37-g). 
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Glycocholic acid 
Cholic acid, and related bile acids, are excreted in bile conjugated 
with either glycine or taurine. In man, both glycine and taurine conjugates 
occur, but certain species conjugate bile acids almost wholly with one or 
the other of these compounds. 
B. Other compounds with the N-C-COOH configuration 
Benzyl penicillin (Penicillin G) - Excreted primarily by 
kidney but to some extent by liver. 
Iopax 
{Uroselectan) 
2-pyridone-
N-acetic acid 
c.llz. - C OOH 
I 
(,N) 
rVr 
II 
0 
Diodrast 
( Iodopyracet) 
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These iodinated compounds were early urographic agents. The nucleus 
of Iopax (2-pyridone-N-acetic acid) has the same high clearance as the other 
compounds (p. 11, p. 1& ). Diodrast is excreted to some extent by the liver 
(p. 72 ). The iodopyridines (Diodrast and Neo-iopax) were originally used 
in the treatment of gall bladder infections. They were tested for their 
ability to opacify the gall bladder, but it was found that they outlined 
the urinary tract instead. These compounds, with Iopax, were the principal 
ones used in urography for about twenty years (109). 
Note that the position of the carboxyl on Neo-iopax is different 
from the others. 0 o-lf e-N- Ct/J.. II I 
Cl/z 
I 
CHz. 01~ I c.-11- C-COO H H H 
Ornithuric acid 
Birds conjugate with ornithine rather than with glycine. Either 
ornithuric acid or hippuric acid is excreted by the tubules of the chicken 
(p. I If- ). Many reptiles also conjugate benzoate or p-oaminobenzoate with 
ornithine (205). 
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C. Glucuronic acid conjugates 
rr: ;7 
R·o-c -e-c-c-e -cooN 
H H 0 H II 
H 
A 11 phenolic11 glucuronide 
rf oTJ 0 #( ,, u 9 
R-c-o-c-c-c-c·c-coo H 
1/H~HH 
An "acyl" glucuronide 
Sperber has shown that the glucuronides of menthol, phenol and 
resorcinol are excreted by the tubules of the chicken (p. /~ ). Certain acyl 
glucuronides probably also are excreted by the renal tubules. Anisic acid 
(o-methoxybenzoic acid), for example, is converted to the acyl glucuronide 
and to the glycine conjugate and rapidly excreted in urine (100, p. 144). 
Bilirubin glucuronide is freely excreted in bile. This compound is 
a di-glucuronide, conjugated (as an acyl glucuronide) at the two propionic 
acid groups of bilirubin (p. ' ' ). Phenolic glucuronides also appear in 
bile (p. 6f). 
D. Sulfate and taurine conjugates 
0 
" ~o-s .. oH  I( 
0 
Phenyl sulfate 
Sperber noted the tubular excretion of the sulfat of phenol, resor-
cinol (m-di-OH-benzene) and hydroquinone (p-di-OH-benzene) and of the di-
sulfates of resorcinol and hydroquinine in the chicken. The tubular excre-
tion of phenyl sulfate in the cat and dog is open to question (p. /S ). 
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Sulfate and glucuronide conjugates of steroids occur in urine and presum-
ably in bile. Indoxyl sulfate is a normal constituent of urine. 
Ho··· 
Taurocholic acid Scymnol sulfate 
Taurine conjugates of bile acids are usual in most vertebrate spe-
cies, but some mammals, particularly vegetarian species, conjugate the 
bile acids partly with glycine. In elasmobranchs, however, the sulfate 
ester of the bile alcohol, scymnol, is a characteristic major component of 
bile. Scymnol has the nuclear configuration of cholic acid, but the side 
chain is of the cholesterol type. One of the terminal methyl groups of 
the side chain is oxidized to the alcohol, but another oxygen in the side 
chain probably forms a ring attached to carbon #24 (50, 78). Hammarsten 
(95) first isolated scymnol sulfate from shark bile. Haslewood {98, 99) 
has shown similar bile alcohol sulfat to be the principal 11bile salts" of 
certain frogs (ranol sulfate) and the carp (cyprinol sulfate). 
These substances provide a preliminary indication that certain sul-
fonates or sulfate esters are excreted by the liver. Both the renal and 
hepatic systems, therefore, exhibit broad specificities, including certain 
sulfate derivatives as well as carboxylic acids. Other sultanates excreted 
by the liver or kidney will be classified later. 
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E. Other conjugates 
Little is known concerning whether other types of conjugates are 
actually excreted by the kidney tubules or the liver, although mercapturic 
acids, etc. occur in urine. 
F. Phthaleins 
Phenolphthalein Fluorescein 
(di Na salt is called Dranine) 
Phenolphthalein derivatives: 
Phenol-tetrahalogen.phthalei~ Four halogens on ring #3 of 
phenolphthalein. 
Tetrahalogen-phenolphthalein: Two halogens on each phenolic 
ring (1 and 2) of phenolphthalein; ortho to phenolic 
groups of phenolphthalein. 
Bromsulfalein (BSP): Four bromines on unoccupied positions 
of ring #3 of phenolphthalein. A sulfonic acid group 
on ring #1 and on ring #2; ortho to phenolic groups. 
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Fluorescein derivatives: 
Rose Bengal (tetraiodotetrachlor~fluorescein): Four chlorines 
on ring #3. Four iodines (ortho to phenolic groups) 
on rings 1 and 2 of fluorescein. 
Mercurochrome 220: Two bromines in 11 outside" ortho position 
of rings 1 and 2; an-Hg OH group in one of the inside 
ortho positions. 
Eosin (tetrabromofluorescein) and Erythrosin (tetraiodo-
fluorescein): Four halogens ortho to the phenolic 
groups on rings 1 and 2. 
There is some question whether the acid form of the phthaleins (and 
presumably the sulfonphthaleins) has a free carboxyl (or sulfonyl) or whether 
it has a lactone structure. The acid form of phenolphthalein, as the dried 
solid, has the carboxyl group involved in a lactone ring as indicated by 
its infra-red spectrum (57). Others have ascribed a lactone structure to 
the acid form in solution (36). 
The various salts must all have free carboxyl groups. Some possible 
structures for the acid are: 
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As a lactone, phenolphthalein is a cyclic ester in which the alcohol 
has a triphenyl-methyl structure. It is different from many other lactones 
in the extreme rapidity with which the lactone ring may be opened. This is 
evidenced by the rapidity with which it becomes colored upon the addition 
of alkali; the colored salts have quinoid structures which necessitate 
opening of the lactone ring. 
If it is to be assumed that these substances are excreted by a 
mechanism involving free carboxyl or sulfonyl groups, it would be comforting 
to know that these phthaleins have a free carboxyl. Although there is some 
indication that they do not have a free carboxyl when in the acid form, it 
is obvious that they can readily and reversibly acquire one. It may not be 
necessary to assume that the carboxyl of a phthalein must be free in order 
to participate directly in a reaction wherein a high energy intermediate, 
such as an acyl adenylate, is formed. These compounds do have a rather 
atypical behavior as lactones. 
The phthaleins are excreted principally by the liver, but some such 
as BSP occur in urine to some extent. 
G. Sulfonates 
Sulfonphthaleins: 
Phenolsulfonphthalein, PSP, Phenol red 
Bromcresol purple (dibrom-o-cresol-sulfonphthalein): This 
compound has a bromine and a methyl on each of the 
two phenolic rings (all in ortho positions) . 
Bromcresol green (J- Jl- 5-5 t-tetrabrom-m-cresol sulfonphthalein): 
Two bromines on each phenolic ring (all ortho) . One 
methyl on each phenolic ring (meta) . 
PSP is excreted primarily by the kidneys, but is also freely excreted 
in bile. Bromcresol green and bromcresol purple are excreted to only a slight 
extent by the kidney but both are powerful inhibitors of PSP transport. 
Other sulfonates: 
Azorubin s 
Another dye eliminated freely in bile is azorubin s. This compound 
has been used for liver function testing. It is an azo dye containing two 
sulfonyl groups. 
/>-H~ Ho!s~c~c-c" -f) 
l:J-...t/ 'c~ SOJH 
\H II +D 
Indigo carmine 
(Indigotin- 5-5' disulfonic acid) 
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Indigo carmine, a sulfonated indigo, is excreted by the kidney and 
liver . Since it is readily excreted by the toadfish, an aglomerular fish, 
its renal excretion may be presumed to be tubular (141). It is also excreted 
by the liver and clearly outlines the bile passages (107, p. 606) . 
Some of the sulfonates have been classified with other groups . The 
taurine conjugates are sulfonates but have been classified with the sulfate 
and taurine conjugates . The urographic agent, Skiodan, is classified under 
the urographic agents. BSP, classified with the phthaleins, is a sulfonated 
phthalein (not a sulfonphthalein) . 
H. orographic agents 
Urokon Renografin 
Hypaque 
Miokon 
These recently introduced urographic agents are triiodinated deriva-
tives of benzoic acid . Chemically, they resemble one of the cholecystographic 
agents, Cholografin. These urographic agents are administered intravenously 
and are eliminated almost entirely by the kidneys . They are excreted by the 
renal tubules and have high clearances (115) . The amide side chains confer 
a lower toxicity on the compounds . 
I - CH2 - so3 Na 
Skiodan 
(Sodium iodomethane sulfonate) 
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Skiodan is an unusual urographic agent with a sulfonate group. 
Several other urographic agents have been classified elsewhere: 
Hippuran with the glycine conjugates; the pyridone derivatives, Iopax, 
Diodrast and Neo-iopax, with11 other compounds with the N-C-COOH configuration". 
I. Cholecystographic agents 
Priodax 
(Iodoalphionic acid) 
I H I~c=~-cool-l 
~ Ca./1&" 
Nil 
I 
C -c /Ia -CH~- Cl/1 ,, 
0 
Ora bilex 
Telepaque 
Teridax 
These recently introduced cholecystographic agents are phenyl-
propionic acid derivatives or closely related compounds. These compounds 
are administered orally and are excreted freely by the liver. Some of them 
are excreted to a considerable extent by the kidney as well. About 70 per 
cent of Orabilex, for example, is excreted in urine. Many compounds have 
been studied, which represent different types of variations on these basic 
structures. Some of this work is discussed by Archer (5) and by Epstein, 
Natelson and Kramer (76). 
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Cholografin 
The nev cholecystographic agent, Cholografin, is quite different 
from the phenyl-propionic acid derivatives. Chemically, it resembles certain 
of the urographic agents. It is, in fact, tvo Urokon molecules joined by a 
two-carbon bridge. Cholografin is administered intravenously, as are the 
urographic agents to vhich it is related. 
The iodinated phthaleins, vhich vere formerly the principal chole-
cystographic agents used, have been classified under the phthaleins. 
J. Benemid and Carinamide 
o H 
0 ,, AI ~COON CIIJ-S-n~ ,, 0 
Benemid Carinamide 
These compounds block transport in the kidney, and Benemid has been 
shown to inhibit BSP excretion by both kidney and liver. 
K. Miscellaneous 
0 0 ,, 
~ ''-fi-CHl-c-N-OH llz.N'-ff c H H 
PAH-hydroxamic acid 
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PAH-hydroxamate was asserted to have a high renal clearance, but 
re-investigation indicated that it is not excreted by the tubules. It has 
no carboxyl group. 
Other compounds without carboxyl or sulfonyl groups have been asserted 
to be excreted by these mechanisms. These substances were discussed on 
pp. 2,.o·Z.I. The structural formula of one of these compounds, chloro-
thiazide, is given on p. 2. o. 
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THE INTIIAL EX1'ERJMENTAL APPROACH TO THE f®aL 
TUBULAR EXCRETION STUDIES 
A. Background and rationale 
The experimental work which is to be described had as its primary 
purpose the elucidation of the enzymic reactions responsible for the active 
excretion of these carboxylic acids and sulfate derivatives. The first 
part of the work dealt with the renal tubular system; the very similar 
hepatic system was studied in later work. The rationale of the experimental 
approach made to this problem was based primarily on the following assumptions: 
1). that the process of excretion is active, supported by energy 
derived from metabolism of the cells of the proximal renal tubule. 
2). that the excretion of these substances involves enz.ymatic reac-
tions within the cell. These reactions specifically involve 
the carboxylic or sulfonyl groups of the excreted substances. 
3). that, despite the obvious differences between the excreted sub-
stances, the various compounds excreted by the kidney enter into 
essentially identical reactions in the process of transport. The 
intimate manner in which these substances compete with each other 
for excretion indicates that they are competing for the same en-
z.yme, not for total energy supply or for ATP {in the sense that 
these limit the excretion rate). The excretion system seems to 
be essentially the same in different animals. 
4). that one of the reactions involved in the excretion is an acid 
activation. This implies that, if this is the step at which the 
various substances compete (which has seemed likely) and that 
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they are competing for the same enz,yme, the activating enz,yme 
must be capable of activating certain carboxylic acids and 
certain sulfonic acids or sulfat . This indicates a remark-
ably broad specificity for this enz,yme. This activation may 
well be complex, that is, involve more than one individual 
reaction. 
The high concentration gradients attainable by the excretion 
system indicate that the compounds excreted form intracellular 
intermediates of high group potential . There is much to indi-
cate that the process is supported by oxidative phosphorylation, 
and that the excreted compounds might therefore enter into reac-
tion with ATP. The compounds belonging to this group, in the 
cases where the evidence is clear, are all acids. The most ob-
vious reconciliation of these various factors is an acid activa-
acti vationJ 
tion. If we look at the activation of acetate as a typical acidA 
it may be seen that such a process is supported by oxidative 
phosphorylation, and the first step in the activation (formation 
of adenyl acetate) involves a direct reaction with ATP. 
The experimental work of this thesis has dealt for the most part with 
this activation step of the excretion process, which may be considered to fix 
a derivative of the excreted substance within the cell. It must be kept in 
mind that, although this must be a key step in the excretion, the overall 
process requires other steps. If the activation concepts discussed are to 
form the basis of the experimental approach made, it would be desirable to 
attempt to fit this aspect of the process into the whole. 
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It is indicated (pp. ~0-3) that the transported substances first enter 
the cell by free diffusion of the non-protein bound fraction. This diffusion 
brings the substance through the capillary wall, into the interstitial fluid 
surrounding the tubule cells and thence into the cell. The processes which 
follow, by removing the transported substances into urine or bile, maintain 
a gradient to support this diffusion. 
Somewhere within the cell it will be considered that the substance 
enters into an acid activation reaction. This activated form of the transported 
substance would be the natural intracellular intermediate of the process. 
Various types of activated acids, such as coenzyme A thioesters or adenyl 
derivatives like active sulfate (PAPS), are generally nucleotides. Whatever 
the reasons, nucleotides are intracellular substances and remain fixed within 
cells. This is another property of this type of intermediate which seems to 
fit the nature of the excretion process. 
All of the excreted substance which is present within the cell is not 
necessarily in this activated form. As discussed in the case of BSP accumula-
tion in liver tissue slices (pp. ~Z-3), Brauer and Pessotti (32) observed 
uptake by the slices to give inside/outside concentration ratios of the order 
of 20 to 30 times. Their observations indicated that this intracellular BSP 
was taken up passively and was not chemically changed, but merely bound by 
the protein of the cell. On the other hand, studies of isolated renal tubules 
of fish which were suspended in media containing phenol red, have indicated 
that under normal conditions very little intracellular accumulation of this 
dye occurred. The dye was concentrated to high levels within the lumina of 
the tubules (81). Puck, Wasserman and Fishman (160), however, found that 
when these tubules were suspended in an unusual medium (high potassium, no 
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calcium), phenol red accumulated within the tubule cells to levels perhaps 
2000 times that of the external medium (pp. 34)-/ ). This intracellular 
uptake was blocked by oxygen deprivation and was inhibited by PAH or Diodrast 
so that it obviously was dependent on metabolic processes within the cells. 
This accumulation is quite different from that observed with BSP in liver 
slices. Phenol red is bound by protein to a considerable extent, although 
less so that BSP. The high intracellular concentrations of phenol red ob-
served by Puck et al. were probably in part due to protein binding, but 
this is not the predominant factor. 
It was implied (p. %7 ) that this step, by which a derivative of the 
excreted compound is 11 fixed 11 within the cell, is the principal step at which 
competition between excreted substances occurs. This is indicated by the 
observation made by these workers that this intracellular uptake of phenol 
red was inhibited by PAH or Diodrast. The very high intracellular levels 
that these workers observed (2000 times external) is difficult to explain. 
As mentioned on p. "$/J Lipmann (169, 127) noted that the equilibrium con-
stants for the overall synthesis for activated acids is frequently close to 
one. For example, the synthesis of active sulfate (PAPS) from sulfate and 
ATP, according to the following overall formula, occurs with only a small 
change in free energy. 
2 ATP -/- sulfate --~) PAPS -/- 2 P -/- ADP -/- H_,l. 
P is inorganic phosphate 
The first step of this reaction, although very endothermic, is balanced by 
exothermic steps which follow. The formation of coenz.yme A thioesters of 
certain acids is analogous in this respect. The equilibrium ratios between 
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an acid and its activated form can be seen to be influenced by many factors 
within the cell, for example, relative levels of ATP, ADP and phosphate. 
Efficient removal of pyrophosphate by the action of pyrophosphatase also has 
a large effect. If we consider that the intracellular phenol red observed 
by Puck et al . to be principally an ac t ivated phenol red and to be more or 
less analogous to the active sulfate discussed above, intracellular/ extra-
cellular gradients as high as 2000 times are difficult to conceive, though 
all the factors influencing the equilibrium are favorable. Because of rela-
tive ignorance about the intracellular levels and ratios of these factors, 
further speculation about them woUld do little to solve the problem. How-
ever, in the normal excretion process, intracellular accumulation does not 
occur to a very great extent in these isolated tubules {81, 82, 160). 
The final step in the excretion process is the deposit of the free 
transported substance into the tubular lumen. In the normal excretion pro-
cess the high concentration gradient is established at the luminal border of 
the cell (brush border). It is for the accomplishment of this step that an 
activated acid would seem to be especially well suited to bring about a 
gradient of high magnitude. An activated acid has been thermodynamically 
exalted by the expenditure of ATP . Its hydrolysis, to give the free acid 
as one of the products, will yield a large amount of energy, which if 
properly coupled is capable of establishing a high gradient. 
Since at this point we have no information about what type of activa-
ted acid is involved, there are several possibilities for what the reaction 
products would be. For example, a thioester of coenzyme A would yield co-
enzyme A and the free acid; an activated acid of the type of PAPS {adenosine-
3 '-phosphate-5 '-phosphosulfate) would yield PAP (adenosine-3'-phosphate-5'-
phosphate) and the free acid; an acyl adenylate (probably less likely than 
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the others) would yield adenylic acid (AMP) and the free acid. In any of 
these cases one of the hydrolysis products is a nucleotide, which would be 
expected to remain within the cell and recycle in the process or be avail-
able for other processes. A split of the activated acid by phosphate, a 
sulfhydryl compound, etc . , might be considered as alternate possibilities 
to a split by water {hydrolysis) . In these instances, however, either the 
free acid is not one of the products (it is the free acid which appears in 
urine), or the reaction would involve not only the degradation of one high 
energy bond but the synthesis of another . Less energy would then be made 
available by the reaction. A simple hydrolysis, therefore, seems most 
probable . 
Since the excretion process has a physical orientation such that the 
excreted substances are taken in at the pericapillary border of the cell and 
actively transpoted into the lumen of the tubule, it is necessary to assume 
that one or the transport reactions must be so oriented. The occurrence of 
the concentration gradient at the luminal border indicates that the step by 
which the transported substances are excluded from the cell and placed into 
urine is the oriented step. It is not readily visualized how such an orien-
ted process could occur unless it took place at the border of the cell itself. 
The enzyme which hydrolyses these postulated activated intermediates would 
seem to be necessarily a part of, or closely associated with, the cell wall 
of the luminal border . In its action, it must split the activated acid so 
that the nucleotide component remains within the cell and the free trans-
ported acid is expelled from the cell . The efficiency of the excretion 
process is directly dependent upon the ability or the luminal border or the 
cell to accomplish this scission without orientation error. 
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It also appears that phenol red, for example, may only penetrate the 
luminal border by this mechanism and that back diffusion of phenol red from 
the tubular lumen is prevented. In a glomerular tubule it might be con-
sidered that the phenol red is quickly washed through without opportunity for 
back diffusion. However, in isolated tubule preparations, phenol red concen-
trates within the lumen and obviously does not diffuse back. Shannon (196) 
has shown that the aglomerular tubules of the toadfish are essentially im-
permeable to phenol red except by its unidirectional, active transport. 
B. The possibility of the involvement of coen;rme A 
In the first part of this work the author considered that the looked-
for activation reaction was probably a coenz.yme A-linked activation, ana-
logous to acetate or fatty acid activations. Accordingly, procedures for 
various methods of assaying this type of reaction were first worked out. 
The author was aware at this time of Taggartts experiment (223, 222) 
in which PAR, labeled with oxygen-18 in the carboxyl group, was passed thro_ugh 
the dog kidney; the PAR recovered from urine showed that no significant 
amount of the carboxyl oxygen was lost in passing through the kidney {p. 'l. ~) . 
This seems to exclude a coenzyme A- linked activation since the formation of 
a thioester would involve the loss of half the carboxyl oxygen from the PAH. 
Note that in a thioester (- CO - SR) one of the oxygens of -COO- is gone. 
The author felt, however, that a hydrated thioester ~ould be an intermediate 
since it could conceivably be formed and degraded without loss of carboxyl 
oxygen. In ester (or thioester) formation, an intermediate in the reaction 
is a hydrated form - see for example (152, p. 168). 
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0 OH 0 
1 n 
- C - SR 1--:>=~ H2o -/- ... C - SR I - C - OH -/- HSR -~ 
OH 
A hydrated thioester like the compound in brackets above was considered to 
be a possible intermediate in which the two oxygens of the carboxyl group 
are still present. Coenzyme A thioesters are produced enzymatically by way 
of an intermediate step, an acyl adenylate, but it was considered that this 
compound could possibly be formed without loss of oxygen of the carboxyl group. 
An intermediate of this tyPe would not likely be very stable and would con-
vert to the normal thioester. If, however, it had a half-life of only a 
few seconds, this might suffice to get it through the renal tubular cell. 
Its stability could also conceivably be influenced by association with the 
activating enzyme during its existence. 
Actually, the work of Boyer, KOeppe and Luchsinger (25) appears to 
rule out the direct participation of coenzyme A by any mechanism. They found 
that in the formation of acetyl-coenzyme A by a rabbit heart preparation, 
labeled oxygen from acetate appeared in adenylic acid. This reaction pro-
ceeds by formation of an acyl adenylate, which then reacts with coenzyme A 
to form a thioester, displacing adenylic acid (13). In the case of acetate, 
the thioester formed could not contain both oxygens from the acetate since 
one is lost to adenylic acid in the formation of the acetyl-coenzyme A. If 
the excretion of PAH involved the formation of a coenzyme A thioester 
(hydrated or not) by a similar mechanism, one of the carboxyl oxygens of PAR 
would necessarily be lost to adenylic acid. This mechanism would therefore 
be incompatible with Taggart's observation that PAH passes through the 
kidney without significant exchange of carboxyl oxygen (223). 
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Most of the experimental work of this thesis was directed toward 
demonstration of acid activation in a more general way not necessarily de-
pending upon a specific mechanism, or , in the later work with a sulfate-
activating system, a specific type of activation not involving coen~e A 
was considered. Some of the methods originally adapted were, however, 
intended for investigation of coenzyme A- linked activations. Most of these 
methods proved to be useful anyway, so they will be briefly described. 
Some of the evidence for or against the involvement of coen~e A 
was somewhat equivocal at the time. Cross and Taggart (52) noted that co-
enzyme A in the medium had no effect in stimulating PAH uptake by rabbit 
kidney slices (p. 3~) . Wiebelhaus , Beyer , Russo, Brennan and Wynosky (238) 
were unable to show a decreased ability of kidney slices from pantothenate 
deficient rats to accumulate PAR. On the other hand, these workers showed 
that if pantothenate was administered to dogs while receiving an infusion of 
PAR and acetate , PAR excretion was enhanced above that obtained with PAR and 
acetate alone. Pantothenate without acetate had no effect. These workers 
felt that pantothenate (or coenzyme ! ) may not have been reduced to limiting 
concentrations in the pantothenate deficient rats, but pantothenate had an 
effect in increasing the stimulation due to acetate. Coenzyme A is also 
involved in this mechanism, somewhat indirectly, in relation to the inhibi-
tory effects of fatty acids and release of this inhibition by acetate. 
Schachter, Manis and Taggart (182) showed these effects to be due to synthe-
sis of acyl glycines from these acids, which involves activation of the fatty 
acids as coenzyme A thioesters (pp. 37-9 ) . 
The author was particularly suspicious of the possible involvement of 
the fatty acid activating enzyme for fatty acids of intermediate chain length. 
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This enzyme is indirectly involved in the excretion process because of this 
role in forming acyl glycines of fatty acids, which compete witll PAR. In 
addition, this enzyme was known to activate non-fatty acids such as benzoic 
or phenylacetic (136, 184) suggesting a broader specificity. This en~e 
has been subsequently inyesttgated by Kellerman (112) for its direct involve-
ment in PAH excretion with negative results. 
I 
VI 
EKPERIMENTAL STUDIES OF RENAL TUBULAR EKCRETION 
A. Methods adapted for study of acid activation 
The analytical methods first adapted were the following: 
Inorganic phosphate. - The method which was considered to be most 
generally applicable for subsequent work was t~at of Lowry and Lopez (133). 
This is a molybdenum blue method in which ascorbic acid is used as the re-
ducing agent. Since the color development takes place in a less acidic 
solution than in the ordinary Fiske-subbaRow procedure, the determination 
is less influenced by labile organic phosphates . 
Inorganic pyrophosphate. - The method adapted is based on inorganic 
phosphate determination before and after hydrolysis by the enzyme, inorganic 
pyrophosphatase . Inorganic pyrophosphatase was prepared from dried baker's 
yeast by the method of Heppel and Hilmoe (102) . From one pound of yeast, 
about 81 ml of enzyme solution was obtained. This preparation would com-
pletely hydrolyze 1 /U mol of inorganic pyrophosphate in 1/ 2 hour at a 1/ 1000 
dilution under the appropriate incubation conditions . The preparation is 
stable and may be stored frozen. 
In order to obtain a specific assay for pyrophosphate, this prepara-
tion must be free of hydrolytic activity on nucleotides or other organic 
phosphates likely to be present. It was accordingly shown that under condi-
tions where pyrophosphate is completely hydrolyzed, less than 2% error would 
result from hydrolysis of AMP , ADP or ATP. These nucleotides did not inhibit 
the action of the enz.yme on inorganic pyrophosphate. 
Sulfhydryl determination • - This procedure was adapted from that of 
100. 
Grunert and Phillips (93). Sulfhydryl disappearance is often used in studies 
of coenzyme A-linked activation. The basis of the method is the purple color 
produced with sulfhydryl compounds by nitroprusside. Cysteine hydrochloride 
was used as a standard. The color produced fades rapidly, and details of 
the order and technique of mixing reagents have a large effect on the color 
development. It was, therefore, necessary to make a detailed study of these 
factors in order to obtain reproducible results. However, with careful 
attention to these details, good reproducibility was obtained, and the opti-
cal density was proportional to concentration. 
This method was compared with an iodate titration method for sulfhydryl 
(247), using several different sulfhydryl compounds . Certain substances give 
anomalous results with one method or the other. It is apparent that the 
standard used must be carefully selected according to the substance being 
measured. 
Adenylic acid determination. - Adenylic acid may be determined by in-
organic phosphate analysis before and after complete hydrolysis by 5'- nucleo-
tidase. An attempt was made to determine adenylic acid with a purified pros-
tatic acid phosphatase (58), but this enzyme did not prove to be suitably 
specific for this purpose. 
The procedure of Heppel and Hilmoe (101) was used to prepare 51-
nucleotidase from bull semen (Bull semen was generously supplied, free of 
charge, by the Massachusetts Selective Breeding Association, Inc., Shrewsbury, 
Mass.). The activity of this preparation was tested with 5t- adenylic acid 
(AMP), JT- adenylic acid, ATP and pyrophosphate. ATP- ase activity was somewhat 
too high for use in the specific determination of AMP. Further fractionation, 
according to the procedure of these authors, would improve the specificity, 
but this was not done at the time . 
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PAR determination. - PAH was determined by the method of Smith, 
Finkelstein, Alimosa, Crawford and Graber (203). This method is based on 
the diazotization of the para-amino group of PAH and couPling with N-
(1-naphthyl)-ethylenediamine. This procedure is based on that of Bratton 
and Marshall (27) for sulfanilamide determination. 
Hydroxylamine methods. - Hydroxylamine is a versatile reagent for the 
study of acid activations. Hydroxylamine will react with various types of 
acid derivatives to form hydroxamic acids, which give a color with acid 
ferric chloride. 
R - CO - X ..j. H2N ... OH --~) R - CO - NH - OH -/- HX 
Hydroxylamine Hydroxamic acid 
At neutral or slightly acid pH, hydroxylamine will react with carboxylic acid 
anhydrides and related derivatives, such as phosphates, adenylates or thio-
esters (128, 129, 130). The reaction proceeds non-enz.ymatically in some cases, 
but, in other instances, hydroxylamine is incorporated into the reaction mix~ 
ture and the reaction is catalyzed by enz,ymes present. Alkaline hydroxylamine 
will react non-enzymatically with certain esters such as acetylcholine and 
may be used to determine them (103). Neutral hydroxylamine may also be used 
similarly in the determination of acyl glucuronides (178). 
A method for hydroxamic acids was adapted, combining certain features 
of the procedures of Schachter (178) and of Hestrin (103). Synthetic PAH 
hydroxamate was used as a standard. ' In the various applications made of this 
method, several modifications were made to adapt it to different situations. 
Paper chromatography of PAH and related substances. - Chromatographic 
separation of PAH, PAH hydroxamate, Diodrast, phenol red and related sub-
stances was attempted in several solvent systems. Spots were located by 
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ultra-violet light or by diazotization and coupling on paper. The solvent 
systems of Ekman (72) and butanol-acetic acid, as employed by Schachter (178), 
gave suitable separations with these substances. 
B. The possibility of the direct involvement of certain conjugation reactions 
1. Introduction 
The bulk of evidence indicates that the various acids excreted 
by this mechanism are found in the urine in an unchanged form (224, 202). 
Taking hippuric acid as an example, this compound reaches the kidney as 
hippurate and there is no evidence that it appears in urine in a changed form. 
Hippurate itself is a product of the conjugation of benzoic acid and glycine, 
a process which takes place primarily in the liver. Hippurate, rather than 
benzoate, however, is more properly regarded as the substance excreted, and 
hippurate itself is apparently not altered by the excretion process. Similar 
considerations apply to the excretion of bilirubin or bile acids by the liver. 
The inter-relation between the excretion process and certain conjugations has 
been discussed on pp. 5f-6bJ particularly for certain substances excreted by 
the similar mechanism in the liver. Despite the intimate association of 
excretion and conjugation in these instances, the author has pointed out 
several reasons for believing the two processes to be distinct. 
On the other hand, the remote possibility exists that some undetected 
conjugation process could be a part of these renal and hepatic excretion 
mechanisms. If this be the case, this conjugation must involve the carboxyl 
or sulfonyl of the excreted compounds, since they have no other feature in 
common. Assuming then that an acyl glucuronide might be the form actually 
excreted, the reason that these apparently rather diverse substances are 
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excreted by a common mechanism might be viewed as being due to their all 
being excreted as glucuronides and that the excretion mechanism acts speci-
fically on glucuronides. That such a conjugation might go undetected is 
emphasized by the case of bilirubin excretion by the liver . Although it 
was recognized for many years that bilirubin was excreted in a changed form, 
the nature of this change remained unknown until recently because of the 
lability of the acyl glucuronide excreted. Another observation which points 
out the lability of acyl glucuronide conjugates is mentioned by Schachter (178) . 
He observed urinary hexuronic acid concentrations to be about three times as 
high as that of benzoyl glucuronide after the administration of benzoate. 
This indicates extensive breakdown of the conjugate. 
In the case of hepatic excretion, Brauer (p. 60 ) has emphasized that 
in the cases where detailed studies have been made (bilirubin, bile acids, 
BSP), conjugation reactions are found to be intimately associated with excretion. 
2. Preliminary in vivo experiments to detect conjugates of excreted 
compounds . 
Although such conjugations were considered a rather remote 
possibility in the excretion of PAH, the following experiments were done as 
a partial test of this viewpoint. A healthy female dog (12. 7 Kg) was given 
600 ml of water by stomach tube and anaesthetized with intravenous Pento--
barbital. A saline infusion was started and a control urine collected by 
catheter. After a priming dose of PAH, this substance was infused at a con-
stant rate to maintain a relatively constant level in the blood. A ~AH 
urine11 was later collected and a blood sample drawn. 
The plasma and urine levels of PAH in this experiment were 1.85 and 
56. 5 mg per 100 ml, respectively. Hydroxylamine-reactive substance was 
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determined in the fresh urine specimens according to the procedure of 
Schachter (178) . This method is used to determine acyl glucuronides, but 
hydroxylamine might well react under these conditions with other labile acyl 
conjugates. Although the control urine contained 0. 32)U mols/ ml of hydroxyl-
amine-reactive substance, the PAH urine contained none (2.91)1 mols/ ml of 
PAH were present in this urine) . 
In another experiment with this dog, higher plasma levels of PAH and 
more concentrated urine specimens were desired. Plasma and urine levels of 
PAH were 15. 5 and 3,220 mg/100 ml, respectively. The values of hydroxyl-
amine-reactive substance in the control and PAH urine specimens were 2. 81 
and 1.69JU mols/ ml. Assuming the creatinine concentration of the two speci-
mens to be a measure of urinary concentration, and correcting the hydroxyl-
amine-reactive substance accordingly, the increase of hydroxylamine- reactive 
substance due to PAH administration does not account for more. than 0. 4% of 
the total PAH present ( total PAH of the PAH urine was 167)U mols/ ml). In 
these two experiments, it may be estimated that 70% or more of the urinary 
PAH was excreted by the tubules . 
Paper chromatograms were made of urine and of urine reacted with 
hydroxylamine in the first dog experiment. The salt content of the urine 
produced serious streaking when developed with butanol~water. Another chro-
matogram developed with butanol-acetic acid- water showed no indication that 
anything but unchanged PAH was present in the urine. If satisfactory chroma-
tographic development had been attained with a neutral solvent this result 
would be more conclusive. 
As an additional check of the hydroxylamine method for acyl glucuronide, 
the following experiment was done. 
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Five grams of sodium benzoate were ingested by the author. A control 
urine was collected just before this dose, and a 220 ml "benzoate urine" was 
collected two hours, 35 minutes later. Hydroxylamine-reactive substance in 
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the control urine was 1.26 p mols/ml and in the benzoate urine was 10.6 )l mols/ml. 
After correcting the control value in accordance with the creatinine ratios in 
the two specimens, it was indicated that in the benzoate urine, about 9.7 }1 
mols/ml represented benzoyl glucuronide. The principal metabolite, hippuric 
acid, was crystallized from the urine by cooling and acidification. After re-
crystallization, an amount of hippuric acid equivalent to 50% of the ingested 
benzoate was obtained. The fraction of benzoate excreted as the glucuronide 
was about 11% of the total excreted. The rate of hippurate excretion was 
close to that obtained by Schachter (178) in a subject of similar weight (60 Kg). 
The rate of excretion of acyl glucuronide was, however, about 5 times higher 
than in Taggart's subject. 
It is indicated by these experiments that hippurate or PAR, which are 
glycine conjugates, are not subjected to further conjugation of the free car-
boxyl group with glucuronic acid, or some other substance which might give a 
hydroxylamine-reactive derivative in the urine. It has been pointed out that 
Schachter (178) observed that, following a dose of benzoate, the urinary ben-
zoyl glucuronide was accompanied by a three~fold excess of free glucuronic 
acid. This would account for only a small fraction (less than lo%) of the 
total hippurate simultaneously excreted. 
C. fTeliminary attempts to detect activation of PAH in respiring kidney 
homogenates. 
A large number of experiments were done in the Warburg apparatus in 
an effort to obtain evidence for PAR activation in kidney homogenates. Res-
piring homogenates were used since any details of a presumed activation could 
not be wholly known, and the cofactors to be supplied were, therefore, not 
known. A respiring homogenate would presumably be capable of supplying the 
necessary activation cofactors, obviating the necessity of knowing exactly 
what cofactors were required. Kidney slices had been used by others in many 
studies of this excretion mechanism. A homogenate system is the ne~t logical 
step toward the eventual reduction of the problem to its en~tic basis. 
The systems used were adapted from that of Aisenberg and Potter (2). 
Potter also describes this system inManometric Techniques, of Umbreit, Burris 
and Stauffer (232, p. 179). This system employs fumarate and pyruvate as 
substrates. ~hosphate buffer, MgC12 and ATP are added. Sucrose is added to 
maintain the proper osmolarity. Additions or omissions of other substances 
to the incubation mixture were compensated for by equivalent changes in the 
amount of sucrose added, to maintain the same osmolarity. Homogenates of 
dog kidney cortex were prepared with a Potter-Elvehjem homogenizer, using 
10 ml of 0.25 M sucrose per gram of tissue. In some experiments, rat kidney 
was used. 
KOH was added to the center wells and oxygen consumption was measured. 
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The total volume in each Warburg vessel was 3 ml. PAH was added to some vessels. 
In order to detect activation of PAR, neutralized hydroxylamine was 
added to some vessels and was present during the incubation. Hydroxamic 
acids were measured at the end of the incubation in vessels with and without 
PAR. The use of hydroxylamine in these experiments is somewhat different than 
in the application previously described, in which hydroxylamine was used to 
detect conjugates, particularly acyl glucuronides, in urine. In the Warburg 
experiments it was desired to trap activated PAH from the presumed intra-
cellular intermediate, as it was formed. Intermediates of different types 
might possibly form hydroxamates, so that this method of detecting activation 
does not require specific pre-assumptions about the nature of the intermediate. 
If these acids are activated in the transfer process, it is likely 
that the step of transport by which the acid is removed from the cell into 
urine involves the hydrolysis of the activated intermediate (pp. ,;-6). A 
kidney-homogenate would be expected to have a strong hydrolytic activity for 
these substances, so that it is unlikely that they would accumulate. It was 
considered that there was a better chance of detecting the intermediates by 
incubation with hydroxylamine than by incubation prior to hydroxylamine addi-
tion. In many other cases reaction with hydroxylamine has been shown to pro-
ceed better in the presence of the enzymic system generating the activated 
intermediate. 
Although there was considerable variation between experiments, and 
between different vessels in the same experiment, the incubation systems 
were similar to the following: 
Volume Final Total.)l. mols Osmotic 
in ml Addition Molarity per 3 ml Equivalents 
0.3 0.1 M KH2.P04 (pH 7.3) 0.01 M 30 90 0.06 0.1 M K fumarate 0.002 6 18 
0.06 0,1 M K oyruvate 0.002 6 12 
0.4 0.03 M MgC12 0.004 12 36 
0.3 O.OlM diK•ATP 0.001 3 9 
0.3 0.2 M Neutral hydroxylamine 0.02 60 180 
0.2 0.15 M Na·PAH 0.01 30 60 
0.49 0. 5 M sucrose 245 245 
0.49 H20 
0.4 1~ kidney in 0.25 M sucrose 100 100 
3ml- total Total - 750 
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Although good respiration was attained by the homogenates, no signifi-
cant amounts of hydroxamate were formed in vessels with or without PAH. 
Hydroxylamine was used at several concentrations in different experiments ; 
its concentration in the incubation mixture was , in different instances, 
0. 02 M, 0. 047 M and 0. 5 M. In the later case, the incubation mixture was 
hypertonic . Acetate (0. 002 M) had little effect in stimulating respiration. 
Synthetic PAH hydroxamate incubated with the kidney homogenates was 
stable , so that the failure to detect this derivative in vessels Where hydroxyl-
amine was incubated with PAH and kidney homogenate was not due to breakdown 
of this compound, if it had been formed . 
It was necessary to study the effects of several factors on the res-
piration of the homogenates . One exasperating difficulty was traced to some 
unknown impurity in the MgC12 used in some experiments . When an equivalent 
amount of MgS04 was used, respiration was 5 to 6 times higher. The difference 
was not attributable to chloride or sulfate . This was shown by comparison 
between vessels in which equivalent amounts of all ions were supplied by 
MgC12 -f. K2S04 and by Mgso4 -.f. m:n . Good respiration was obtained in all 
vessels not containing the culpable MgCl2 . 
In flasks containing hydroxylamine (0. 047 M), the uptake of oxygen 
seemed to be depressed to 15 or 20% of cont rol values. When concentrated 
hydroxylamine (0.5 M) was used a rather rapid evolution of an unknown gas 
was observed, so that the depression of respiration with the lower amounts 
of hydroxylamine may be , in part, a masking of oxygen uptake by an evolution 
of gas . On the other hand, hydroxylamine may block metabolism by reacting 
with active acetate , etc .; although hydroxylamine is not a particularly 
toxic substance. The LD in the dog is about 200-300 mg/Kg (oral) or 60 mg/Kg 
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(intravenous). The 1050 in the mouse (route not specified) is more than 
400 mg/Kg for hydroxylamine hydrochloride (208, p. 162) . 
The hydroxylamine used was prepared by neutralizing the hydrochloride 
with KOH, and therefore considerable amounts of KCl were present. When an 
equivalent amount of sucrose in the incubation mixture was replaced by Eel, 
rather than neutralized hydroxylamine, respiration was depressed about 50%, 
as compared to 80% with neutralized hydroxylamine. A high fraction of the 
total osmolarity (about 60%) was due to KOl in this instance where it was 
found to be inhibitory. 
The effect upon respiration of changes in total osmolarity of the in-
cubation mixture was not large. Respiration was about equal in mixtures con-
taining 200 and 250 m osmols/liter; respiration was reduced about 30% at 300 
m osmols/ liter. Osmolarities were checked by freezing point depression, using 
a Fiske osmometer in the Department of Pharmacology . 
The nature of the gas evolved in vessels containing concentrated hydroxyl-
amine was not determined . The evolution took place in the absence of homo-
genate and was more rapid from alkaline solutions of hydroxylamine. The appa-
rent evolution was about 30% less with KOH in the center well than with H2S04 
in the center well, which may indicat e that the evolved gases were partly 
acidic in character . 
Further work with thi s homogenate system was not done . However, several 
changes for improvement of the homogenate system were suggested by this work. 
Calculations based on the amount of kidney tissue in each flask relative to 
the rate at which PAH is excreted by the intact kidney, indicated that border-
line amounts of tissue were used . Thus , considerably more concentrated homo-
genates would be indicated . Salt-free hydroxylamine of lower concentration 
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would probably also improve the situation. These and certain other changes 
might permit demonstration of activation of these acids by kidney tissue . 
The following work with the closely related liver system, however, suggests 
quite different methods which might, with certain changes, be applied to 
kidney. 
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VII 
THE SELECTION OF THE SULFATE ACTIVATING SYSTEM FOR STUDY OF 
ITS POSSIBLE ROLE IN THE EXCRETION OF THESE SUBSTANCES 
If it is assumed that an acid activation is involved in the excretion 
of these compounds by the liver or kidney, the exact nature of the activation 
reactions or the enz.ymes responsible still remain obscure. It is indicated 
that the competition between different excreted substances occurs at this 
activation phase of the excretion process, and that the competition is for 
a single enz.yme in either organ (pp. 25·n . The assumption that the com-
petition is for a single enz.yme does not necessarily mean that the activa-
tion itself may not consist of more than one step. The activation of sulfate 
by yeast, for example, is a two-step process catalyzed by two separable 
enz.ymes (241, 242, 168). 
The activation of these substances could be mediated by an enzyme 
which functions only in this excretory process, but, on the other hand, it 
seems about equally probable that one of the known activating enzymes might 
be involved in the activation of these acids, in addition to its known sub-
strate. The attempt to · trap activated intermediates as hydroxamates (Section 
VI) did not require a choice between these alternatives. The enzyme which 
activates the acids excreted by this mechanism must have, however, an un-
usually wide substrate specificity. While this does not necessarily indi-
cate that this enz.yme would activate other acids, it is quite possible that 
it would. It is not necessary to assume that all the substances activated 
by this enzyme would have the same fate, that is, enter into the excretion 
mechanism. The activating enzyme for fatty acids of intermediate chain 
length, for example, can activate certain non-fatty acids such as benzoic. 
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The fate of the activated benzoate {glycine conjugation) is different from 
the usual metabolic degradation of the fatty acids activated by the same 
enzyme (f!J-37 ). 
It therefore seems reasonable to regard several of the known activating 
enz.ymes with suspicion. Since several of the substances known to be excreted 
by either the kidney or liver are sulfates or sulfonates, the sulfate acti-
vating system is as likely a candidate for suspicion as are several others. 
It would not be a very practical approach to this problem to test all the 
known activating en~es, but certain of them seem more likely to be impli-
cated, either because they activate acids related to the excreted substances 
or because they show some indication of a broad substrate specificity. 
Kellerman {112) has investigated the activating enzyme for fatty acids 
of intermediate chain length (octanoic thiokinase) for its involvement in 
renal tubular excretion. This enzyme failed to activate compounds excreted 
by the renal tubule. Kellerman showed, however, that an acyl-adenylate inter-
mediate is likely in the excretion mechanism, since hippuryl-adenylate can 
apparently be formed and hydrolyzed without loss of carboxyl oxygen. The 
involvement of this type of intermediate would thus be in accord with 
Taggart's observation that PAH, labeled with oxygen-18 in the carboxyl group, 
passes through the kidney tubular cell without loss of label (223). These 
experiments are described in more detail on pp. 1/2-6 . This same enzyme 
was previously shown by Schachter, Manis and Taggart {182) to be involved 
in this excretion mechanism in an indirect manner, since it is implicated 
in the synthesis of fatty acyl-glycines which inhibit PAH transport {pp. 37-9). 
Several of the compounds excreted by either the kidney or the liver 
are glycine conjugates, so that an amino acid-activating enzyme, particularly 
a glycine-activating enzyme, might be suspected of involvement in the excretion 
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process. However, the amino acid-activating enz.ymes exhibit rather narrow 
specificities. For example, a highly purified tryptophan-activating enz.yme 
shows activity only with L-tryptophan and certain analogs and is inactive 
vlth D-tryptophan and other amino acids {56). It is probable that separate 
enz.ymes exist for the activation of individual amino acids or individual 
groups of amino acids {198, 126). Evidence for activation of all the common 
amino acids of proteins, including glycine, has been shown with pigeon pan-
creas extracts {126). The various amino acids stimulate the incorporation 
of radio-activity from pyrophosphate into ATP, which implies that acyl-
adenylates are involved. In other words, the reverse of the following reac-
tion is catalyzed by the activating enzymes: 
ATP ~ amino acid 
' 
amino acyl-adenylate ~ PP 
There is, however, some question whether all the amino acids are acti-
vated by the same process and about the role of these activations in protein 
synthesis (155). 
These excretion processes operate with quite diverse types of compounds 
so that these amino acid-activating enzymes seem to be unlikely candidates. 
In the chicken, for example, conjugates of such diverse amino acids as orni-
thine and glycine are excreted by the kidney tubules (p. /4 ). Schachter, 
Manis and Taggart (182) demonstrated that rabbit kidney slices accumulate 
alanine conjugates of benzoic or p-aminobenzoic acids, as they do with PAR, 
a glycine conjugate. These alanine conjugates also inhibit the accumulation 
of PAH by the slices. Rabbit kidney slices accumulate p-aminobenzoyl-L-alanine 
and its D-isomer equally well, although rabbit kidney can conjugate only with 
L-alanine (pJ39 ). In these examples of the excretion of amino acid 
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derivatives, the same types of specificity seen with amino acid activations 
do not appear to be involved. The amino acid-activating enzymes cannot be 
definitely ruled out on the basis of such evidence alone, however. 
The substances excreted, presumably by the same enzymatic mechanism, 
include sulfate derivatives as well as carboxylic acids. It therefore seems 
no more reasonable to assume that a carboxylic acid-activating enzyme might 
also activate certain sulfate derivatives than to assume that sulfate-acti-
vating enzymes might also show activity with certain carboxylic acids. The 
first step in the activation of sulfate- i.e., formation of an acyl-adenylate-
is identical to the first step in the activation of fatty acids, acetate and 
other acids (127). The experimental work to follow is an investigation of 
the involvement of the sulfate activating system with this excretion system, 
particularly by the liver. Therefore, the pertinent aspects of the sulfate 
activating system will be discussed, together with certain aspects of sulfate 
activation which indicate its possible involvement in the excretion mechanism. 
The participation of sulfate in many metabolic reactions, principally 
the formation of sulfate esters, involves the ATP-dependent activation of 
sulfate (127). De Meio and his co-workers were the first to study in detail 
the formation of sulfate esters of phenols using liver slices and later homo-
genate systems {63, 62, 65). It was shown by Bernstein and McGilvery (17) 
and by De Meio et al. (67, 68) that, when mitochondria and microsomes were 
separated from a rat liver homogenate by ultracentrifugation, the supernatant 
contained the complete enz.ymic system for activating sulfate and transferring 
it to various phenols. This enzymic system required magnesium, an acceptor 
phenol and ATP (or an ATP generating system). Recombination experiments 
showed that the microsome fraction was inhibitory because of its ATP-ase 
activity (67). 
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Bernstein and McGilvery (16) found that a higher initial rate of sul-
fate esterification resulted if the enz,yme system was pre-incubated with sul-
fate, ATP and magnesium ion before a phenolic acceptor (m-aminophenol) was 
added. All the pre-incubation components mentioned were necessary for the 
higher initial rate; pre-incubation with m-aminophenol and various combina-
tions of these substances was without effect on the initial rate. This indi-
cated that a sulfate- containing intermediate accumulated during the pre-
incubation. Pre-incubation, in effect, accomplishes a kinetic separation 
of the overall process into an aytivating phase and a transferring phase. 
It is also indicated that, in the formation of a phenolic sulfate, it is the 
sulfate that is activated, rather than the phenol. Segal (193) also made 
kinetic studies employing pre-incubations. By the use of iodoacetate as an 
inhibitor he concluded that both activation and transfer involved essential 
enz,ymic sulfhydryl groups. 
The sulfate-activating and transferring activities of liver super-
natant were separated from each other by De Meio et al. (68). After ammonium 
sulfate fractionation, preparations containing the separate activities were 
obtained by heat-treatment, which selectively inactivated the transferring 
enz.yme, and by glycylglycine treatment, which inactivated the activating 
enzyme. Hilz and Lipmann (105) were also able to separate these two acti-
vities from lamb liver supernatant by an alumina gel technique. These 
enzymic separations allowed the two phases of sulfate esterification to be 
more adequately studied apart from each other. The use of radioactive sul-
fate and ATP led to the separation of "active sulfate" and its preliminary 
characterization as an adenyl sulfate by Hilz and Lipmann (105) and by 
De Meio and Wizerkaniuk (66). Pyrophosphate was shown to be a product of 
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the formation of active sulfate, and, being an end product of the reaction, 
pyrophosphate strongly inhibited the process. In the usual enzyme prepara-
tions pyrophosphate is rapidly eliminated from the equilibrium by pyrophos-
phatase. The formation of the adenyl sulfate was therefore presumed to arise 
by a pyrophosphoryl split of ATP mediated by sulfate. The separation of this 
active sulfate by paper electrophoresis did not allow an accurate measurement 
of phosphate in the compound because of high blanks. 
Segal (194) was able to reduce the non-sulfate-dependent phosphate 
release of a rat liver preparation, so that the phosphate release during 
sulfate esterification could be more accurately assessed. He consistently 
observed that 3.3 to 3.8 moles of inorganic phosphate were liberated per mole 
of sulfate ester formed. This is in excess of the two phosphates expected 
from a pyrophosphoryl split of ATP followed by pyrophosphatase hydrolysis of 
the resulting pyrophosphate. Segal concluded that more than one ATP molecule 
was involved in the formation of active sulfate. 
A more satisfactory purification of active sulfate by Robbins and 
Lipmann (166, 167) resulted in its definite characterization as adenosine-31-
phosphate-5'-phosphosulfate (PAPS, Phosphoadenosine-phosphosulfate). This 
intermediate was therefore shown to be an adenyl sulfate (APS) which has an 
additional phosphate at the 3•-hydroxyl of the ribose. The location of the 
sulfate as linked to the 5'-phosphate may be implied from the pyrophosphoryl 
split of ATP involved in the formation of the compound. These workers veri-
fied the sulfate position by other means, as well. The extra phosphate of 
PAPS was shown to be at the 3f-position by hydrolyzing off the sulfate; the 
resulting PAP (adenosine-31-51-dipbosphate) was found to be identical with a 
product prepared from coenzyme A, which contains a 3•-phosphate, and different 
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from an analogous product (adenosine-~ 1-51-diphosphate) derived from tri-
phosphopyridine nucleotide (TPN). The position of this phosphate was also 
revealed by its lability to a specific 3'-nucleotidase. Independent con-
firmation of these structures was obtained by comparison of enz,ymatically 
derived PAPS with synthetic APS and PAPS. 
Although the activating and transferring activities were separable 
in liver preparations, the isolation of separate enz,ymes catalyzing the indi-
vidual steps of activation ran into difficulties (168). Bandurski, Wilson 
and Squires (241, 10), however, separated the enzymes catalyzing the indi-
vidual steps of sulfate activation from yeast by a protamine fractionation 
method. They showed that sulfate activation occurred in two ATP requiring 
steps: 
(1) ATP + sulfate 
(2) ATP -/- APS 
APS -/- PP 
PAPS -/- ADP 
The first reaction is catalyzed by ATP-sulfurylase and involves a 
pyrophosphoryl split of ATP by the sulfate. The resulting adenyl sulfate 
(APS) is analogous to other acyl-adenylates. The forward reaction is favored 
by the presence of pyrophosphatase which removes the PP. 
The second reaction is catalyzed by APS-kinase. This reaction is a 
phosphorylation of the ribose of APS at the JT- position and is similar in 
type to other sugar phosphorylations, such as the hexokinase reaction. 
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These reactions have also been studied in detail by Robbins and Lipmann 
(168, 169) using yeast enzyme preparations. Both the activation reactions 
require magnesium. Cobalt is also active, but calcium is inhibitory in the 
ATP-sulfurylase reaction. The ATP-sulfurylase reaction (Reaction 1) sp~cifically 
requires ATP, although the APS-kinase reaction proceeds with the triphos-
phates of cytidine, guanosine, inosine, uridine or adenosine . Although 
these individual reactions of activation have not been studied in the same 
detail in liver, Robbins and Lipmann {169) present evidence that the reac-
tions are essentially the same. The ATP-sulfurylase activity of liver is 
higher than that of yeast. 
The active sulfate produced by these reactions may then act as a 
sulfate donor in the formation of various types of sulfate esters. These 
reactions are catalyzed by different sulfokinases, which are specific for 
various sulfate acceptors or groups of acceptors {127) . The phenol sulfo-
kinase {transferring enzyme) of liver , for example, will transfer sulfate 
from PAPS to numerous phenols, such as p-nitrophenol, m-aminophenol , phenol, 
etc ., according to the following reaction {90) : 
(3) PAPS -/- phenol PAP -1- phenyl sulfate 
This reaction does not require magnesium, as do the activation reactions . 
The reaction for the overall activation of sulfate and transfer of 
sulfate to a phenolic acceptor is therefore as follows {sum of reactions 1, 
2 and 3) : 
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(4) sulfate -/- 2 .ATP -/- phenol -~) phenyl sulfate -/- PAP + P.!P -/- ADP 
A study of the nucleotides involved in these reactions in a rabbit 
liver system has also been made by Brunngraber (35) . The accumulation of 
PAP is inhibitory to the overall process of sulfate esterification. Liver 
contains a specific nucleotidase which hydrolyzes off the 3'- phosphate group 
of PAP to give inorganic phosphate and adenylic acid . This nucleotidase 
requires magnesium and is fluorid~sensitive . PAP does not accumulate in 
fluoride-free systems, presumably because of the action or this nucleotidase . 
Whether PAP may recycle in the sulfate esterification system in other ways is 
not determined (35) . The other products of the esterification reaction, ADP 
and PP, are recycled or removed by well known cellular processes . 
Phenol sulfokinase also will transfer sulfate between different phenols 
(90, 35) . Para- nitrophenyl sulfate (p-NPS) is usually used as the donor; 
it loses its sulfate to form p-ni trophenol (p-NP) . 
PAP 
(5) p-l~S ~ phenol - ---4) p-NP -/- phenyl sulfate 
This reaction specifically requires either FAP or PAPS, which act catalyti-
cally. The intermediate formation of PAPS from the PAP is involved. This 
reaction is a very sensitive assay for PAP or for PAPS, as well as for the 
enz.yme . This same reaction may be catalyzed by sulfatases in liver (177) . 
The sulfatase activity of the liver preparations used in sulfate activation 
studies is, however, very low (65, 90) . The phenol sulfokinase differs from 
sulfatases in having no hydrolytic action and in the requirement for PAP (90) . 
Baum and Dodgson (11) have presented evidence that liver arylsulfatases are 
not involved in direct arylsulfate synthesis . 
Other sulfokinases will transfer sulfate from PAPS to other types of 
acceptor. The incorporation of sulfate into various steroids has been shown 
(64, 176, 193, 191) . Nose and Lipmann (154, 127) have separated sulfokinases 
specific for J-j.9- hydroxysteroids and for phenolic steroids (estrone) . In-
corporation of sulfate into certain tyrosine derivatives has been studied 
in a rat liver system by Segal and Mologne (195) . 
D'Abramo and Lipmann (55) have shown that chick embryo cartilage 
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preparations will synthesize APS and PAPS and will incorporate labeled sul-
fate or sulfate from PAPS into chondroitin sulfate . Other mucopolysaccharides 
probably are sulfurylated by similar mechanisms (127). 
PAPS also seems to be involved in the enz.ymatic reduction of sulfate 
to sulfite in yeast , as shown by Wilson and Bandurski (243) . ATP- sulfurylase 
also shows an activity with selenate and traces of the selenium analog of 
APS have been detected. This reaction with selenate may be involved in sele-
nate reduction and other reactions of selenate in certain organisms (241, 242, 
244) . 
Wilson, Bandurski and Squires (10, 244, 9) have shown that yeast ATP-
sulfurylase is active not only with sulfate but also with other group VI 
anions - selenate, sulfite, chromate, tungstate and molybdate. With sulfate 
as substrate, adenyl- sulfate is formed and may be isolated, but the acyl-
adenylates presumably formed with the other anions are very unstable and 
break down spontaneously. In the case of selenate, traces of the adenyl-
derivative have been demonstrated, but this derivative is mostly hydrolyzed 
to adenylic acid and selenate in the presence of the enzyme . With molybdate, 
for example, ATP is split in the presence of the enzyme to give pyrophosphate 
and the unstable adenyl-molybdate , analogous to the reaction with sulfate 
(Reaction 1 on p. /If ). In the presence of an excess of pyrophosphatase 
the PP is rapidly hydrolyzed to inorganic phosphate . The adenyl- molybdate 
spontaneously breaks down to adenylic acid and molybdate . Since both 
products of the sulfurylase reaction are efficiently removed, the reaction 
is strongly encouraged in the forward direction. The net result, therefore, 
is a rapid molybdate-dependent breakdown of ATP to adenylic acid (AMP) and 
phosphate . 
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(6) ATP ~ molybdate (AMP • molybdate) -/- PP 
~ + 
AMP 2P 
+ 
molybdate 
or 
molybdate 
(7) ATP -----~ 
sulfurylase 
and pyrophosphatase 
Increasing amounts of phosphate are split from ATP by sulfate, sulfite, 
selenate, chromate, tungstate and molybdate (10, 244) . Equimolar amounts of 
sulfate, selenate and molybdate induce the release of 0.05, 0.46 and 5.16p 
mols of phosphate, respectively . The molybdate dependent phosphate release 
is a convenient and simple assay of ATP- sulfurylase (244, 169) . 
Measurement of the reverse of reaction 6 by the incorporation of 
labeled PP into ATP in the presence of the various group VI anions, indicates 
that PP is incorporated into ATP only with sulfate and to a lesser extent 
with selenate . The instability of the other adenyl derivatives prevents 
their reacting with the pyrophosphate . A pyrophosphate incorporation assay 
thus depends directly on the stability of the adenyl intermediate; whereas, 
the phosphate release assay depends on the instability of the intermediate. 
There are several indications that a single enz.yme is responsible for 
the activity with all these anions (244) . In several protamine precipitated 
fractions of the yeast enz.yme, the activities of different fractions were 
in similar relation to each other whether measured with sulfate, selenate, 
sulfite or molybdate . Sulfate inhibits molybdate or sulfite dependent 
phosphate release from ATP . The inhibition of the sulfite reaction by sulfate 
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was shown to be competitive. In addition, during purification procedures 
for the enzyme, the specific activity was increased about 100 times, and 
although molybdate was used to assay the enzyme during the various steps of 
purification, the activity with sulfate or selenate was similarly retained. 
Most of the studies of sulfate activation with vertebrate tissues have 
been with liver. If the involvement of this activating system in hepatic and 
renal excretion mechanisms is to be considered, some interest attaches to the 
occurrence of sulfate activation in kidney and other organs . The general 
similarity of the two excretion systems suggests that the enzymatic mechanisms 
must be very closely related. 
Using rat tissue slices, De Meio and Arnol t {63) found that liver, 
intestine and spleen conjugated phenol; adrenal, brain, diaphragm, heart, 
kidney, ovary, stomach, uterus and testicle did not . With cat tissue slices 
both liver and kidney conjugated phenol . It is probable that, under the con-
ditions of these experiments, much of the observed conjugation was with 
glucuronic acid rather than sulfate . With two different strains of rat, 
however, these workers found that liver slices conjugated considerably less 
phenol when sulfate was not included in the medium. There were marked dif-
ferences between these two strains in total conjugating activity and in the 
fraction of the phenol which apparently was conjugated with sulfate. Segal 
{193) observed no sulfate conjugating activity for phenols in the high speed 
supernatant fractions of homogenates of rat spleen, heart, kidney or hepatoma 
induced by dietary butter yellow. The conjugating activity of liver is found 
in this fraction. Nose and Lipmann (154) found that rabbit liver, kidney and 
intestine contained significant amounts of phenol-sulfokinase. These workers 
used a yeast preparation as a PAPS-feeder system in these experiments, so that 
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actual sulfate activation by the rabbit kidney was not demonstrated in this 
instance. Sulfate activation may probably be implied from the presence of 
the sulfokinase, however. Kent and Pasternak (114) have demonstrated sul-
fate activation in sheep colonic mucosa. Chick embryo cartilage prepara-
tions also activate sulfate (55). 
Although sulfate activation seems to occur quite widely in liver, its 
demonstration in kidney of different species is not very satisfactory at 
this point. Note that, in the cases where sulfate activation was not de-
tected in kidney, the conjugation of phenol with sulfate was the criterion 
upon which the observations were based. There are several other important 
utilization pathways for active sulfate. Whereas sulfate activation occurs 
in chick embryo cartilage and in yeast, phenol conjugation does not occur; 
at least, in the studies of sulfate activation in these preparations, con-
jugation of phenols has not been reported. Conjugation reactions vary con-
siderably from species to species and even between different strains of 
rats (63). Inability to conjugate phenol with sulfate, therefore, is rather 
poor evidence that sulfate activation does not occur. 
• There are a few indications that the sulfate activating system could 
possibly be involved in the activation of the acids transported by the liver 
and perhaps the kidney. The activation of sulfate by a pyrophosphoryl-split 
of ATP to produce an adenyl-derivative (Reaction 1 on p. Jig ) is identical 
in form to a number of carboxylic acid activations . There is, therefore, 
no good reason to believe that this inorganic acid-activating enzyme could 
not have an activity with certain organic acids - particularly certain sul-
fonates and sulfate esters. As already discussed, there is considerable 
evidence that the excreted sulfate derivatives and carboxylic acids are 
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involved with the same enz.ymes in the transport systems. 
Although the sulfate-activating system has not been clearly shown 
to activate any carboxylic acids or even any sulfate derivatives, its speci-
ficity is as broad as any other known activating enzJ~e . Yeast ATP-sulfury-
lase catalyzes a reaction with several group VI anions other than sulfate -
i.e., sulfite, selenate, chromate, tungstate and molybdate (pp. l~f-3) . These 
rather bizarre 11 substrates 11 have no obvious relationship to hepatic or renal 
excretion mechanisms, but their activity with this enzyme certainly indicates 
an unusual enzyme specificity. 
De Meio et al. (67) noted that rat liver supernatant preparations had 
less sulfate-conjugating activity in glycylglycine buffer than in phosphate 
buffer . Glycylglycine was later used t o inactivate the sulfate-activation 
component of rat liver preparations, which contained both activating and 
transferring enzymes {68) . This method was used to prepare transferring 
enzyme free of activating enzyme. The preparation of transferring enzyme 
included the following steps : ammonium sulfate fractionation of rat liver 
supernatant, dialysis to remove sulfate and addition of glycylglycine (0. 03 M) . 
0 In 24 hours at pH 7. 4 and at 0 to 5 C. , the sulfate- activating component 
was lost . Glycylglycylglycine had a similar effect . Alanylglycine and 
glycine had moderate inactivating effects , and benzoylglycine did not inac-
tivate the enzyme. Several other substances were tested. The enzyme was 
protected from such inactivation by phosphate or, to a lesser extent, by 
sulfate. 
This rather unusual method of inactivation seemed to the present author 
to be a possible indication of a fairly specific affinity of the enzyme for 
certain glycine derivatives . A number of glycine derivatives such as benzoyl-
glycine are excreted by the kidney or liver . Why a specific affinity of 
glycylglycine for sulfate-activating en~e would bring about an inactiva-
tion is not clear, but benzoylglycine which might be considered a more 
11 normal 11 substrate did not inactivate the enzyme. However, some doubt 
about this interpretation of the action of glycylglycine on the enzyme has 
been cast by some of the experimental work to follow. Note also that Robbins 
and Lipmann (169) have used a glycylglycine buffer of higher concentration 
( 0. 05 1<1) in measurements of ATP-sulfurylase in rat liver supernatant. The 
inactivating effect of glycylglycine has also been shown by Baum and Dodgson 
(11), so that it must be real enough, but preliminary subjection of the liver 
supernatant to ammonium sulfate fractionation and dialysis appears to be 
essential to the inactivation. Whatever the explanation of this glycylglycine 
effect, it was one of the factors which led the author to test the involve-
ment of the sulfate-activating system in these excretion mechanisms. 
Another indication that the sulfate-activating system could be involved 
in transport may be seen by examining equation 3 (p. l/9), which describes the 
phenol-sulfokinase mediated transfer of sulfate from PAPS to phenol. The 
bracketed compound in this reaction, as written below, is the intermediate 
which it seems necessary to postulate in this transfer. 
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(8) ~ 0 g ~ .r=\l PAPS -1- phenol .... ·-- adenine-<"""")..cHa· o-P
0
, -o-~-0~ _ _ PAP /- phenyl 
~. 0 sulfate 
Ho o,F(OH #4 
09 'oM 
This intermediate may be considered to be either a PAPS-phenol addition com-
pound or a PAP-phenyl sulfate addition compound. 
Phenyl sulfate is a compound apparently excreted by this mechanism. The 
postulated intermediate in equation 8 is identical to the compound which could 
conceivably be formed by direct activation of phenyl sulfate - that ls, a re-
action with ATP to form adenyl-phenyl sulfate (mediated by ATP-sulfurylase), 
followed by phosphorylation of the ribose at the Jt-position (mediate~ by 
APS-kinase) . This substance is therefore the type of intermediate which has 
been postulated in a more general way (pp. 9Z-S) for the renal and hepatic 
excretion systems. If the excreted substances are presumed to be activated 
by a sulfate-like mechanism, this would represent the looked-for intermediate 
in the case of phenyl sulfate. There is, therefore, good evidence that at 
least one of the intermediates postulated to be produced by a sulfate-
activation mechanism in the excretion process actually must exist in a sul-
fate-transfer system. 
Unfortunately, the renal tubular excretion of phenyl sulfate is not 
fully resolved. While Sperber has presented evidence that this substance is 
excreted by the tubules in the chicken and the goat, Gillessen and co-workers 
report that phenyl sulfate is reabsorbed in the cat and dog (p. 1~). It is 
perhaps possible that the discrepancy bet~een these observations could be 
due to a process such as deconjugation of the phenol and reconjugation with 
glucuronic acid. Sperber (211) found that hippurate depressed phenyl sulfate 
excretion by the chicken. 
Because of conflicting views on the excretion of phenyl sulfate, the 
PAP-phenyl sulfate intermediate in equation 8 is not the best possible indi-
cation for the involvement of the sulfate-activating system in transport. 
It seemed to be sufficient evidence, however, to justify an investigation 
of the sulfate-activating system from this viewpoint. 
It is possible to consider that activated intermediates of the ex-
creted compounds (comparable to the PAP-phenyl sulfate, equation 8) could be 
formed in ways other than by a direct activation. For example, sulfate could 
be activated to PAPS, followed by an exchange reaction between the sulfate of 
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PAPS and another acid. This is analogous to a fatty acid activation by 
exchange of a fatty acid with acetate of acetyl-coenz.yme A, which has been 
observed in Clostridium klgyveri (215). This type of activation of the ex-
creted compounds, however, would be contraindicated by demonstration of an 
affinity of the excreted compounds for the sulfate-activating enz.yme. Some 
of the experimental work to follow is pertinent to this point. 
These intermediates could also be considered to be formed by a direct 
combination of the excreted compounds with PAP, mediated by phenol sulfo-
kinase. This is the reverse of reaction 8. The gain in free energy for 
this reaction would be considerable in the case of phenyl sulfate so that a 
reasonable yield by this mechanism is unlikely. Gregory and Lipmann (90) 
state flatly that 11 no evidence has been found of transfer of sulfate from 
this compound ( phenyl sulfate) to PAP. 11 This is not the case, however, for 
certain substituted phenyl sulfates, such as p-nitrophenyl sulfate or 3,5-
dinitrophenyl sulfate. The corresponding phenols have much higher acidities 
than does phenol, and they form sulfates of much higher group potential, as 
might be expected. 
The energy of hydrolysis of the sulfate from PAPS, as judged by equi-
librium constants for its synthesis, is considerably higher than for that 
of the pyrophosphate linkages in ATP (169, 127). The sulfates of these 
nitrophenols are also compounds of very considerable sulfate group potential 
(90). The equilibrium constant for the transfer of sulfate from PAPS to 
p-nitrophenol (p-NP), for example, is about 26. 
K : tp-NPS) (PAP) 
p-NP) (PAPS) 
= 26 
This reaction is readily reversed, and for this reason p-rzys readily acts 
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as a sulfate donor to other phenols in the presence of phenol sulfokinase 
and PAP. The sulfate group potential of phenyl sulfate, on the other hand, 
is much lower. Thus, a PAP-phenyl sulfate intermediate is not likely to be 
formed by a direct reaction with PAP; it would likewise appear improbable 
that the other excreted compounds would react in this manner. 
Another related possibility to be considered is that the excreted 
substances are activated as simple acyl adenylates in the excretion process, 
rather than phosphorylated adenylates comparable to PAPS. These adenylates 
might result from the action of ATP-sulfurylase, not followed by phosphoryla-
tion of the ribose by another ATP molecule (APS-kinase reaction). To the 
extent that the activation of sulfate itself may be considered to be compar-
able, however, a t\o~o-step activation seems more likely. The formation of APS 
is a very endergonic reaction, and only trace amounts of APS are present at 
equilibrium. The coupling of this reaction with the exergonic APS-kinase 
reaction and the removal of PP by pyrophosphatase allows an activated sulfate 
(PAPS) to be formed under much more favorable equilibrium conditions (169, 127). 
These considerations imply that PAP derivatives would be more likely than 
adenyl derivatives in the excretion processes. 
In addition, an activation of the excreted substances by this mechanism 
seems to be consistent with Taggart's observations that PAH passes through the 
kidney of a dog without loss of carboxyl oxygen (223). As pointed out pre-
viously (pp. ~~-6), Kellerman has shown that benzoyl adenylate or hippuryl 
adenylate may presumably be enzymatically synthesized and hydrolyzed in such 
a way that carboxyl oxygen is not lost (112). There is no reason to believe 
that a PAP derivative would behave differently from these adenyl derivatives 
in this respect, since the bond between the "adenyl component" and the acid 
is the same in either type of compound. 
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VIII 
EXPERIMENTAL STIDIES WITH A SULFATE-ACTIVATING SYSTEM FROM LIVER 
A. En;yme preparation and preliminary studies 
The sulfate-activation system has been well characterized in liver 
from a variety of animals, but the presence of this system in the kidney of 
certain species is not established. As pointed out (pp. f2.3-1} the failure to 
demonstrate sulfate esterification by kidney of these species may very likely 
depend, however, upon lack of phenol sulfokinase activity, rather than upon 
lack of sulfate activation per se. Because the presence of this system in 
kidney is somewhat uncertain, it was considered advisable to use liver, at 
least for preliminary characterization of the system. The experimental re-
sults with liver preparations have induced the author to continue the work 
from the standpoint of studying the hepatic system for excretion of these 
organic acids. The results can, therefore, be considered to apply directly 
only to liver. It was considered by the author, however, that whatever 
could be shown to apply to the liver excretory system would have much perti-
nence to the related mechanisms of the kidney tubule. 
The en~e preparations Used in the following work were prepared in 
most cases by the procedure of Hila and Lipmann (105), as follows. These 
workers found lamb liver to be a good source of sulfate activation and 
phenol sulfokinase activity. The fresh lamb livers were purchased from 
the New England Dressed Meat and Wool Co., Somerville, Mass. One preparation 
was made with dog liver obtained through the Department of Physiology, Boston 
University School of Medicine. The enzyme preparations from lamb liver were 
used where not otherwise specified. 
1.30. 
Preparation of enz.yme: 
The liver was cut into pieces and chilled in ice (lamb liver, if 
allowed to stand at room temperature for 30 minutes, is inactive). Subse-
quent operations were carried out at 0 to 5° C. The liver was ground with 
a meat grinder, and 200 grams of liver mince were suspended in 600 m1 of a 
solution containing 7.5% sucrose and 0.83% KHco3• Suitable portions were 
homogenized at full speed for 20 seconds in a Lourdes homogenizer. The homo-
genate was spun at 1600 r.p.m. for 15 minutes in an International refrigera-
ted centrifuge (head #840). The supernatant (containing mitochondria and 
microsomes) was poured through cheese cloth. To the 460 m1 of supernatant 
so obtained, 46 ml of 1.5 M Eel (11.2%) was added with vigorous stirring, 
in order to agglomerate mitochondria. Mitochondria were spun off in the 
same centrifuge at the maximum speed (4200-4500 r.p.m.) for one hour. The 
still cloudy supernatant was recentrifuged in two loads at 33,300 r.p.m. 
(100,000 X g, maximum) in a Spinco preparative ultracentrifuge (head #40) 
for one hour. The clear supernatant was frozen in aliquots of 5-10 ml. 
Preparations stored for more than a year in a deep freezer have shown good 
activity. This supernatant contains the enzyme system for activation of 
sulfate and transfer of sulfate to a phenolic acceptor. 
For use, a tube of this enzyme preparation was thawed, the amount 
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needed was withdrawn, and the tube re-frozen. Some deterioration of activity 
occurred with each thawing and re-freezing so that a tube was not ordinarily 
used more than 5 or 6 times. The enzyme was kept in an ice bath when not frozen. 
The first preparation with lamb liver, which was used in most of the 
following work, had about the same activity (60 m p mols of p-NPS/hr/mg protein) 
as similar preparations used by Hilz and Lipmann (105). Protein was determined 
by a biuret method. 
One preparation was also made with rat liver by the similar procedure 
of Segal (193, 194). The liver was homogenized in four volumes of Tris/HCl 
buffer, pH 7.5 containing 10-3 M neutralized Versene. Centrifugation was 
accomplished in one step- one hour at 57,000 X g, maximum. The supernatant 
was lyophilized. This preparation, when reconstituted to its original volume, 
proved to be only about 20% as active in esterification of p-NP (p-nitrophenol) 
as were the lamb liver preparations. The rat liver preparation was not further 
used. 
Test system for p-nitrophenyl sulfate synthesis: 
In most experiments p-nitrophenol was used as the sulfate acceptor. 
Because of its intrinsic yellow color in alkaline solution, p-NP is readily 
and sensitively determined by measurement of its extinction after the addi-
tion of alkali. Its sulfate (p-NPS) is not colored, so that p-NPS synthesis 
is measured by the disappearance of p-NP. 
Several minor changes were made in the determination as the work pro-
gressed, but the following procedure, adapted from those of De Meio, Wizer-
kaniuk and Schreibman (68) and of Hilz and Lipmann (105) was used in the 
beginning work. 
Assay mixture: 
Potassium phosphate buffer, pH 7 • 
MgS04 • • • • • • • • 
K2,S04 • • • • • • • • • • • • • 
ATP (di K salt) • • • • • • • • 
p--NP • • • • • • • • • • • 
cysteine • • • • 
enzyme • 
• 50 p. mols 
6. 25 J.l mols 
3. 75 p. mols 
5 f'J. mols 
• • 500 m p. mols 
•• 10 Jl mols 
0.1 ml 
Final volume • • 0.5 ml 
Tubes were incubated for 60 minutes at 38° after the addition of enzyme. The 
reaction was stopped by adding 2 ml of alcohol and the precipitated protein 
was removed by centrifugation. One ml of the supernatant solution was added 
132. 
to 5 ml of 0.1 N KOH. Extinction was measured in a Klett colorimeter at 
420 m p (Filter #42). An unincubated control contained 0.4 m1 of incubation 
mixture and 0.1 ml of enzyme; the alcohol was added before the enzyme and 
the tube was not incubated. The blank was 0.4 ml of water and 0.1 ml of 
enzyme. All tubes were run in duplicate. 
A fairly broad absorption maximum was shown by p-nitrophenol at 400 
to 410 mJU, but better linearity between Klett units and concentration was 
obtained with a 420 mp filter than with a 400 mp filter. More absorption 
was obtained from p-NP using the 420 mp filter, and subsequent readings were 
made using this filter. Concentrations of p-NP were estimated from the ob-
served Klett units by comparison to the unincubated control, which contained 
500 mp mols of p-NP in most cases . 
In the measurement of serum phosphatase using p-nitrophenyl phosphate 
as substrate, p-NP is frequently measured without a preliminary deproteiniza-
tion since the alkali added to develop the p-NP color has a clearing effect 
on the protein (3) . The slight cloudiness is corrected for by a serum blank. 
This simplification of the procedure for sulfate esterification was tried. 
Alkali was added and the colors read directly on the Klett colorimeter. A 
slight cloudiness resulted, however, and at this wave- length the determina-
tion is quite sensitive to cloudiness . Although fairly good results were 
obtained by this method it was judged to be advisable to retain the step of 
deproteinization with alcohol. Deproteinization by the addition of ZnS04 
and KOH and placing in a boiling water bath for 2 to 3 minutes also seemed 
to be suitable, but gave no advantage over the simpler procedure with alcohol. 
The indicator color of p-NP is stable after the alkali is added in 
order to measure the extinction. In addition, there is no breakdown of the 
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synthesized p-NPS in the alkali . Tubes containing approximately 340 mjl mols 
of p-NP and 160 mp mols of p-NPS after incubation showed less than 1% change 
in optical density after eight hours of contact with 0.1 N KOH. 
The amount of p-NPS formed in this system, as judged by p-1~ dis-
appearance, is approximately proportional to the amount of enz.yme added , as 
shown in Figure 1 (p. 135). No disappearance of p-~~ occurs upon incubation 
without enzyme . 
Of the various reactants in the incubation mixture, the p-NP is the 
most limiting since only 500 mp mols are present in the 0. 5 ml during in-
cubation. In several instances with two hour incubations as much as 35 to 
45% of this p-NP is converted to p-NPS . In one experiment tubes were incu-
bated with different amounts of p-NP. With 250 mp mols of p-NP, 43 mp mols 
per hour were esterified, and with 500 mJU mols, 60 m p mols per hour were 
esterified. Further increase of the p-NP concentration in the incubation 
mixture would likely increase the amount of p-NPS formed, but the amount 
esterified would represent a decreasing fraction of the p-NP present. Since 
the esterification is measured by difference, higher p-t~ concentrations 
would give less relative accuracy. The concentration of 500 m~Q mols per 
0. 5 ml of incubation mixture, used in most instances, therefore, appears to 
be a good compromise. This limitation of p-NP available, together with the 
ready reversibility of the (p-~~, PAPS/ p-NPS, PAP) equilibrium (90, 154), 
render the system somewhat unlinear . 
The effects of leaving out magnesium, ATP or of substituting cytosine 
triphosphate (CTP) for ATP may be seen in the following table. 
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Incubation conditions m 11 mols of p-NPS/ 2 hrs . 
Complete mixture 129 
No Mg -f. ..f. 10 
No ATP 5 
CTP (no ATP) 10 (not done in duplicate) 
Similarly, when ATP-sulfurylase was measured using molybdate as a substrate 
(as described later) , no activity resulted when magnesium or ATP were left 
out . With CTP, less than 2% of the activity of a complete system was ob-
served . These results are in agreement with those of Robbins and Lipmann 
(168, 169) who found that, although the APSwkinase reaction in yeast was 
supported by several nucleotide triphosphates , including CTP , the ATP-
sulfurylase reaction specifically required ATP . The requirements of a 
liver system are apparently the same (105, 67) . MgC12, rather than MgSo4, 
was used in most subsequent work in order that the sulfate could be varied 
independently without varying magnesium. 
It was found that the complete incubation mixtures had a pH of about 
6. 61 as compared with the buffer pH of 7. All the components of the incuba-
tion mixture were tested for their effect in altering the intended pH. The 
dipotassium-ATP used was found to be responsible. With the introduction of 
5 p mols of K2 • ATP, about 9. 5 p mols of hydrogen ion were introduced- as 
estimated from the buffer capacity in this range of the phosphate buffer used. 
Accordingly, 9. 5)U mols of KOH were added to all tubes containing ATP . As 
a rule, 50JU mols of buffer (pH 7) were used per tube . A sample incubation 
mixture to which 9. 5 }X 1.mols of KOH were added gave a pH of 6. 98. Activity 
at pH 6. 6 was about 10% higher than at pH 7 under these conditions . Although 
136. 
the assay was apparently not very sensitive to moderate changes of pH in this 
range, all substances added to the incubation mixture in amounts greater than 
about 1~ mol were neutralized. 
In most of the subsequent work imidazole buffers prepared according to 
Rauen (162), rather than phosphate buffers, were used. This change was made 
since phosphate measurements were made in some cases and since the action of 
glycylglycine in inactivating sulfate-activating enzyme was to be studied. 
Phosphate prevents this effect of glycylglycine (68). Activity in imidazole 
buffer was found to be about 10% higher than in phosphate, both at pH 7. 
The effect of the complete omission of sulfate on this system is not 
readily determined since the enzyme preparation contains a small amount of 
sulfate from which it is not readily freed (105). The following experiment 
is pertinent to this point. 
Additions to tubes Activity 
Sulfate Selenate m p mols of p-NPS/.2 hrs. 
(5 !;! mols} (10 e. mols} 
-1- None 153 
-1- ...;.. 117 
None None 34 
None 
-1- 3 
The activity of the complete system (153 mp mols/.2 hrs.) was only reduced 
to 34 when sulfate was left out, but this residual activity was further re-
duced to 3 by 10 )l mols of selenate. Selenate is an inhibitor of ATP-
sulfurylase in yeast (244). Therefore, this inhibition by selenate indicates 
that the residual activity observed above when sulfate was not added appears 
to be due to "endogenous" sulfate. The competition between sulfite and sul-
fate has been shown to be competitive, and, while this has not been shown 
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to be the case with selenate and sulfate , it is reasonably certain that they 
are competitive, since they are alternate substrates for ATP- sulfurylase in 
yeast (244) . Note that the selenate inhibited the activity about 24% in 
the presence of the added sulfate, whereas the same amount of selenate inhi-
bited about 90% in the presence of residual sulfate. This behavior is typical 
of competitive inhibition. In addition, since leaving out the sulfate re-
duces the activity to 22% of control and this is further reduced to 2% of 
control by a presumed sulfate competitor, the activity of this system is 
entirely due to esterification of the p-~~ by sulfate. De Meio, Wizer kaniuk 
and Schreibman (68) have stated that these systems do not conjugate with 
glucuronic acid under these conditions . 
In another experiment, the added sulfate was varied from 0. 1 to lOp 
mols per 0.5 ml of incubation mixture . These results are shown in Figure 2. 
At substrate concentrations below 1 p mol/0. 5 ml the activity is sharply 
reduced. Extrapolation of the slope between 0. 5 and O. l )U mol of sulfate 
indicates that the activity is zero when minus 0. 2 )U mol of sulfate is added. 
This is equivalent to saying that the incubation mixture to which no sulfate 
is deliberately added contains about 0. 2 p mols of sulfate. Each incubation 
mixture contains 0. 1 ml of enzyme and approximate measurements indicated that 
the enZYme contained from 0. 1 to 0. 2;u mol of sulfate per 0. 1 ml. Sulfate 
was estimated roughly by preparation of a trichloroacetic acid filtrate, 
addition of BaCL2 and visual comparison of the resulting cloudiness to sulfate 
standards so prepared. These approximate measurements also support the con-
tention that the p-NP disappearance is essentially all sulfate-dependent. 
From Figure 2 it may be seen that maximum activity is obtained with 
l)U mol of sulfate present. At higher substrate concentrations the activity 
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decreases. It is very slightly lower at 5)U mols and about 20% lower at 
10~ mols of sulfate. This inhibition by excess substrate was observed in 
three different experiments where sulfate was varied in this manner. In 
these cases imidazole buffer was used. When phosphate buffer was used in 
another experiment, the activity continued to increase slightly as the sub-
strate concentration was increased from 1 to 10)1 mols of sulfate. The reasons 
for these anomalous effects were not investigated. 
From the equation for the overall sulfate esterification of p-NP 
(Equation 4, p. ttq ) it may be seen that several products are formed. The 
accumulation of any of these substances, as well as limitation of p-NP avail~ 
able to the reaction, would tend to limit the esterification rate . The 
apparent inhibition of the reaction by excess sulfate may be due to any of 
these factors . Brunngraber {35 ) has found that the phenol sulfokinase reac-
tion may be inhibited by accumulation of PAP . 
In this aspect of the experimental work it was intended to test the 
possibility that the substances excreted are activated in the same en~c 
system that activates sulfate. If they are, it follows that these substances 
must be alternate substrates to sulfate in a sulfate-activating system; they 
would therefore be expected to be competitive inhibitors of sulfate activa-
tion. If they compete at any of the steps involved in the activation of sul-
fate and transfer of sulfate to a phenolic acceptor, they should therefore 
inhibit the overall process of sulfate esterification. 
The first excreted substance to be tested as an inhibitor of the 
lamb liver system was PAH. PAH is excreted principally by the kidney, but 
it is also excreted by the liver to a lesser extent (p. f 8 ) . Rather than 
an individual tube for each determination, only two tubes, one containing 
NaCl (as a control) and one containing Na· PAH, were incubated in this 
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experiment. Aliquots of 0.5 m1 were withdrawn at the stated times, de-
proteinized with alcohol and p-NP determined. The incubated mixtures con-
tained 6. 25JU mols of sulfate per 0. 5 ml and 6.25p mols of either NaCl or 
PAH per 0. 5 ml. Phosphate buffer was used. The results are shown in Figure 3. 
It may be seen from Figure 3 that the disappearance of p-NP is 
reasonably linear with time up to four hours . PAH is only slightly inhibi-
tory {4 to 9%) under the conditions of this experiment. An experiment done 
later gave 11% inhibition with 6. 25p mols of PAR and 0. 2,u mol of added 
sulfate/ 0. 5 ml . In the following studies of these compounds as inhibitors 
of sulfate activation, standardized incubation conditions were selected so 
that the various substances may be compared. 
De Meio and co-workers {67, 68) noted that glycylglycine buffer pro-
duced lower activity in a sulfate conjugating system and that the activating 
component of a rat liver preparation was inactivated by contact with {or 
dialysis against) 0. 03 M glycylglycine for 24 hours at 0 - 5° c. This method 
of inactivation of the enzyme seemed unusual , and the author thought this 
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might indicate a specific effect of a glycine conjugate in this system {pp . l2~-~. 
Since several of the compounds excreted by the kidney or liver are glycine 
conjugates , this effect of glycylglycine was studied in a few experiments . 
In one experiment the enzyme used was combined with glycylglycine (or 
NaCl, as a control) and imidazole buffer , pH 7. This was kept in a refrigera-
tor for 24 hours , then combined with the other components of the incubation 
mixture and its p-NP conjugating activity measured . In this case, complete 
inactivation occurred not only in the tube containing glycylglycine , but in 
the NaCl control tube also . During the inactivation in the cold , the molarity 
of glycylglycine was 0. 067 and during the assay its molarity was 0. 03 . This 
p-NPS 
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was the result of an error, since it was intended to use 0. 03 M glycylglycine , 
as did De Meio et al. (68) , during the inactivation in the cold. In the sub-
sequent experiment this error was corrected, and closer control of temperature 
was maintained during the inactivation. The glycylglycine and control NaCl 
tubes were kept at 0° C. in a beaker of ice water in the cold room during the 
24 hours t inactivation. The results of this experiment were quite different. 
There was a gradual decline in activity of both tubes in assays made after 8, 
16 and 24 hours of contact in the cold. After 24 hours the control tube re-
tained 43% of the original activity, and the glycylglycine tube retained 33% 
of the original activity . It would appear that under these conditions the 
effect of glycylglycine is not very remarkable ; the enz,yme certainly was 
not completely inactivated. The rat liver supernatant used by De Meio ~ al . 
had been fractionated with ammonium sulfate and dialyzed; this may in some 
way sensitize the enzyme to glycylglycine inactivation. Robbins and Lipmann 
(169) have used 0. 05 M glycylglycine buffer in the assay of ATP-sulfurylase 
in rat liver supernatant . No further work was done on this glycylglycine 
effect since it did not seem too pertinent to the excretion processes being 
investigated. 
The feasibility of using phosphate determinations to measure sulfate 
activation in the lamb liver preparations was tested . In the formation of 
1 mole of PAPS , 1 mole of PP is produced in the ATP-sulfurylase reaction 
and 1 mole of P in the APS-kinase reaction. 
The pyrophosphatase activity of the lamb liver supernatant was high. 
When 0.4JU mol of PP were added to these incubation mixtures, the PP was 
completely hydrolyzed to phosphate in less than 1/ 2 hour. In order to 
measure the pyrophosphatase activity, it was later found to be necessary to 
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dilute the enz.yme about 100 times . This pyrophosphatase activity was 
magnesium- dependent. The pyrophosphate resulting from sulfate activation 
in these preparations cannot, therefore, be measured as such, since it is 
rapidly and efficiently hydrolyzed to phosphate . 
The lamb liver preparation also had a fairly high magnesium-dependent 
ATP- ase activity. This release of phosphate, together with moderate amounts 
of phosphate present in the enzyme preparation, gave a high phosphate back-
ground of about 2p mols of phosphate in incubated tubes . Although a stimu-
lation of phosphate release could be detected in tubes containing sulfate, 
it could not be measured very accurately since it represented 5% or less of 
the total phosphate . The sulfate stimulated phosphate release was of the 
order of magnitude expected from the known capacity of the system to activate 
sulfate . 
The lamb liver supernatant was fractionated with ammonium sulfate 
according to the procedure given by De Meio , Wizerkaniuk and Schreibman (68) . 
No improvement in the ability to measure sulfate-dependent phosphate release 
resulted, however . About 3/4 of the sulfate-activating capability was lost 
in the fractionation procedure, and the ATP- ase activity was only moderately 
reduced . Even after prolonged dialysis , the sulfate in the fractionated 
preparation was higher than in the original preparation, thereby making it 
more difficult to attribute a stimulation of phosphate release to added sulfate . 
Selenate and molybdate were then tried as inhibitors of sulfate conju-
gation of p-NP. In the tubes to which selenate was added it was noted that a 
salmon color developed during incubation and precipitated with the protein 
when alcohol was added at the end of incubation. Schwarz and Folz (192) 
noted that certain selenium compounds are readily reduced to red, elemental Se. 
1~. 
It thus appears that the selenate (or perhaps selenite impurity) added to 
the incubation mixtures may have been in part reduced to selenium. The 
cysteine added to the incubation medium was suspected as being the responsi-
ble reducing agent. It was found that the development of the salmon color 
was dependent on the presence of both cysteine and the enzyme preparation; 
heat-denatured enzyme was ineffective. There is some indication, therefore, 
that selenate may be enzymatically reduced to selenium in the presence of 
cysteine by lamb liver supernatant. This interesting effect was not further 
studied. The sulfate-conjugating activity of these enzyme preparations was 
just as good without cysteine, so it was deemed advisable to leave cysteine 
out of the incubation mixture to prevent possible difficulties. Further 
fractionation of the liver supernatant requires the use of cysteine to pro-
tect these sulfhydryl enzymes {105), but cysteine is not necessary with un-
fractionated enzyme preparations. 
Figure 4 shows the inhibition of p-NP conjugation by selenate or molyb-
date. These tubes contained lJl mol of sulfate and 5;u mols of ATP and, where 
indicated, lOJU mols of either sodium selenate or molybdate. Cysteine was not 
included. Since molybdate in the presence of yeast ATP-sulfurylase causes a 
rapid breakdown of ATP (10, 244), it was considered likely that in this long 
incubation with a rather large amount of molybdate, the ATP supplied to the 
reaction {5 ~ mols) might become limiting. This possibility was tested by 
adding an additional 5JU mols of ATP per 0.5 ml of incubation mixture to each 
of the incubated mixtures after two hoursr incubation. The effect of this 
addition was then observed during the third hour of incubation. This addition 
was made without changing the volume relationships in the incubated tubes by 
applying the required amount of an ATP solution to small circles of filter 
paper and adding the dried papers. 
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It m~ be seen from Figure 4 that, in the tube containing no inhibitor, 
p- NP disappearance was uniform during the first two hours . This tube was not 
stimulated by the ATP addition. The decreased conjugation during the third 
hour was most likely due to limitation of available p-NP; at the end about 
45% of the p-NP was converted to p-NPS . 
The tube containing selenate showed neither this p-~W limitation nor 
significant stimulation by the added ATP . In the tube containing molybdate, 
however, a drop-off in activity occurred during the second hour. The activity 
was restored by the ATP addition to more than its original activity. This is 
a preliminary indication that molybdate has an effect with liver ATP-sulfury-
lase similar to its effect with the yeast en~e in rapidly splitting ATP. 
For the two hour incubation, lOp mols of selenate or of molybdate, 
competing with lp mol of sulfate, inhibited by 72% and 88%, respectively. 
A two hour incubation was used in most cases in the following work with this 
system. 
B. The testing of various compounds as inhibitors of a sulfate-activating 
system from mammalian liver. 
In order to test the possibility that, in the course of excretion, 
these substances are activated by the same system that activates sulfate, a 
wide variety of these compounds was surveyed with respect to their ability 
to inhibit sulfate activation. If the sulfate-activating system activates 
these substances also, it follows, that as alternate substrates, they should 
compete with sulfate because of their affinity for the same enz.yme. These 
substances were first tested for their ability to inhibit the esterification 
of p-NP in a sulfate-activating system from liver . 
As already described, the formation of sulfate esters of phenols in 
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these systems is a three step process. 
A.TP-sulfurylase 
(1) ATP -/- sulfate .APS -f.. PP 
pyrophosphatase 
pp 2 p 
APS-kinase 
(2) APS -/- ATP ----_,.) PAPS -/- ADP 
phenol sulfokinase 
(3) p-NP /- P .APS p-NPS -/- P !P 
The demonstration that a compound inhibits the formation of p-NPS does not 
allow a definite assignment of the competition to a particular step of this 
process . The phthaleins or sulfonphthaleins excreted by liver or kidney, 
for example, are phenolic substances, and they might conceivably inhibit at 
the third step, rather than in the activation steps, since they could possibly 
act as alternate sulfate acceptors to p-NP. Another system using molybdate, 
rather than sulfate, was adapted in order to localize the inhibitions observed. 
The ATP-sulfurylase catalyzed reaction, whereby ATP is rapidly split 
in the presence of molybdate, is well characterized in yeast (pp. /21-3). 
The author has already described an experiment in which molybdate was tested 
as an inhibitor of sulfate esterification (pp ./~~~7) by a liver preparation. 
Molybdate was found to be inhibitory to sulfate esterification, and, with an 
extended incubation, the rate of esterification fell off . Addition of ATP 
restored the activity. This rate limitation, apparently associated with loss 
of ATP, suggests that molybdate has the same effect with liver ATP-sulfurylase 
as with the yeast enzyme. 
When sodium molybdate was substituted for sulfate as the substrate and 
p-NP left out of the system, it was found that a considerable amount of phosphate 
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was hydrolyzed from the ATP. Tubes incubated with and without molybdate for 
30 minutes contained 5.03 and 2.25 p mols of inorganic phosphate , respectively . 
These tubes contained .ATP, 5 p. mols ; MgC12, 6. 25 p mols; imidazole buffer, 
50 JU mols; lamb liver supernatan~ 0.1 ml; 5JU mols of molybdate were added 
to 1'Mo 11 tubes . This stimulation of phosphate release by molybdate did not 
occur in the absence of ATP or magnesium. With cytosine- triphosphate re-
placing ATP, the activity was less than 2% of the activity with ATP. 
The molybdate- stimulated phosphate release from ATP was dependent upon 
the addition of the lamb liver supernatant, but, in these tubes, a small 
amount of molybdate-stimulated phosphate was released in the absence of en-
zyme. When 5p mols of molybdate were added , the error due to this effect was 
about 6% . In the following work where this molybdate assay method was used, 
only l)l mol of molybdate was added to the tubes . It was shown that most of 
the non - enzymic error occurred during the deproteinization step with tri-
chloroacetic acid. By minimizing the time spent in this operation and centri-
fuging in the cold, the error from this source was probably of the order of 
1 to 2%, and was , for practical purposes , ignored. In one experiment this 
error was compensated chemically during the deproteinization step by adding 
molybdate to tubes not containing it . The results did not indicate that 
this more complicated procedure was necessary . A gentler deproteinization 
with alcohol was tried . However, although alcohol did not inhibit the de-
velopment of color in phosphate standards, some component of the incubation 
mixture which inhibited color development was apparently not removed by alcohol . 
The determination of phosphate by the Lowry- Lopez method, of course, 
involves the addition of a relatively large amount of ammonium molybdate after 
the deproteinization step (133) . The ammonium molybdate added to develop the 
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color, however, was about 250 times greater, in terms of molybdenum content 
than that already present in 11Moll tubes . No color developed prior to this 
addition, and the s~all amount of molybdate in the incubation mixtures did 
not influence the phosphate determination. 
The effect of varying the concentration of the molybdate substrate on 
the rate of reaction was determined in order to select a suitable substrate 
concentration to use in inhibition studies. The reaction rate at different 
molybdate concentrations is shown in Figure 5, plotted according to the 
method of Lineweaver and Burk (125) . The maximum velocity (Vmax) calculated 
from these data is 3 p mols of P per 30 minutes, and the substrate concentra-
tion giving half-~aximal velocity (Km) is 0. 97 ~ mols of molybdate per 0.5 ml . 
The average rates for molybdate-stimulated P release at different substrate 
levels, corresponding to the data of Figure 5, are as follows: 
IJ.. mols Mo per 0. 5 ml 
10 
5 
1 
0. 5 
0. 1 
Mo dependent P in JJ. mols/ 30 min. 
2. 74 
2. 56 
1.52 
1.05 
0. 35 
In order to show the involvement of the excreted substances with the 
en~es which activate sulfate, these compounds were tested as inhibitors in 
both types of system - a sulfate-esterification system and a molybdate system. 
If the inhibitor is active in both of these systems, the inhibition may be 
localized to the ATP- sulfurylase step. Inhibition of sulfate esterification 
could occur at any of the following enzymatic steps: ATP- sulfurylase, 
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Fig. 5 RATE OF MOLYBDATE-STIMULATED PHOSPHATE RELEASE 
VS. MOLYBDATE CONCENTRATION 
( Lineweaver- Burk Plot ) 
v =velocity of reaction in.)lmols of P /30 min. 
{S}= substrate concentration in)J.mols of molybdate /0. 5 ml 
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APS-kinase, phenol sulfokinase or pyrophosphatase (pp. t¢7-~). Only two of 
these en~es, ATP-sulfurylase and pyrophosphatase, are involved in the 
molybdate system (244). Adenyl molybdate, the intermediate formed in this 
reaction, because of its extreme instability, and perhaps also its recalci-
trant nature, does not couple with APS-kinase, as does adenyl sulfate. Molyb-
date or tungstate have been shown by Gregory and Lipmann (90) to be without 
effect upon the phenol sulfokinase reaction of liver. 
In order to attribute an inhibition observed in both systems to the 
ATP-sulfurylase step, the possible effect of the inhibitor upon pyrophospha-
tase must also be considered. For this reason, most of the substances were 
also tested for inhibition of the pyrophosphatase activity of lamb liver 
supernatant. The sensitivities of the sulfate-esterification system and 
the molybdate system to removal of end-product by pyrophosphatase are prob-
ably quite different. With sulfate as the substrate, the reaction requires 
the efficient removal of PP formed in the ATP-sulfurylase reaction {127). 
On the other hand, ATP is rapidly split by molybdate in the presence of yeast 
ATP-sulfurylase, even though PP is allowed to accumulate (244). The insta-
bility of the other product of this reaction, adenyl molybdate, removes it 
so effectively from the equilibrium that the reaction is not sensitive to 
accumulation of the pyrophosphate. The same is probably true of lamb liver 
enz,yme, but when phosphate rather than pyrophosphate is being measured, pyro-
phosphatase is necessary to the system in a different WaY. It was shown, 
however, that a large excess of pyrophosphatase is present in the lamb liver 
supernatant (pp. 1~3-~). If a step of a system is inhibited, the effect upon 
the system as a whole will depend upon the extent to which this step limits 
the system. Particularly in the molybdate assay system, it should require a 
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very strong inhibition of pyrophosphatase to produce even a small observed 
inhibition of the system. This makes it possible to rule out minor inhibi-
tory effects on pyrophosphatase as insignificant to the system as a whole. 
Since it was intended to test the substances excreted by the liver 
and kidney as competitors of sulfate, particularly in the ATP- sulfurylase 
reaction, it was desirable that sulfate (or the sham substrate, molybdate) 
sho11ld be limiting to the overall systems . In addition, it was desirable 
that the two systems be as alike as possible with respect to other factors 
except the substrate used and that substrate concentrations be so chosen that 
inhibitions in the two systems are reasonably comparable, to facilitate com-
parison. Another factor to be considered is that lower substrate concentra-
tions will require less of the inhibitors to evince comparable inhibitions . 
Several of the substances to be tested were dyes, e . g. , phenolphthalein, 
which are highly colored in the alkali necessary to measure p-NP. It was 
anticipated also that some of these compounds would inhibit color development 
in phosphate measurement. 
The choice of substrate level for the sulfate- esterification system 
was made by consideration of the data of Figure 2 on p. 139. Increase of 
the sulfate concentration from 1 to 5;u mols of sulfate per 0.5 m1 did not 
increase the reaction rate. If the higher substrate concentration were used, 
a very considerable enzymic inhibition might occur without any decrease of 
reaction rate . There is a very sharp drop-off of rate below liU mol of sul-
fate per 0. 5 ml, and it was considered that concentrations below this level 
would render the system too sulfate- sensitive (and inhibitor-sensitive) . 
Reproducibility would probably suffer from venturing into this range . A 
substrate concentration of lp mol of sulfate per 0.5 ml was accordingly 
chosen for the inhibitor studies . 
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In order that the molybdate system behave similarly to inhibitors, 
substrate concentrations should be so chosen that approximately equal 
11 enzyme saturations" are attained in the two systems. The best way to accom-
plish this would be on the basis of the Michaelis~enten constants for the 
two systems {sulfate esterification and molybdate). Since the Km is the 
dissociation constant of the enzyme-substrate complex: 
Kin - (E) (S) 
- (ES) 
and 
(ES) - (El (Sl 
-
Km 
Where Kin = Michaelis~enten constant 
E -
-
enzyme 
s = substrate 
ES - enzyme-substrate complex 
-
At equivalent saturation of the enzyme by either sulfate or Mo: 
(ES~0 ... (ES)sulf : (E) (S~0 = {E) (S)sulf 
K"rnt1o Kmsulf 
Since the same concentration of enzyme is used in the assay with either system: 
(S)Mo = ~o 
(S)sulf Kmsulf 
To attain equivalent enzyme saturation with the two substrates, therefore, 
the two substrate concentrations should be in direct ratio to the two Kmts. 
This relationship could not be applied to the present case with very 
good accuracy, however. An apparently suitable estimate of Kin may be made for 
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the molybdate system (pp. ts-o-1). This Km for molybdate is about lp mol of 
molybdate per 0.5 ml. The sulfate-esterification system did not exhibit 
very 11 ideal11 behavior, however, because of substrate inhibition at higher 
levels of sulfate. A crude estimate of the Km for sulfate (the substrate 
concentration giving half-maximal reaction velocity) gives a value of 0.1 to 
0.2p mols of sulfate per 0.5 ml (Figure 2, p. 139). Substitution of these 
values into the expression above indicates that the desired substrate con-
centration for molybdate is of the order of 5 to lOp mols of molybdate per 
0.5 ml. 
Since 1 /U. mol of sulfate per o. 5 ml seems almost to saturate the enzyme 
(Figure 2, p. 139), the range of molybdate concentrations giving about 50 to 
85% enzyme saturation seemed the best to try .first in comparison of the molyb-
date system to the sulfate system. From the data on p. /~~ these saturations 
correspond to molybdate levels of 1 to 5p mols/0.5 ml. That lOp mols per 
0.5 ml was too high a molybdate concentration to give saturation comparable 
to 1 )J. mol of sulfate is shown on p. 11/.7 , since 10 f.l mols of molybdate vs. 
lp mol of sulfate inhibited p-NP conjugation by 88%. 
The cholecystographic agent, Telepaque, was chosen as a typical test 
substance to try as an inhibitor in comparing the two systems. Telepaque 
(0.5 p mol per tube) inhibited p-NP conjugation by about 81% when lp mol 
of sulfate per tube was present. The same amount of Telepaque inhibited 
molybdate-dependent P release 69% and 78% with 5 p mols and lp mol of molyb-
date, respectively. Therefore, substrate concentrations of lp mol/0.5 ml 
were chosen for both sulfate and molybdate to give more or less similar 
response to inhibitors. The systems used to determine the effects of the 
various inhibitors are given below. 
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Sulfate esterification system: 
Reagent Cone. of Vol. of Amount in 
rea ent rea ent mols 
Imidazole HCl buffer, pH 7 0.5 M 0. 100 50 
K2so4 0. 04 M o. 025 1 
K2·ATP 0.2 M 0. 025 5 
KOH 0. 38 M 0.025 9. 5 
MgC12 0. 25 M 0.025 6. 25 
p-:t."P 0. 01 M 0.050 0. 5 
Inhibitor (if present) 0. 050 
H20 0. 100 
Total volume 0. 4 ml 
To 0.4 ml of this incubation mixture , 0. 1 ml of enzyme (liver super-
natant ) was added, and the tubes were incubated for 2 hours at 38°. The 
reaction was stopped by the addition of 2 ml of 95% alcohol. The protein 
precipitate was centrifuged out, and a 1 ml aliquot added to 5 ml of 0. 1 N 
KOH. Extinctions were read in a Klett colorimeter at 420 m }.l. Tubes were 
incubated with and without inhibitor . The standard (representing 500 mp 
mols of p-NP) was an unincubated control to which the alcohol was added prior 
to addition of enz.yme. The blank was 0. 4 ml of water and 0. 1 ml of enz.yme. 
Activity was expressed in mp mols of p-NP disappearing per 2 hours . When 
inhibitors, colored in 0. 1 N KOH (such as phenolphthalein) were used, equal 
amounts were added to Uninhibited tubes after incubation, as well as to 
standards and blanks . All tubes were run in duplicate. 
Molybdate system: 
The incubation mixture for the molybdate system was the same as for the 
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sulfate-esterification system, except that p-NP was not added, and lp mol 
of sodium molybdate replaced lp mol of potassium sulfate. Tubes containing 
0. 4 ml of incubation mixture and 0. 1 ml of liver supernatant were incubated 
for 30 minutes at 38°. Reactions were stopped by the addition of 4 ml of 
5.63% trichloroacetic acid. Tubes were centrifuged in the cold and phosphate 
determined by a modified Lowry-Lopez procedure (133). Care was taken to 
minimize the time during which the mixtures were in the acid solution. To 
10 ml of a freshly prepared acetate buffer-ascorbic acid mixture was added 
1 ml of the supernatant (containing 5% trichloroacetic acid). Color was 
developed by the addition of 1 ml of 1% ammonium molybdate in 0.05 N H~04. 
Colors developed well and were found to be somewhat more stable with 1/ 4 the 
usual amount of ascorbic acid. After about 15 minutes of color development, 
the blue colors t.-rere measured at 720 m,Al with an Evelyn colorimeter. Phos-
phate was determined by comparison to standards containing 4p mols of P. 
When necessary, inhibitors which were colored in the color development mix-
ture (pH 4) were calorimetrically compensated for. With all the inhibitors, 
extra standards were prepared containing the inhibitor, so that any effect 
upon the phosphate color development would be detected. Penicillin, for 
example, markedly slowed the development of color, but by allowing about an 
hour for color development, the tubes could be accurately compared. Two 
substances used, Benzomethamine bromide and Oxyphenonium bromide, proved to 
be incompatible with the phosphate determination. 
In order to determine the inhibition of molybdate-stimulated phos-
phate release, four tubes, each in duplicate, were incubated. Two tubes 
not containing the inhibitor were incubated - one with and one without molyb-
date. The difference in phosphate between these tubes represents Me-stimulated 
P release in the absence of inhibitor. Two similar tubes containing the 
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inhibitor were also incubated - one with and one without molybdate. The 
Me-stimulated P release in the presence of the inhibitor was obtained from 
the difference in phosphate between these tubes. The 11% inhibition11 of Mo-
stimulated P release due to the inhibitor was obtained by comparison between 
these two sets of tubes. 
It was necessary to incubate all four of these tubes since many of 
the compounds tested as inhibitors also had an effect of reducing the back~ 
ground phosphate in the absence of molybdate. This situation is best repre-
sented by an example in which this effect was large. That this effect was 
not attributable to inhibition of phosphate color was shown by standards, 
with and without the inhibitor. The cholecystographic agent, Telepaque, was 
being tested in the following instance as an inhibitor of Me-dependent P. 
Tubes contained 1 p mol of molybdate and 0.5 p mols of Telepaque, when 
present. Incubation was for 30 minutes with lamb liver supernatant. 
Composition of tube p mols P at Mo-dependent P 
30 minutes mols per 30 minutes) 
Mo 3.51 1.55 without Telepaque 
No Mo 1.96 
Mo I- Telepaque 1.80 0.34 with Telepaque 
No Mo -1- Tele~gue 1.!!:6 
In this experiment, the inhibition of Mo-dependent P by Telepaque 
was 100 (1 - 0. 34/ 1 . 55) % = 78%. Note, however, that the "background" 
phosphate in the no Mo tubes was reduced by Telepaque from 1. 96 to 1 .46, 
a difference of 0.50 Jl mols. The phosphate present in tubes without molyb-
date may be considered to have two principal sources . About 1/ 2 p mol of 
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inorganic phosphate is originally present in the enz,yme, and additional 
phosphate is produced from ATP during the incubation. This 11 ATP- ase11 
activity exhibited some rather strange characteristics. The compounds 
tested which had large inhibitory effects on Me- stimulated P also depressed 
this 11 ATP-ase11 • The proportionality bet ween these two effects of the inhi-
bitors was poor , however. Control inhibitors , like NaCl or sodium acetate, 
did not effect the background phosphate . Sulfate and selenate were notable 
exceptions to this rule . Both inhibited molybdate- dependent phosphate re-
lease, but sulfate produced a very slight increase in the phosphate release 
with molybdate absent, and selenate (lO JU mols/ 0. 5 ml) likewise induced an 
increase in this value of about 0. 1~ mol of phosphate/ 30 minutes . This is 
consistent with the effects of sulfate and selenate with yeast ATP- sulfury-
lase, as observed by Wilson and Bandurski (244) . 
These observations suggest that a portion of this "ATP- ase11 activity 
is somehow related to ATP- sulfurylase. The acids tested as inhibitors in 
this system are rather notably non-t oxic, so it would not be expected that 
they would be involved in non- specific inhibitions. The system behaves, in 
fact, as though some component were present which has a molybdate-like effect, 
since the same substances which inhibit Me-dependent P also inhibit the back-
ground phosphate . An attempt was made to determine whether, if such a com-
ponent were present in the enzyme preparations, it could be removed by dia-
lysis . The enzyme was accordingly dialyzed with agitation for 2 hours at 
0° C. against a solution similar in composition to that used in the original 
preparation of the enzyme . The effect of Telepaque was then determined with 
this dialyzed preparation. The blanks were reduced because most of the phos-
phate was removed from the enzyme by dialysis. However, the effect of 
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Telepaque in reducing the blank was only about 10% less than with the un-
dialyzed enzyme ( 0. 46 1J. mols-- per JO minutes after dialysis ; 0. 50 )U mols 
per JO minutes before dialysis) . Dialysis of the enzyme also had little 
effect upon the Telepaque inhibition of Me-dependent P (81% after dialysis ; 
78% before dialysis) . If such a. molybdat e- like substance is present in the 
enzyme, it was not appreciably removed by the two hours of dialysis . Whether 
it could be present in the incubation mixture was not tested . Whatever the 
cause of this effect it may be suitably corrected for by the use of the 
controls specified. 
In the course of purification of yeast ATP-sulfurylase, Wilson and 
Ba.ndurski (244) obtained an increase of activity (molybdate assay) upon dia-
lysis of a crude ext ract (Step II) . They att ributed this to 11removal by dia-
lysis of sulfat e, a competitive inhibitor of the molybdate reaction, and to 
loss of molybdate- inhibitable .ATP-ase activity . " Bandurski (9; discussion 
at end of article ) has also suggested "caution in utilizing the molybdate 
assay for [ATP~ sulfurylase in crude enzyme preparations . Molybdate is a 
potent inhibitor of ATP-a.se and thus in crude preparations containing more 
ATP- a.se than sulfurylase one may observe an inhibition of P liberation from 
ATP by molybdate . 11 
It is rather difficult to evaluate the pertinence of these comments 
to the lamb liver preparations . With the lamb liver, however, rather than a.n 
inhibition of phosphate liberation by molybdate, a marked stimulation is 
observed. The reaction is molybdate-dependent and with higher levels of 
molybdate the phosphate release may be about twice that observed with lp 
mol of molybdate per 0. 5 ml . This reaction with l~~b liver supernatant, 
moreover , follows Michaelis~enten kinetics rather closely (Figure 5, p. l52). 
Whether the background phosphate release, which has just been discussed, 
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represents a umolybdate-inhibitable ATP- ase 11 cannot be directly measured 
since molybdate induces an increase of phosphate release in these prepara-
tions . However , this background phosphate release observed in the absence 
of molybdate is inhibited by other substances, such as Telepaque, which 
also inhibit sulfate . 
The molybdate-stimulated phosphate release involving ATP- sulfurylase 
might be considered a molybdate-stimulated apyrase activity, since it in-
volves the split of PP from ATP (118). Coupled with the action of pyro-
phosphatase the products are AMP and phosphate . 
There are several indications that the sulfate- esterification system 
and the molybdate system, as constituted, measure the same en~e . By the 
use of near- limiting amounts of sulfate as substrate for sulfate-esterifica-
tion, this system has been sensitized to competitors of sulfate in the ATP-
sulfurylase step - the only step in which sulfate per ~ is the substrate . 
The molybdate system is also a measure of this same step, by analogy to the 
action of molybdate in yeast . Considerable evidence has been discussed which 
indicates that the effect of molybdate in these lamb liver preparations is 
the same. Sulfate is inhibitory in the molybdate system; molybdate is 
inhibitory in the sulfate-esterification system, and selenate inhibits both 
systems (Table I, p. J'' ). As will be seen in Tables I-IV (pp. /,6-9 ) , a 
number of substances were tested as inhibitors in both systems . The inhibi-
tions observed in the two systems were remarkably parallel, particularly with 
the stronger inhibitors . 
In testing this wide variety of compounds as inhibitors in these two 
systems, a number of analytical problems required minor changes in the systems 
in order to test certain of the compounds . everal of the phthaleins were 
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insufficiently soluble in the imidazole buffer at pH 7. In the cases of 
Rose Bengal and Mercurochrome, the substitution of a Tris buffer of pH 7. 5 
permitted these compounds to be tested suitably. Tetraiodo- phenolphthalein, 
tetrabromo-phenolphthalein and phenolpht halein were not sufficiently soluble 
under these conditions . 3everal solvents were tested for their ability to 
increase the compatibility of these dyes with the system. Amounts of the 
solvents permitting the dyes to be dissolved , however, were inhibitory to 
sulfate activation. By using 0. 05 ml of 7% bovine serum albumin, together 
with Tris buffer of pH 7. 5, these dyes were also readily tested in the system. 
The activity of the sulfate- esterification system was about 14% lower 
in Tris , pH 7. 5, than in imidazole , pH 7. With the Tris ~ albumin, the acti-
vity was about the same as in the imidazole buffer . Albumin itself , without 
added enzyme was inactive in esterifying p-NP . In order to evaluate the 
effects of these changes in the incubation mixtures on actual determinations 
of inhibition of sulfate- esterification, Telepaque (0. 5 p mols per tube) was 
tested under these various conditions . In each case, comparison was made to 
similarly constituted incubated and unincubated controls . 
Inhibition of sulfate esterification by Telepaque 
System % Inhibition 
Imidazole, pH 7 81 
Tris , pH 7.5 81 
Tris, pH 7. 5 ,l albumin 37 
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The behavior of this system toward Telepaque, as an inhibitor, was not 
altered by the change in buffer . The reduction of inhibition in the presence 
of albumin is apparently due to protein-binding of the Telepaque by the albumin. 
The effective concentration of free Telepaque is thereby lowered . Albumin 
addition seemed to be a good method, however, to make the three phthaleins 
compatible in this system. The inhibitions obtained with these substances 
in the presence of albumin are probably induced by considerably lower concen-
trations of free phthalein than would be indicated by the amounts actually 
added to the system. They are intrinsically better inhibitors than is indi-
cated by the inhibitions observed when albumin is present. Phenolphthalein 
and its tetraiodo- and tetrabromo- derivatives are apparently quite exten-
sively bound by albumin, as evidenced by the marked increase of solubility 
upon the addition of albumin. In the int act animal these compounds , of course , 
are bound by plasma proteins, and they are presented to the liver in this form . 
When used, the albumin was present in the incubation mixture at 0. 7% concen-
tration. 
In testing phenolphthalein glucuronide, considerable hydrolysis of 
this compound to free phenolphthalein occurred , due to glucuronidase in the 
enz.yme preparation. The inhibition values reported for this compound, and 
presumably also for menthol glucuronide , may be considerably in error . It 
would be necessary to free the lamb liver supernatant from glucuronidase 
in order to test these compounds unambiguously. The use of saccharate to 
inhibit glucuronidase (122) might also be a suitable method . This has, how-
ever, not been done . 
Mercurochrome proved to be a strong inhibitor of sulfate esterification. 
An attempt was made to det ermine whether this effect might be due to ionic 
mercury by noting the effect of cysteine. In these experiments, cysteine, 
itself seemed to have a variable inhibitory effect on the system. Although 
cysteine appeared to have a relatively minor effect on the inhibition by 
mercurochrome, this conclusion is not very certain. 
1~. 
Preliminary experiments were frequently made in order to determine 
the range of inhibitor concentration to be used, but in many cases these 
could be chosen from previous experience with related compounds . Concentra-
tions of inhibitors above 10 p mols/ 0. 5 ml (10 times that of the substrates, 
sulfate or molybdate) were not used . Values of inhibitions observed below 
10% were considered questionable, and, when feasible, the experiments were 
repeated with higher levels of inhibitor . 
The following tables summarize the data obtained by testing a variet;}r 
of compounds as inhibitors of the sulfate-esterification and molybdate systems 
described. The basic incubation mixtures and analytical methods are given on 
pp. /57- t . The substances tested are mostly acids related to the liver and 
kidney excretion systems being studied . Certain control subst'inces are also 
included . The evaluation of a given compound as an inhibitor depends on both 
the inhibition observed and the stated amount added to the incubated tubes . 
It should be kept in mind that the stated amount of inhibitor per tube is 
competing against l mol per tube of ei t her sulfate or molybdate . Incubation 
volumes were 0. 5 ml, and the enzyme system added was a lamb liver homogenate , 
freed of particulates by ultracentrifugation (lamb liver supernatant) . This 
preparation contains a complete enzymic system for activating sulfate and 
transferring active sulfate to a phenolic acceptor . 
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TABLE I 
INHIBITION OF LAMB LIVER 
ATP...S ULFURYLASE 
p mols % Inhibition 
Inhibitor per tube Sulfate Molybdate 
System System 
Known substrates of ATP- sulfurylase 
Potassium sulfate 1 69 
Sodium molybdate 10 86 
Sodium selenate 10 69 89 
Inhibitors of excretion 
Benemid t~ 93 26 
Carinamide 10 67 75 
Bromcresol green 0.05 62 50 
Bromcresol purple t 0. 05 36 10 
0.1 30 
Bile salts 
Glycocholic acid u-5 15 32 
TABLE II 
INHIBITION OF LAMB LIVER 
ATP-S ULFURYLASE 
p mols ~ Inhibition 
Inhibitor per tube Sulfate 
System 
Cholecystographic agents 
Telepaque 0. 5 81 
Cholografin 0. 5 47 
Priodax 0. 5 73 
Orabilex 0. 5 40 
Phenolphthalein and derivatives 
Phenolphthalein1 0. 5 34 
Tetrabromo- phenolphthalein1 0. 5 84 
Tetraiodo-phenolphthalein1 0. 5 88 
Bromsulfalein (BSP) {~. 05 95 
Fluorescein 1 
Rose Bengal 2 0. 05 84 
Mercurochrome 2 0. 02 32 
Mercurochrome 2 
-1- cysteine 3 0. 02 25 ? 
1 Tested in Tris/HCl buffer , pH 7. 5; albumin (0. 7%) present . 
2 Tested in Tris/HCl buffer , pH 7. 5. 
Molybdate 
System 
78 
26 
87 
34 
25 
80 
48 
30 
91 
3 Five ;u mols of cysteine added; the effect of cysteine in the system 
was variable. 
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TABLE III 
INHIBITION OF L.AMB LIVER 
ATP-S ULFURYLASE 
p mols % Inhibition 
Inhibitor per tube Sulfate Molybdate 
System System 
Substances excreted Qrimarily by 
renal tubules 
Phenolsulfonphthalein (PSP) 1 51 12 
Penicillin G t~ 88 28 
p-Ai'llinohippuric acid (PAH) 10 9 25 
Hippuric acid 10 25 29 
Diodrast (diethanolamine salt) 10 48 48 
Diethanolamine - control 10 minus 9 8 
Hypaque (Renografin) 10 5 22 
Neo- Iopax 10 32 40 
Skiodan 10 1 23 
Menthol glucuronide 10 381 401 
Phenolphthalein glucuronide 0.5 591 
Tetraethylammonium bromide (TEA) 10 0 29 
NaBr - control 10 minus 1 20 
1 Inhibition values uncertain because of ~-glucuronidase activity of lamb 
liver supernatant. 
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TABLE IV 
INHIBITION OF LAMB LIVER 
ATP- SULFURYLASE 
p mols % Inhibition 
Inhibitor per tube Sulfate Molybdate 
System System 
Miscellaneous 
NaCl 10 2 14 
Acetate 10 minus? 3 
Benzoic acid 10 40 30 
p-Aminobenzoic acid (PAB) 10 4 24 
Glycylglycine 10 minus6 16 
Benzomethamine bromide 10 50 
OxyphenoniQ~ bromide 10 82 
In addition to these inhibition studies with lamb liver supernatant, two 
of the compounds have been tested with a similar preparation from dog liver . 
The dog liver supernatant was less active than the lamb liver in sulfate esteri-
fication, but its ATP- sulfurylase activi t y by the molybdate assay was somewhat 
higher than in lamb liver . The dog liver supernatant was similarly inhibited 
by phenolphthalein and tetraiodo- phenolpht halein but to a lesser extent . The 
test system was identical to that used with the lamb liver, i.e., Tris/ HCl 
buffer, pH 7. 5 and bovine serum albumin were used with the molybdate test system. 
Inhibitions observed with the dog liver supernatant were 32% by tetraiodo- phenol-
phthalein (0. 5p mols/ tube) and 27% by phenolphthalein (2;u mols/ tube) . The 
corresponding values in lamb liver were 80% by tetraiodo- phenolphthalein (0. 5 
;u mols/ tube) and 25% by phenolphthalein (0. 5 p mols/ tube). This is, therefore, 
a preliminary indication that some of these compounds have similar effects in 
liver preparat ions from other species . 
The results of these inhibition studies will be discussed later (Section 
VIII, C) in relation to hepatic and renal excretion mechanisms . 
Experiments were done in an attempt to establish the nature of the inhi-
bitions observed as competitive or non- competitive. Inhibited tubes contained 
either Telepaque (0.2p mols/ tube) or Rose Bengal (0. 02~ mols/ tube), competing 
against varying amounts of sulfate . The sulfate added was varied from 0.1 to 
5 p mols/ tube . Incubation conditions were otherwise the same as previously 
used . The results of these experiment s are shown in Figures 6 and 7, plotted 
according to Lineweaver and Burk (125). 
The sulfate- esterification system does not graph as a straight line; 
that is, it does not closely followMichaelis~1enten kinetics . The principal 
difficulty is the inhibition by higher levels of sulfate noted before, (Figure 
2, p. /3~ ) . This inhibition by sulfate is responsible for the upturn at the 
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Fig. 6 INHIBITION OF SULFATE ESTERIFICATION BY TELEPAQUE 
(Lineweaver- Burk Plot ) 
v = velocity of sulfate esterification ( .~Jmols of p-NPS /2 hrs.) 
[S] = substrate concentration(.).l.mols of sulfate /0.5 ml ) 
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Fig. 7 INHIBITION OF SULFATE ESTERIFICATION BY ROSE BENGAL 
( Lineweaver- Burk Plot ) 
v = velocity of reaction (A Klett units/ 2 hrs.) 
[S] = substrate concentration ( fimols of sulfate /0.5 ml ) 
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left end of the uninhibited reaction in the Lineweaver- Burk graphs. The 
reasons for this inhibition of the overall reaction by excess substrate is 
rather obscure . Sulfate esterification is a coupled series of reactions, and 
it seems most likely that some of the subsequent steps may become limiting 
when the first reaction, i . e . the ATP- sulfurylase reaction, is stimulated by 
excess substrate. The overall reaction is limited to some ext ent by the p-NP 
available to the reaction. In the experiment of Figure 6, for example, 30% 
of the available p-NP was converted to p-NPS in the most active tubes . A net 
inhibition of the reactions by excess substrate very likely depends upon the 
increased accumulation of an inhibitory product . pyrophosphate would be un-
likely because of the large excess of pyrophosphatase . Brunngraber (35) has 
found that the phenol sulfokinase reac t ion is inhibited by accumulation of PAP . 
Whatever the reasons for the anomalous behavior of this system, it makes diffi-
cult a clear judgment by this means as to whether the inhibitions induced by 
Telepaque or Rose Bengal are competitive with sulfate . 
Despite the lack of ideal behavior by the sulfate activating system, 
in the case of Telepaque (Figure 6), the curves for the uninhibited reaction 
and the inhibited reaction appear to have the same y- intercept . The inhibition 
by the Telepaque is, in other words, completely overcome by additional sulfate. 
This is a basic characteristic of a competitive relationship between Telepaque 
and sulfate. If this is also the case with Rose Bengal vs . sulfate, it would 
require a higher level of sulfate to demonstrate it . With this sulfate esteri-
fication system, however, it could not be shown unambiguously that the inhibi-
tion is competitive. 
Since the sulfate- esterification and molybdate systems have two enzymic 
steps in common, ATP- sulfurylase and pyrophosphatase, the effects of the inhi-
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bitors upon the pyrophosphatase activity of the lamb liver supernatant were 
also measured . 
The basic test system for pyrophosphatase included, in 1 ml of incuba-
tion mixture, the following components- imidazole buffer (pH 7), lOO p mols; 
MgC12 14 p mols; sodium pyrophosphate, approximately 0. 6 )1 mols; en~e 
dilution, 0.1 ml; and inhibitor, as indicated. Tubes were incubated for 30 
minutes at 38° and deproteinized by the addition of 1 ml of 10% trichloro-
acetic acid. Phosphate hydrolyzed from PP was determined by the Lowry- Lopez 
method. 
Most of the inhibitors used in the sulfate- esterification and molybdate 
systems were also tested as pyrophosphatase inhibitors. They were added to 
the pyrophosphatase system in the same concentration as used previously. Where 
more than one concentration had been previously used, the one having the most 
pertinence was chosen. 
The lamb liver supernatant contains a large excess of pyrophosphatase, 
and added pyrophosphate was rapidly hydrolyzed. In order to assay its pyro-
phosphatase activity, the lamb liver supernatant was considerably diluted, so 
that its concentration in the incubation mixture was only 1/ lOOth of that in 
the sulfate- esterification or molybdate assay. Even at this dilution, about 
80 to 90% of the pyrophosphate in uninhibited control tubes was hydrolyzed 
during the half- hour incubation. The observed inhibitions of the lamb liver 
pyrophosphatase by these substances are given in Tables V to VII. 
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TABLE V 
INHIBITION OF LAMB LIVER 
PYROPHOSPHATASE 
p mols 
% Inhibitor per o. 5 ml Inhibition 
Known substrates of ATP- sulfurllase 
Potassium sulfate 1 6 
Sodium selenate 10 24 
Inhibitors of excretion 
Benemid 1 minus 4 
Carinamide 10 19 
Bromcresol green 0.05 minus 6 
Bromcresol purple 0. 1 5 
Bile salts 
Glycocholic acid 1 minus 13 
TABLE VI 
INHIBITION OF LAMB LIVER 
PYROPHOSPHATASE 
Inhibition 
Cholecystographic agents 
Telepaque 
Cholografin 
Priodax 
Ora bilex 
Phenolphthalein and derivatives 
Phenolphthalein1 
Tetrabromo- phenolphthalein1 
Tetraiodo- phenolphthalein1 
Bromsulfalein (BSP) 
Fluorescein 
2 Rose Bengal 
p mols 
per 0. 5 ml 
0. 5 
0. 5 
0.5 
0. 5 
0. 5 
0. 5 
0. 5 
0. 05 
1 
0. 05 
% Inhibition 
18 
1 
9 
minus 1 
6 
5 
6 
13 
20 
48 
1 Tested in Tris/ HCl buffer, pH 7 . 5; albumin (0. 7%) present . 
2 Tested in Tris/HCl buffer, pH 7. 5. 
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TABLE VII 
ll'ffiiBITION OF LAMB LIVER 
PYROPHOSPHATASE 
Inhibition 
p mols 
per 0.5 ml % Inhibition 
Substances excreted 2rimaril~ b;y: 
renal tubules 
Phenolsulfonphthalein (PSP) 1 28 
Penicillin G 5 7 
Diodrast 10 11 
p-Aminohippuric acid (PAH) 10 5 
Hippuric acid 10 16 
Hypaque 10 minus 2 
Neo-Iopax 10 18 
Skiodan 10 21 
Menthol glucuronide 10 15 
Tetraethylammonium bromide (TEA) 10 21 
Miscellaneous 
NaCl 10 minus 2 
Benzoic acid 10 7 
p-Aminobenzoic acid 10 19 
Glycylglycine 10 minus 7 
The only substances which inhibited pyrophosphatase by 20% or more 
under these conditions were selenate (24%), fluorescein (20%), Rose Bengal 
(48%), PSP (28%), Skiodan (28%) and tetraethylammonium bromide (21%) . There 
is no relation between inhibition in this system and inhibition in the sulfate-
esterification and molybdate systems . It is therefore unlikely that the in-
hibitions observed in the sulfate- esterification or molybdate systems were 
in any case due to pyrophosphatase inhibition. 
It has been mentioned (p . t~3 ) that molybdate will induce a rapid split 
of ATP in the presence of yeast ATP- sulfurylase even though PP is allowed to 
accumulate (244) . Therefore, the molybdate system is considerably less sen-
sitive to PP accumulation than is sulfate esterification. The measurements 
made with the molybdate system in Tables I to IV do depend on pyrophosphatase 
action to the extent that the PP which is split from ATP must be converted 
to inorganic phosphate in order to be measured as such. In the molybdate 
assay system there is an obvious several- fold excess of pyrophosphatase present, 
over what would be required to accomplish this. Since even when the lamb 
liver supernatant is diluted 100 times more than in the molybdate assay, it 
will still hydrolyze roughly 90% of comparable amounts of PP within 30 minutes; 
the undiluted enzyme must hydrolyze the PP generated within the system within 
a minute or two . The highest inhibition of pyrophosphatase observed above -
48% with Rose Bengal - is certainly not of an order of magnitude that its 
pyrophosphatase inhibition could be considered responsible for the 91% inhi-
bition induced by an equal concentration of Rose Bengal in the molybdate system. 
The generally similar response of the sulfate-esterification and molybdate 
systems to these inhibitors also indicates that under the conditions of these 
experiments pyrophosphatase is not a limiting component . It is quite certain, 
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therefore, that either of these systems is primarily measuring ATP-sulfury-
lase, as was intended. 
C. Discussion and conclusions 
The reasons for considering that the excretion of these diverse com-
pounds by the kidney and liver involves an ATP-supported acid activation have 
been extensively discussed. In particular, this type of mechanism affords an 
explanation of the very high concentration gradients which these excretory 
systems are capable of establishing. The manner in which these systems are 
dependent upon metabolic energy from oxidative phosphorylation is also sugges-
tive of an acid activation, The compounds which are thus excreted by either 
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of these organs seem to be excreted by a co~~on mechanism and to compete in-
timately with each other for excretion. From what is known of these excretion 
systems, it appears that in the kidney, for example, the various acids actively 
excreted by the tubules actually compete for the same enzyme at some step of 
the excretion process . As a whole, the substances excreted by these two organs 
fall into groups having both hepatic and renal representatives; certain of 
the compounds are excreted by both the renal tubules and the liver . The 
author considers that the hepatic and renal excretion processes for these sub-
stances must operate by nearly identical mechanisms, differing only in the 
details of enzymic specificity for the excreted substances . 
Since many of these compounds are sulfate derivatives, the sulfate-
activating system was considered, along with other activating systems, as being 
possibly involved in these excretion processes , Certain known characteristics 
of the sulfate- esterification system were considered to be suggestive enough to 
justify specific testing of this system in the excretion processes (pp. /2•·9 ) . 
Liver tissue was used as the source of the sulfate-esterification system, 
since the presence and nature of this system is better characterized in liver. 
These experiments were done to test the possibility that these sub-
stances are activated by the same enzYmic system that also activates sulfate. 
This assumption implies that the excreted compounds are alternate substrates 
to sulfate for the enzyme, ATP-sulfurylase, and should therefore be expected 
to be competitive inhibitors of sulfate in the sulfate-esterification process. 
A sulfate-esterification system was therefore developed in order to test these 
excreted substances as inhibitors. By partial limitation of sulfate this 
system was sensitized to inhibition of the ATP-sulfurylase step. 
An alternate system was also adapted to test these compounds as inhi-
bitors. In this system molybdate was employed as a sham-substrate for ATP-
sulfurylase (10). An attempt was made to balance the sulfate-esterification 
and molybdate systems against each other so that inhibition of ATP-sulfurylase 
to a given degree would affect both systems to a roughly equivalent extent. 
Since the two systems contain two enzymes in common, ATP-sulfurylase 
and PP-ase, it was necessary to rule out the possibility that inhibitions 
observed in these systems were due to PP-ase inhibition. The excreted com-
pounds were therefore also tested as inhibitors of the PP-ase activity of 
the enzyme preparations used. Although some of the compounds had some inhi-
bitory effect on the PP-ase activity, there was no apparent relation between 
inhibition of PP-ase and inhibition in the other systems. The effects upon 
PP-ase were judged to be insufficient to be responsible for the inhibitions 
observed in the sulfate-esterification and molybdate systems (pp. l7g-1), parti-
cularly in view of the large excess of PP-ase in these assay systems. 
The enzyme used was prepared from lamb liver by ultracentrifugation 
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of a liver homogenate to remove particulates . The results of these inhibi-
tor studies should therefore be considered from the standpoint of the hepatic 
excretion mechanism. If ATP- sulfurylase is involved in the activation of 
these substances in their excretion by the liver, they should, by competition 
with sulfate or molybdate, act as inhibitors in both these systems. Substances 
excreted by the kidney would be expected to act as inhibitors only to the 
extent that they are also excreted by the liver . Inhibition in these systems 
or activation by this system would not necessarily indicate that a compound 
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is excreted by this mechanism. Active sulfate, for example, has other path-
ways open to it. Although compounds excreted freely by the liver should be 
expected to be good inhibitors of these in vitro systems, the reverse is not 
necessarily true . Bromcresol green and bromcresol-purple, which are powerful 
inhibitors of the renal tubular transport of phenol red, are poorly excreted 
themselves . These compounds probably have a high affinity for enz.rmes involved 
in renal tubular excretion, but are either refractory substrates or coupling 
with the complete excretory system occurs poorly. 
The inhibition data of Tables I- IV (pp. 16 ,-1) will therefore be examined 
in detail from the standpoint of pertinence to the hepatic excretion mechanism. 
The evaluation of these compounds as inhibitors requires consideration of the 
amount added to inhibited tubes, as well as the inhibition observed. It should 
be kept in mind that the stated amount of inhibitor added is competing in each 
case against 1 p mol of either sulfate or molybdate. Amounts of inhibitors 
greater than 10)U mo1s/tube were not used. 
In cases where the inhibitions observed in the sulfate and molybdate 
systems are quite discrepant, it is somewhat difficult to evaluate an inhibitor . 
Note that the inhibitions observed with Skiodan (lOJUmols/tube), for example, 
were 1% in the sulfate system and 23% in the molybdate system. Differences 
of this order are certainly not attributable entirely to error in phosphate 
and p-NP determinations. If an observed effect is caused by inhibition of 
ATP-sulfurylase alone, inhibition in one system and not the other would not 
be feasible. Therefore the least biased estimate of the inhibition of ATP-
sulfurylase would be the low value. 
There are other reasons for imbalance between the two systems. The 
molybdate system has a more 11 linear11 behavior than the sulfate-esterification 
system. The two systems were only approximately balanced against each other 
at a level of about 80% inhibition, so that agreement between the systems 
might be expected to deteriorate at low levels of inhibition. Most of the 
instances of really poor agreement have occurred with the low-grade inhibitors. 
In these cases the inhibition in the molybdate system has been consistently 
higher (see Table III: diethanolamine, PAR, Hypaque, Skiodan, tetraethyl-
ammonium bromide and NaBr. Table IV: NaCl, acetate, p-aminobenzoate and 
glycylglycine). In these instances the actual inhibition of ATP-sulfurylase 
is probably rather small. Particularly at low levels of inhibition the 
measured values must be considered to be only rough approximations. 
Sulfate was shown to inhibit the molybdate system; molybdate inhibited 
sulfate esterification, and selenate inhibited both systems. These results 
are in keeping with the known role of these substances as alternate substrates 
of ATP-sulfurylase (10). It is also a good indication that both systems are 
measuring the same thing. 
The inhibitors of excretion: Benemid, Carinamide, bromcresol-green 
and bromcresol-purple, were moderate to strong inhibitors in these systems. 
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At lOp mols/tube, Benemid inhibited sulfate- esterification by 93%. Since 
it was considered that the full inhibitory capacity was not being measured, 
only 1 ~mol/tube was added when tested with molybdate . Under these condi-
tions it inhibited 26%. Benemid thus apparently has an affinity for ATP-
sulfurylase almost comparable to that of sulfate or molybdate. Carinamide 
inhibits to a lesser extent - at lOp mols/tube, 67% and 75% in the sulfate 
and molybdate systems, respectively. Bromcresol-green and bromcresol- purple 
inhibited these systems very strongly and were among the best inhibitors of 
the compounds tested. These compounds strongly inhibited at levels of 0.05 
to O.lp mols/tub~ which is 10 to 20 times lower than were sulfate or molybdate 
concentrations. 
The actions of these four inhibitors of transport are better known 
in the kidney system, but Benemid has been shown to block BSP excretion by 
the liver (23). Whether bromcresol- green and bromcresol-purple are excreted 
by the liver, or whether they act as inhibitors of hepatic excretion, as they 
do of renal tubular excretion is not known. As just mentioned, Benemid is 
an inhibitor qf excretion in both organs . 
lycocholic acid inhibited the sulfate system by 15% at 0.5 p mols/tube 
and the molybdate system by 32% at 1 p mol/tube. This natural substrate for 
the hepatic excretion system apparently has an affinity for ATP-sulfurylase 
almost comparable to that of sulfate, but somewhat less than that of the 
cholecystographic agents tested and much less than such a substance as BSP. 
Bile acid conjugates do not appear to be very good competitors of excretion 
in the intact animal (pp.h7-t) . 
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The £our cholecystographic agents: Telepaque, Cholografin, Priodax and 
Orabilex, were all rather good inhibitors in both sulfate and molybdate systems. 
At o. 5 p. mola/tube, inhibitions f'r0111 26% to 8]$ were observed with these com-
pounds. There was reasonable agreement between inhibitions observed in the 
two systems, although the values with Cholograt'in were 47% and 26% f'or the 
sultate and molJbdate systems, respectively. All of' the phthaleins listed 
in Table II are f'reely excreted by the liver. Phenolphthalein, tetrabromo-
phenolphthalein and tetraiodo-phenolphthalein inhibited rather well at 
0.5 ;u mols/tube even though these systems contained albumin (0. 7%). The 
actual concentrations of' tree dye would be considerably less than indicated 
by the amount of' dye added. These compounds are probably therefore intrin-
sieall7 better inhibitors than they appear to be. Tetraiodo-phenolphthalein, 
although it is a cholecystographic agent, is classed here with its closer 
chemical relatives. 
Fluorescein is the least inhibitory of' these phthaleins tested. It 
inhibited 3~ in the molybdate system when 1 p. mol/tube was added. It was 
not re-tested at this level in the sulf'ate system because its yellov..green 
color gave too high a blank f'or this method. Its inhibition is comparable 
to that of' glJcocholic acid. Hanzon (96) :t'ound nuoresoein to be only a 
moderately good inhibitor of' hepatic excretion in the intact rat. 
Rose Bengal and BSP were very powerf'ul inhibitors in both systems. 
These are the dyes most commonly used in testing 11 ver function. BSP inhi-
bited the sulf'ate systfltl 95% when 1 p. mol/tube was added. This value is too 
close to 1~ to be certain that it represents a reasonable measure of its 
inhibitory capacity. When tested with the molybdate system it was found to 
inhibit 48% when 0. 05 p mols/tube were added. Rose Bengal (0. 05 p. aols/tube) 
inhibited 84% and 91$ in the sulfate and molybdate systems, respectively. 
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Mercurochrome is also excreted very freely by the liver (173). It 
was a verr powerful inhibitor of' the sulfate syste!ll; 0.02 Jl mole inhibited 
sulfate esterification by 32%. When 5 f mole or cysteine were also added to 
the tube, the inhibition by mercurocbro:m.e was decreased to 25~. Because 
cysteine seem.ed to have a variable effect, this value is not very certain. 
It appears, however, that the m.ercurochro11e inhibition is not markedly re-
duced by cysteine and is not therefore entirely attributable to ionic mercur,y. 
A nUilber of compounds excreted primarily by the kidney tubules were 
also tested in these systems. As a rule, these compounds gave moderate to 
low inhibitions when tested at 10 Jl mole/tube. However, phenolphthalein 
glucuronide, phenolsulfonphthalein and penicillin G showed stronger inhibi-
tion. Phenolphthaleia glucuronide inhibited sulfate esterification by 5~ 
at o. 5 }1 mole/tube. Phenolphthalein is excreted in bile partly in conjugated 
form {p. 6 'I ) , presumably as the glucuronide. The inhibition value tor this 
compound mq be considerably in error because of' the glucuronidase activity 
ot the lamb liver supernatant. Phenolsul.tonpbthal.ein {1 p. mol/tube) inhibi-
ted 51~ in the sulfate system and 12% in the molybdate system. The reason 
tor the rather wide discrepancy between the two systems is not clear, but 
this compound apparent13' is one of' the stronger inhibitors 8Dlong this group 
of substances excreted prinoipal]J- in urine. Phenol red is, however, excreted 
freely in bile as well as in urine {1) . Penicillin G (10 )l mols/tube) in-
hibited the sultate system by 88%. At 5 p. mols/tube it inhibited the molyb-
date s;rete~~. by 28%. Penicillin is also excreted to sene extent by the liver 
(p. 4'6 ). 
Hippuric acid was a moderatelY good inhibitor of these s,ystems at 
10 p mole/tube; PAH was a somewhat less effective inhibitor. There is 
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some evidence that PAR, at least, is excreted to a moderate extent 1n bile 
(p. 1./.l ). 
Of the urographic agents tested (all at 10 p mole/tube), Diodrast and 
Neo-Iopax were moderately strong inhibitors. Diodrast was tested as a 
diethanolamine salt, but diethanolamine, as a control, had little eftect on 
the qstems. The effects of Hypaque and Skiodan were rather small. Winter 
and Taplin (245 ), using r-31-labeled Diodrast aDd Hypaque, found that lqpaque 
allowed better localization ot the kidneys by external scintillation counting. 
Diodrast vas less organ specific, and a considerable proportion was excreted 
by the liver. These observations are compatible with the relative strengths 
of Diodrast and Bypaque as inhibitors of lamb liver .lTP-sulfurylase. 
Menthol glucuronide at 10 Ill mols/tube appears to be a moderate inhibi-
tor in both systeas. The presence of glucuronidase activity in the lamb 
liver supernatant renders these values rather uncertain. 
TetraetQylammonium broqide and NaBr, its control, had a rather slight 
effect on these systems. TEA is a quaternary amine actively excreted by the 
kidney tubules by a mechanism distinct .trom that tor PAH or phenol red (p. 2..1 ) • 
It was included in this series as a control. 
As a rule, of the acids excreted prilaarily by the kidney, those which 
are in part excreted also by the liver are the stronger inhibitors or lamb 
11 ver ATP-sulturylase. As a group, the compounds excreted by the kidney 
inhibit aueh less, and only at higher concentrations, than the compounds ex-
creted by the liver (glycocholic acid, cholecystographic agents and phenol-
phthalein deriYatives). 
Ot the various control substances tested: NaCl, acetate, p-amino-
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benzoate and gl.ycylglycine had little inhibitory effect at 10 p. mols/tube. 
Benzoate at 10 p. lllOls/tube inhibited 4(1/. in the sultate system and .30% in 
the molybdate qstem. Ingested benzoate is excreted prill&rily in urine as 
conjugates; it is not clear whether benzoate itself is excreted to a small 
extent b.r the liver. 
Benzometb.a.mine bromide and Ox;rphenoDium brOIIide at 10 J:l raols/tube 
inhibited sulfate esterification by 50% and 82%, respectively. These sub-
stances interfered with phosphate determination and could not be tested in 
the molybdate system. They are quaternary umoniWl compounds and are excreted 
by the liver (120, l2l), but the mech&nisa aUIIt be distinct from that of the 
acids excreted by the liYer. The inhibito17 effects of these quaternary 
amines are nearly comparable in ugni tl.Jie to those of penicillin ard Diodrast 
but not to those of the acids excreted primarily by the liver. Why they 
appear to be moderate inhibitors is not understood. 
It has been mentioned that two of these acids excreted by the liver 
(phenolphthalein and tetraiodo-phenolphthalein) were tested by the molybdate 
assay vi th a aimilar enzyme preparation trOll dog liver, vi th resul. ts sWlar 
to those with lamb liver. Although somewhat lower inhibitions were observed 
with the dog liver, this is at least a prelilliD&rY" indication that the m-
sul.fl.Jl7lase ot other species behaves sillilarly toward these substances. 
These hepatic and renal excretion mechanisu seem to be common to all verte-
brates. The ability to concentrate phenol red extends to at least some 
invertebrates, however (142 a). There is some evidence that these mechanisms 
are more constant from species to species than are the closely related con-
jugation mechanisms. Although dogs, for example, normal]J excrete onl,y 
tauro-bile acids, sinoe they conjugate bile acids only' with taurine, they 
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will excrete glycocholic acid if it is administered to them (2CY7, pp. .30 am 
.36). It would appear that the ability to excrete conjugates is not limited 
to those conjugates which a particular species can produce. Sperber (210, 
211, 212) has shown that the chicken excretes several conjugates which are 
not natural to the chicken. 
The results of attempts to demonstrate competitive inhibition of lamb 
liver ATP-sultm-ylase by Telepaque and b;y Rose Bengal were somewhat equivocal 
(pp. 111-2. ) • These experiments were done b,- vaeying the level of sulfate in 
two series of tubes, with and without the inhibitor. The sulfate-esterifica-
tion aotivit1 vas measured in each tube and the results plotted according to 
the method of Lineweaver and Burk. The equivocal results ver,y likely ori-
ginate in the failure of the uninhibited, sulfate-esterification s7stem to 
followMichaelis~enten kinetics. The substrate itself, when present at 
5 ~ mols/0.5 ml or more, inhibits the reaction. The inhibition of Telepaque 
vas, however, almost completely overcor.te b;y the highest level of sulfate used 
(5 JJ. mols/0.5 lll.), and the uninhibited and inhibited curves obviously ap-
proached the B811le y-intercept in the Lineveaver-Burk graph, however deviously 
(Figure 6). This overwhellrlng of an inhibitor by an excess of substrate, 
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which is responsible tor the approach of the two curves to the same y-inter-
cept, is characteristic or competitive inhibition. When Rose Bengal was 
similarly used as the inhibi tor, the inhibition was reduced at the higher levels 
ot sulfate (Figure 7). It is not so apparent in this case, however, that the 
two curves approach the same y-intercept. If the Rose Bengal inhibition would 
be overcome by increasing the substrate concentration, it would require higher 
level~ of sulfate to demonstrate it. In the excretion s,ystems themselves, 
inhibition of the excretion of one compound by another excreted compound is 
definitely competitive in nature. 
The experiments summarized in Tables I-IV' indicate strongly that 
ATP-sulturylase ot liver is involved in the activation of the various acids 
which are actively excreted in bile b,y this mechanism. About 40 compounds, 
including excreted compounds and control compounds, were tested as inhibitors 
ot ATP-eulturylase ot lamb liver. These soluble en~e systems were designed 
to test the possibility that the excreted substances were alternate substrates 
for this en~e and therefore competitive with other substrates (sulfate and 
molybdate) ot the enzyme. The inhibitions induced by the substances tested 
in these in vitro systems were remarkably in accordance with their affinity 
tor the hepatic excretion mechanism itself. Benemid, known to inhibit the 
hepatic excretion mechanism, inhibited in these systems. Other compounds 
(Oarinamide, bromcresol purple, bromcresol green) known to inhibit renal 
tubular excretion, but whose effect upon hepatic excretion is not known, 
also proved to be inhibitors of liver A.TP-sulturylase. Of 12 compotmds tested 
which are excreted predominantly b,y the liver (glycocholic acid, cholecysto-
graphic agents, phenolphthalein and nuorescein derivatives), all were strong 
inhibitors ot lamb liver ATP-sulturylase. With BSP and Rose Bengal, which 
are used to test liver excretory function, strong inhibition was observed at 
concentrations of about 1/20 that of the substrates. It is indicated by 
these conditions that they have at.finities for ATP-sulfurylase considerably 
greater than does the normal substrate of this en~e, sulfate. Jll ot these 
substances excreted primarily by the liver appear to have affinities for this 
enzyme at least comparable to that of sulfate - as indicated b,y their ability 
to inhibit the enzyme to a significant extent when the molar concentration of 
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the inhibitor is equal to or less than that of sulfate. 
A group of compounds which are principally excreted by the renal 
tubules (phenol red, penicillin, urographic agents, etc.) were also tested. 
As a group, they were much weaker inhibitors of the liver ATP-sulfurylase. 
Several of these substances which are excreted in part by the liver were 
moderate to fairly strong inhibitors of the in vitro systems. Several control 
compounds had rather slight effect in these systems. 
As previously discussed (pp. 159-62), the compounds with greater inhibi-
tory effect also reduced the amount of phosphate split from ATP in the absence 
of molybdate. They did not cause a rapid breakdown of ATP, as does molybdate, 
in the presence of the enz.yme. The behavior of these excreted substances, in 
this respect, was more like sulfate than molybdate. These compounds, as pre-
sumed substrates of ATP-sulfurylase, behave more like true substrates than 
sham substrates. 
It is strongly indicated, therefore, that in this hepatic excretion 
1~ 
mechanism the excreted acids are activated by a reaction involving ATP-sulfury-
lase. The reactions would undoubtedly be analogous to the activation of 
sulfate, as follows: 
ATP-sulfurylase 
~~MM ) ~-~~~ 
In the activation of sulfate, itself, this reaction is followed by an ATP-
mediated phosphorylation or the 3'- position or the ribose or the ade~l sul-
fate. The ATP-sulfurylase reaction, above, is highly endergonic and allows 
only a very small yield of the adenyl sulfate. The second reaction is exer-
gonic, and coupled with the first, allows an active sulfate (PAPS) to be 
formed with a more favorable equilibrium. Efficient removal of pyrophosphate 
by pyrophosphatase is also necessary to encourage the reaction (127). 
The experimental data at hand do not allow a definite judgment as to 
whether the activation of these excreted acids would also involve this 
second step. It would seem probable for the reasons stated, however, that 
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the activation of these acids would require this second step, as does the 
activation of sulfate. This second step, presumably catalyzed by the same 
enzyme involved in the second step of activation or sulfate, would be as follows : 
APS- kinase 
ATP -1- acyl • Al'f!P acyl • PAP -/- ADP 
It is to be emphasized that the information at hand does not allow a definite 
choice between an acyl • AMP or an acyl • PAP as the intracellular intermediate 
of the excretion process , although the latter seems the more probable. An 
acyl adenylate would be formed by the ATP- sulfurylase step alone, whereas an 
acyl • PAP would be formed by the coupled action of ATP- sulfurylase and APS-kinase. 
Kellerman (112) has shown it to be probable that an acyl • .AMP type 
of intermediate could be enzymatically formed and split in such a way that 
oxygen is not lost from the carboxyl group of certain acids . This type of 
intermediate therefore seems to be compatible with Taggartrs observation that 
PAH passes through the dog kidney without loss of carboxyl oxygen (223) . An 
acyl • PAP would be expected to behave similarly since the phosphate-acyl link 
is the same as in an acyl adenylate. 
Another reason to consider an acyl • PAP as the more likely of these two 
possibilities is an indication that at least one such PAP derivative must exist 
as an intermediate in the transfer reaction of sulfate from PAPS to phenol. 
The intermediate is a PAP • phenyl sulfate; its formula is given in equation 
8 on p. 126. This intermediate is an acyl • PAP of a compound which is apparently 
excreted by the kidney tubules; this makes it appear that compounds of the 
type postulated could at least exist. 
The en~es which activate sulfate in the liver are soluble en~es 
of the cytoplasm so that this must be the site where the activation reactions 
(or reaction) associated with the excretion of these acids occurs. 
The final step in the excretion process whereb,y the free transported 
acid is regenerated and deposited in the bile canaliculus must occur at the 
luminal (canalicular) border of the po~gonal cell. It seems necessary to 
conclude that in order to establish the observed high, unidirectional gradients, 
the reaction must occur within the membrane itselt. It seems most likely that 
the final reaction is a simple hydrolysis of the intracellular intermediate 
to give the free acid (which passes into the bile) and PAP (which remains 
within the cell and is presumably tree to re-cycle in the process). The 
pathwa7s open to PJP are as yet not well understood (35). 
In a rather unrelated study, Levv.y and Worgan (123) established that 
the same;6{-gluouronidase was responsible tor hydro~zing certain acyl glu-
Cln'onides as well as phenolic glucuronides. They pointed out that evidence 
tor the unity ot a group-specific enzyme is difficult to establish because 
the possibility exists that the enzyme could be further fractionated into com-
ponents with different specificities. By showing that the en~e preparation 
not o~ hydrolyzed both types of glucuronide, but also that the acyl glucu-
ronides all inhibited the eydro~sis of a phenolic glucuronide, it was much 
more firmly established that the same enzyme is involved. They point out 
that the latter method, wherein the presumed substrates were all shown to 
compete with a single known substrate, is much less dependent upon the purity 
of the enz.yme as a test ot enz.ymic specificity. 
For similar reasons, it is considered that the method employed in 
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testing these excreted compounds for activity with .lTP-sulf'urylase is very 
suitable !'rom the standpoint ot rather definitely showing that the compounds 
excreted by the liver all have an attinity tor the same enzyme. It is shown 
to be an en~e which also activates sulfate, since the compounds all compete 
with sulfate. The employment of a system utilizing an alternate substrate tor 
ATP-sulf'urylase (molybdate) strengthens these conclusions. 
Being quite certain of these points makes it possible to predict with 
reasonable certainty what the intermediates in the reactions ot the excretion 
process are likely to be. It is reasonable to expect that this information 
will aid in devising systems whereby the intermediates UJB.Y be isolated and 
directly identified • 
.\TP-sul.fur1lase is indicated by these studies to be the enzyme tor 
which competition occurs when two compounds are simul taneoU8ly presented to 
the liver. ATP-sulturylase appears also to be the en~e ot the excretion 
sequence which is most important in determining the specitici ty of the excre-
tory s,ystem for different acids. These conclusions are suggested by the manner 
in which the competi tiona occur in the in vitro systems and by the close re-
semblance in specificity between these ATP-sulturylase systems and the excre-
tion mechanism i tselt. 
It is hoped that this work will contribute to a more complete elucida-
tion of this hepatic excretion system and its closely rel~ted sister system 
in the renal tubule. 
19.3. 
lX 
SlMMARY 
A large number or organic acids are excreted by the renal tubules or 
b,y the liver against high concentration gradients. PAR (p-aminohippuric 
acid) and the dye, phenol red, may be considered to be typical examples or 
these substances. Phenol red, tor example, has been shown to be excreted 
b.Y the renal tubules of representatives or all the orders ot vertebrates (202). 
When the excreted compounds are classified into chemically related groups, 
the different groups appear to be quite unrelated to each other. In spite 
oi' these differences, :many workers have accumulated a large body or evidence 
that these substances are all excreted by the same mechanism. This is indi-
cated, in particular, b.Y the intimate manner in which these compounds compete 
with each other i'or excretion. With a i'ew questionable exceptions, however, 
the compounds are all organic acids containing ei-ther carboxyl, sulfonyl or 
sulfate groups. Ii' these substances share a common mechanism in their excre-
tion, the reactions associated with the process should specifically involve 
these groups and the reactions be or such a nature that they may operate with 
either carboxyl or sulfonyl groups. The first step in the metabolic activa-
tion or many carbax,rlic acids (e.g., fatty acids, acetic acid, amino acids) 
is identical to the first step oi' sulfate activation (127). This reaction 
is the pyrophosphoryl split of ATP to give an acyl adenylate (acyl • AMP) 
and pyrophosphate. The dependence upon oxidative phosphorylation and the 
capability of establishing high concentration gradients indicate that high-
energy intermediates are involved in the excretion oi' these acids. By 
analogy to lll8.DY other biochemical activations, the process is very likely 
ATP-driven. 
194. 
The equation of Shannon (197), which describes renal tubular excretion 
or absorption processes in kinetic terms, has had an important role in clari-
f.ring the concepts involved in these transport processes. The assumptions 
made by Shannon are very similar to those made by Michaelis and Menten (147) 
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in deriving an equation describing enzyme action. In Appendix III of this 
thesis, the author has compared these equations and demonstrated that Shannon t s . 
equation may be considered to be a form of the Michaeli~enten equation applied 
to the specific case ot renal tubular transport. Shannon's intracellular sub-
stance B, with which the transported substance combines in the course of trans-
port and tor which different transported substances compete, may accordinglY 
be considered to be a single ena.y.me. It is not essential to the concept to 
consider that aubstance B must necessarily have a ncarrier~ function, and 
Shannon, himselt, did not imply this. These factors are pointed out with the 
belief that the.y may be a useful extension ot the meaning of Shannonts equation. 
While the renal tubular and hepatic excretion systems are not identical, 
a number of these acids are excreted to some extent by both organs, bu"J;, as a 
rule, a given acid is excreted predominantly by one or the other route. When 
the acids excreted by these organs are classified into chemically related groups, 
as has been done in Section IV of this thesis, it is found that each group con-
tains members excreted by both organs. The conclusion is almost inescapable 
from the remarkable resemblance of hepatic and renal groups that the excretion 
mechanisms for these substances are basically identical in the two organs. The 
difference observed between these two s.ystems are or the t,ype attributable to 
differences in substrate specificity for the en~es involved in the transport. 
The close relationship between these two systems has been pointed out 
by other authors. Blondheim (2.3), for example, emphasized this in demonstrating 
that a known inhibitor or renal tubular transport, Benemid, inhibited the 
hepatic excretion, as well as the lesser renal excretion, of BSP. In sec-
tions I-IV of this thesis, the author has attempted to review and summarize 
the available evidence indicating the close similar! ty of the processes in 
the two organs. It is hoped that this will contribute to a wider appreciation 
of these processes as examples of a more widespread biological phenomenon and 
to a more 11 unitarian11 approach in experimental investigations or the excretion 
or these substances. 
In beginning these experimental studies, it seemed advisable to consider 
at least one possible mechanism other than a direct acid activation. The 
products or numerous conjugation reactions of detoxication are excreted by 
these mechanisms. Brauer (29) has suggested that conjugations ma1 be directly 
involved in the excretion mechanism itself, rather than as a source or com-
pounds which are excreted. On the other hand, a great deal or experimental 
work b,y ma01 investigators has been done on the renal tubular excretion or 
PAH, but no evidence has indicated that urinary P.AH was conjugated. The possi-
bility that P!H might be excreted as an acyl glucuronide was tested by the 
author using the hydroxylamine method of Schachter (178) for acyl glucuronides. 
Fresh urine from a dog receiving an infusion of PAR was tested; although 
large amounts of PAH were present in the urine, no increase in the small amount 
of endogenous, hydroxylamine-reacting substance was observed. 
A number of attempts were made to detect an 11activated P.lH" in res-
piring homogenates or dog or rat kidney. Hydroxylamine and P.AH were added 
to the vessels and hydroxamic acids measured at the end of incubation (129). 
Under the condi tiona of these experiments, however, no l'cy'droxamic acid forma-
tion was observed. 
The final aspect or the experimental work of this thesis dealt with 
testing the possibility that the sulfate-activating system or liver also 
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activates these acids in the process of their excretion into bile. It the 
acids excreted by the liver are alternate substrates of ATP-sulfurylase, they 
should act as competitive inhibitors of sulfate, in the reactions of sulfate 
esterification. The sulfate-activating and transfer system used was prepared 
tram a lamb liver homogenate b,y ultracentrifugation at lOO,OOOX g to remove 
mitochondria and microsomes (105). 
About 40 different substances were tested as inhibitors o£ ATP-3ulfury-
lase, the first enz,y.me involved in the two-step activation of sulfate. A 
marked parallelism was found between excretability by the liver and ability 
to inhibit sulfate esterification. or the compounds excreted primarilY by the 
liver (cholecystographic agents, glycocholic acid, several phthalein dyes 
used to test liver function or known to be excreted by the liver), all were 
s~ong inhibitors of this in vitro system. From the experimental conditions, 
it may be judged that all these substances have affinities for the enz,y.me 
comparable to or greater than does its normal substrate, sulfate. As a group 
the compounds excreted by the renal tubules were moderate to slight inhibitors. 
The better inhibitors among the renal group, phenol red and penicillin, are 
also excreted to a considerable extent b,y the liver. Four compounds known 
to be competitive inhibitors of excretion also inhibited sulfate activation. 
Several acids tested as controls had no effect or rather small ettects on 
sulfate activation; benzoate, however, produced a moderate inhibition. Re-
sults with a few compounds were of questionable significance because of ana-
lytical difficulties. 
Two or the compounds excreted by the liver, phenolphthalein and 
tetraiodo-phenolphthalein, gave similar results with a sulfate-activating 
system prepared from dog liver, rather than lamb liver. 
1~. 
Generall1 good parallelism of inhibitory effects was obtained between 
this system and a system in which molybdate replaced sulfate as the substrate 
for ATP-sulfurylase. This enzyme has an activity with a variety of group VI 
anions, including sulfate, selenate, molybdate, etc. {244). 
Attempts to show evidence for competitive inhibition between sulfate 
and Telepaque or between sulfate aDd Rose Bengal were not conclusive. These 
equivocal results were apparently attributable to non-ideal behavior or the 
rather complex sulfate-esterification system. When graphed according to 
Lineweaver and Burk (125), a straight line is not obtained because or inhibi-
tion by high levels of sulfate. 
The close relationship between excretion b.1 the liver and inhibition 
in these sulfate or molybdate systems {which measure ATP-sulturylase) indi-
cates that this enz.yme is prominently and directly involved in the hepatic ex-
cretion ot these substances. Because of the large number of compounds tested, 
it appears very unlikel1 that these relationships could be coincidental. The 
nature of the data suggests that this enzyme, ATP-sulturylase, occupies a key 
position in the sequence ot reactions involved in hepatic excretion. The 
selectivity or the hepatic excretion w,ystem for different acidSis apparently 
mediated principally by this enzyme. Competition between excreted substances 
likewise represents a competition tor this enzyme. Since all the excreted 
compounds compete with a single substrate {sulfate) ot this en~me, it may 
al~So be concluded that a single enzyme is involved at this step ot the 
process in the excretion ot all these substances. All these conclusions are 
strengthened by the similar data obtained with mol1bdate as an alternate 
substrate ot this enzyme. The behavior ot the excreted acids, w1 th respect 
to the splitting ot ATP in the presence ot the enz.yme, resembles the behavior 
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of sulfate rather than molybdate. These substances, in other words, behave 
more like true substrates than sham substrates. 
The implication of this en~e in the hepatic excretion process makes 
it possible to write the reactions involved in the transport of these acids 
with reasonable certainty. It is probable that the reaction catalyzed by 
this en~e with any of the excreted acids is analogous to the reaction 
catalyzed by this enzyme with sulfate (reaction 1). 
ATP-sulfurylase 
1) ATP -/- acid (from sinusoid) acyl • AMP -f.. PP 
pyrophosphatase 
1 a) PP -f. H20 2 P 
APS-kinase 
2) ATP -/- acyl • AMP acyl • PAP -1- ADP 
3) acyl • PAP -f. H20 
hydrolase 
acid (into bile) -1- PAP 
Sum: Acid (from sinusoid) -1- 2 ATP -1- 2 H20 
ADP -1- PAP -/- 2 P 
- - ---.1) acid (into bile) -/-
The data do not bear directly on reactions 2 and 3, but reaction 2 
is considered likely by analogy with sulfate activation and from thermo-
dynamic considerations (127) . Reaction 3 may be assumed from the nature of 
the transport system. ATP-sulfurylase, pyrophosphatase and APS-kinase are, 
in liver, soluble enz.ymes of the cytoplasm. These reactions therefore must 
occur at this site after the diffusion of the free acid into the hepatic 
polygonal cell from the sinusoid. Reaction 3 would seemingly have to occur 
at the cell wall adjacent to the bile canaliculus in such a manner that the 
transported acid is regenerated and expelled from the cell into bile. The 
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nucleotide products remain within the cell and are presumably tree to re-cycle. 
Investigations bearing on the implication of adenylates and similar 
compounds as intermediates in renal tubular excretion have been made by 
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Taggart and by Kellerman. Taggart (223) showed that PAH, labeled with o:x;ygen-18 
in the carboxyl group, passed through the kidney without loss of label. Among 
possible intermediates compatible with this observation, Taggart suggested 
an adenylate. Kellerman (112) demonstrated the probability that an adenylate 
of such acids may be en~atically formed and hydrolyzed without loss of 
carboxyl oxygen. PAP derivatives, which are implied by the present work to 
be intermediates, could be expected to behave similarly to adenyl intermediates 
in this respect, since the acyl-phosphate linkages are the same in both types 
of compound. 
It is reasonable to expect that an ability to predict the probable 
intermediates in this transport mechanism will be ver.y helpful in efforts to 
more firmly define this system by isolation or such intermediates. Because 
of the remarkable resemblance ot this hepatic system to the renal tubular 
system, it is likely that the mechanisms in these two organs will prove to be 
very similar. It is to be hoped that the understanding or transport mechanisms, 
in general, will be furthered by the eventual elucidation of these syst.e~t~~ 
APPENDIX 
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Acyl•AMP 
Acyl•PAP 
ADP 
AMP 
APS 
ATP 
BSP 
CoA 
CTP 
Mo 
p 
PAAH 
PAB 
PAH 
PAP 
PAPS 
p-NP 
p-NPS 
pp 
PSP 
TEA 
Tm 
Tris 
IDPGA 
Versene 
Appendix I 
List of Abbreviations 
acyl adenylate 
a )'-phosphorylated acyl•AMP 
adenosine-5'-diphosphate 
adenosine-5'-monophosphate (adenylic acid) 
adenosine-5'-phosphosulfate (adenyl sulfate) 
adenosine-5'-triphosphate 
bromsulphalein, bromsulfalein, sulfobromophthalein 
coenzyme A 
cytosine-51-triphosphate 
molybdate 
inorganic phosphate 
p-acetylaminohippurate 
p-am.inobenzoate 
p-aminohippurate 
adenosine-Jt, 5'-diphosphate (phosphoadenosine phosphate) 
adenosine-J'-phosphate-5'-phosphosulfate (phosphoadenosine 
phosphosulfate) 
p-ni trophenol 
p-nitrophenyl sulfate 
pyrophosphate 
phenolsulfonphthalein 
tetraethylammonium ion 
"tubular mass", maximal rate of tubular transport 
tris (hydroxymethyl) aminomethane 
uridine diphospho-glucuronic acid 
ethylenediamine-tetra-acetate (EDTA) 
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Appendix II 
Chemical Names of Compounds Referred to by Proprietary Name 
Some of these substances have as many as twenty proprietary synonyms, 
but generally only one has been used in this thesis. f ew of t he common 
synonyms are given below, along with the chemical names of the compounds . 
When a structural formula for a compound has been given, this is referred 
to by page number . 
Benemid, Probenecid .... p- (dipr opylsulfamyl) benzoic acid •••• 
Benzomet hamine bromide •••• N-diet hylaminoethyl- N'-met hyl- benzilamide 
me t hobromide 
Carinamide • • • • p- (benzylsulfonamido ) benzoic acid • • • • p. ?8 
Chlorothiazide •••• see p. ~ o 
Cholografin, Biligrafin, Iodipamide .... N, N1 - adipylbis (3 amino-
2,4, 6-triiodobenzoic acid) 
•••• p . i 8 
Diodrast, Iodopyracet •••• t he diethanolamine salt of 3, 5-diiodo- 4-
pyridone-N- acetic acid •••• p. ?f 
Hippuran •••• Sodium o- iodohippurate •••• p. 7 7 
Hypaque •••• see Renografin 
Iopax, Uroselectan • • • • sodhnn 5-iodo-2- pyridone- N- acetate • • • • p. 7 1 
Neo- Iopax, Sodium Iodomethamate •••• disodium N- methyl- 3- 5- diiodo-4-
pyridone- 2-6-dicarboxylate •••• p. 78 
Mi okon, Sodium Diprotrizoate •••• sodium 3, 5-dipropionamido- 2, 4,6-
triiodobenzoate •••• p. ' ' 
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Orabilex, Bunamiodyl •••• 3-(3-butyrylamino-2,4,6-triiodophenyl)-2-
ethyl s odi urn acrylate • • • • p. ~ 7 
Pentothal Sodium, Thiopental Sodium •••• sodium 5-ethyl-5-(1-methyl-
butyl)-2-thiobarbiturate 
Priodax, Iodoalphionic acid •••• ~ -(4-hydroxy-3,5-diiodophenyl)-oC -
phenyl propionic acid •••• p. r7 
Renografin, Hypaque, Diatrizoate •••• Renografin is the methylglucamine 
salt and Hypaque is the sodium 
salt of 3,5-diacetylamino-2,4,6-
triiodobenzoic acid .... 
Skiodan, Methiodal Sodium •••• sodium iodomethanesulfonate p. i>b 
Telepaque, Iodopanoic acid •••• 3-(3-amino-2,4,6-triiodophenyl)-2-
ethylpropanoic acid •••• p. 8 7 
Teridax, Iophenoxic acid •••• ~-(2,4,6-triiodo-3-hydroxylbenz,yl) 
butyric acid • • • • p. t 1 
Urokon, Sodium Acetrizoate .... sodium 3-acetylamino-2,4,6-triiodo-
benzoate •••• p. i ~ 
Appendix III 
The Equation of Shannon, and its Similarity to the Equation of Michaelis 
and Menten 
The following derivation is that given by Shannon (197) in his review 
on renal tubular excretion, published in 1939: 
In the case of an excreted substance one may assume, first, that 
in the sequence of reactions that result in its transfer, the 
solute enters into reversible combination with some cellular 
element which is present in a constant but limited amount, and 
second, that the decomposition of this complex limits the further 
progress of the solute toward the tubule lumen. There are required 
two consecutive reactions, as follows, 
(l) A -/- B AB --~ Ts-/- B 
where A is the solute at the proximal side of the reaction (in the 
interstitial fluid around the tubule cells), B is the cellular 
element, AB the complex formed reversibly by these two, and Ts the 
solute on the distal side of the limiting reaction. In order to 
arrive at a maximal rate of excretion under these circumstances, 
the second reaction must be a first order process, its rate slow 
in relation to the rate of attainment of equilibrium in the first. 
It is theoretically possible that in the case of certain solutes 
actively transferred, the rate of the second reaction AB ) 
Ts ,1- B is faster than the attainment of equilibrium in the first. 
Under these conditions the rate of transfer of a substance would 
be linearly related to its plasma concentration •••••••• ( This 
is essentially the case with a substance like PAR at low plasma 
levels, i.e., when its rate of delivery to the tubules is con-
siderably below the Tm for the substanceJ. These equations com-
pletely neglect the fact that the transr;r process involves the 
expenditure of energy; they do imply that it is not a limita-
tion in the energizing reactions which limits the rate of trans-
fer in the normal animal. It is implicit in the first reaction, 
A ~ B AB, that this step in the tubular transfer is 
effecte~ at the expense of the free energy of the three reactants. 
However, the designation of the second reaction as a first order 
process does not preclude the possibility that this may be complex 
and involve an increase in free energy. 
In pursuing the quantitative implications of this hypothesis it 
is apparent that if a total B (i.e., as Band AB) is constant 
and limited in amount, it matters little whether it be assumed 
that we are dealing with stoichiometric processes involving con-
centrations in a monophasic system, or with certain absorptive 
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processes in a polyphasic system (106). For simplicity in treat-
ment, however, we have assumed the former of these possibilities 
so that both of these reactions may be described in accordance 
with ·the law of mass action ••••• 
We may therefore write, for the first reaction; 
(Z) K :: 'tU)) 
where (A), (B) and (AB) are equilibrium concentrations at the 
site of the reaction and K is the equilibrium constant. Desig-
nating total B as b, since the sum of the concentrations (B) ~ 
(AB) is constant: 
(J) K - (Al{b- (AB)) - (A)[ b - ~ - ... (AB) (AB) 
In relation to the second reaction, AB ) Ts -/- B, consider 
the general case, 
(4) k (AB) = Ts or (AB) - Ts/k -
where Ts is the amount of substance secreted per unit time at 
various values of (AB); and the special case where transfer is 
at its maximal rate, i . e., 
(5) k (b) = Tm or (b) : Tm/k 
where Tm is the maximal rate of transfer as would be the case 
when total B :: AB. 
Dividing (5) by (4); 
(6) b/(AB) :: Tm/Ts 
Substituting in (3) 
(7) K :: (A) (Tm - Ts) 
Ts 
The concentration of A in the venous blood leaving the secretory 
system is equal to the arterial plasma concentration, a, minus 
the amount secreted per unit time, Ts, divided by the plasma 
flow per unit time, V, i.e., (a- Ts/V) . When the diffusion 
gradient from plasma to the site of the initial reaction is 
not large in relation to (A) , this term may be taken as its 
equivalent, and when V is very large in relation to Ts this 
term reduces to (a). Under any circumstance where the removal 
of A from tubular plasma is great it is apparent that this 
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approximation may introduce a distortion since various parts 
of the secretory system will be presented with the solute in 
different concentrations, also the magnitude of the diffusion 
gradient which cannot be experimentally evaluated, becom 
significantly large in relation to the term {a - Tr/V) 
is the rate of reabsorption~ Errors from this approximation 
will be, under these condit~ons, most marked at low plasma 
concentrations. With this substitution equation {7) becomes 
{8) K = (a - Ts/V) . (Tm - Ts) 
Ts 
Shannon applied this equation to the case of phenol red excretion in 
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the dog. A set of observations in a single experiment was used to calculate 
values of K, Tm and V, in order that a curve could be drawn (based on the 
above equation) relating the arterial plasma level of free phenol red {a) 
to the rate of excretion, Ts. The experimental values were corrected for 
protein binding, and the concentrations of free dye were expressed in terms 
of mg per 100 ml of plasma water. The values calculated were: 
K = 0.92 mg free dye/100 ml plasma water. 
Tm = 8.95 mg free dye/100 ml glomerular filtrate. 
v = 12 
{The plasma water going to the tubules is four times the amount 
of glomerular filtrate and at the lower concentrations of free 
phenol red the free fraction is 0.3. The latter factor increases 
the apparent volume of distribution of the dye in plasma water 
about three-fold). 
A graph of Ts versus a, calculated with these constants, is given in 
Figure 8. This graph is given by Shannon (197, p. 83) with the experimental 
points drawn in. There is a very close correspondence between the curve of 
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Fig. 8 SHANNON's EQUATION . 
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TUBULAR EXCRETION OF PHENOL RED IN THE NORMAL DOG 
( Ts vs. a ) 
Ts = Phenol red secretion ( mg /100 ml glomerular filtrate) 
a = Plasma concentration of free phenol red (mg /lOOm/ dpbsma water) 
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the equation and the fourteen experimental points, covering a_wide range of 
plasma levels. The equation appears to describe the experimental facts 
rather well; the assumptions made in deriving the equation therefore would 
seem to be essentially correct. 
Shannon states that the equation also satisfactorily describes the 
tubular excretion of creatinine in the dogfish and in the chicken, as well 
as the tubular reabsorption of glucose in the dog and vitamin C in man. 
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The equation also was shown to predict the quantitative relationships 
of competition between phenol red and Diodrast and between phenol red and 
Hippuran. The data were considered sufficiently close to the predicted 
relationships ••to warrant a tentative acceptance of a B substance common 
to both systems in accordance with equations 1 and 8. 11 Similar correspon-
dence to the predicted relations was observed in the reabsorptive competition 
between glucose and xYlose. 
The close similarity of the assumptions made by Shannon in deriving 
this equation to the assumptions made in deriving the equation of Michaelis 
and Menten, which describes enzyme action, prompted the author of this thesis 
to investigate the compatibility of the two equations. Shannon's 11cellular 
element which is present in a constant but limited amount" (B, in the 
equations) will accordingly be considered to be an enz.yme. 
As discussed in the body of the thesis, there is reason to believe 
that this excretory process is ATP driven, so that a combination of the ex-
creted acids with ATP (or perhaps coenzyme A) may be indicated as one of the 
steps of excretion. This might suggest that ATP, for example, could be 
Shannon's intracellular substance, B. However, the assumptions made by 
Shannon, and which seem to describe the process satisfactorily, would then 
imply that all the intracellular ATP would be occupied with this excretory 
process when the substance is being excreted at Tm rates. This is definitely 
contraindicated by observations which show that these substances may be ex-
creted at maximal rates without detectable reduction of the capability of 
the kidney to perform simultaneously other ATP-dependent functions. In 
other words, although a combination of the excreted substances with ATP 
may occur (an acid activation), ATP or the total energy supply are probably 
never rate limiting. Shannon stated that the energizing reactions were not 
the rate limiting aspect of the process. It is implicit in the equations, 
however, that substance B is the component which becomes rate limiting as 
the rate of excretion is increased. In comparing this equation to the 
Michaelis~enten equation, it is implied that substance B is an enzyme and 
is accordingly the rate limiting component. 
If B is considered to be an enzyme, Shannon's equilibrium constant, K, 
therefore, has the same meaning as KID, the Michaelis~enten constant (see 
equation 2). In other words, A will be considered to be the substrate, B 
to be the enzyme and AB to be the enz.yme-substrate complex. 
One other slight change of meaning is implicit in the conversion to 
enzymatic terminology. Ts, in equation 1, will be the product of the rate 
limiting reaction. This would not necessarily be the same as the "solute 
on the distal side of the limiting reaction", but could be a derivative of 
the solute (the int nacellular derivative). If this is the rate limiting 
reaction, however, the rate of production of this product will be the same 
as the rate of tubular excretion. Where the term Ts is used elsewhere, 
its meaning is the rate of tubular excretion. The meaning of the term, Ts, 
will be slightly changed by the different viewpoint only when it is used 
ao 
211 
in the first sense. 
Shannon considered that the free concentration of A (the excreted 
substance) in the plasma of the renal vein represented the concentration of 
A in dynamic equilibrium with substance B. This represents the concentration 
of diffusible A after passage through the tubular capillary bed where 
"equilibrium" is established between urinary and plasma A. Since the sub-. 
stance is ordinarily measured in peripheral blood (equivalent to renal 
arterial blood), the concentration of diffusible substance in peripheral 
blood, a, must be corrected to represent concentration in the renal vein. 
This correction was made by subtracting Ts/V, which represents the drop in 
diffusible concentration in passing through the kidney. The quantity 
(a - Ts/V), therefore, represents an estimate of the renal venous concen-
tration, and, accordingly, this quantity is a corrected estimate for sub-
strate concentration, to use Michaelis~enten terminology. 
Keeping the term (a - Ts/V) intact, Shannonts equation 8 will be 
solved for 1/Ts. 
(8) 
(9) 
K = (a - Ts/V) . (Tm - Ts) 
Ts 
K • Ts = (a - Ts/V) 
Ts (K -/- (a - Ts/V] = 
Tm - {a - Ts/V) • Ts 
(a - Ts/V) • Tm 
...L 
Ts 
1 
= K -/- (a - Ts/V) 
(a - Ts/V) • Tm 
: K ( 1 ) 
Ts -r.m- a - Ts/V 
-1- 1 
Tm 
Equation 9 has exactly the same form as the Lineweaver~Burk (125) 
modification of the Michaelis~enten (147) equation: 
when: 
1/v : ~max (_L_' -/- 1/Vmax (SJ J 
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Ts = v •••• rate of tubular excretion is the rate of reaction. 
K = Km ••• Dissociation constant for AB is the dissociation 
constant for enzyme-substrate complex. 
Tm :: Vmax • • Maximal rate of tubular excretion is the maximal 
reaction velocity. 
(a- Ts/V) = (sJ ...• Renal vchoas concentration is the substrate 
concentration. · 
Since Tm and K are constants evaluable for a given substrate, the 
graph of 1/Ts versus the reciprocal of renal venous concentration, 1/(a - Ts/V), 
is a straight line (equation 9). This is shown in Figure 9 for the case of 
phenol red excretion in the dog, using the same constants as in Figure 1 (where 
Ts was plotted versus a). 
Accordingly, Shannon's equation is compatible with an enzymic inter-
pretation, wherein the transport rate becomes limited by the availability of 
a specific enzyme. Competition between excreted compounds may likewise be 
treated in terms of competitive inhibition between substrates according to 
usual methods. In form, Shannonls equation is that of the Michaelis~enten 
equation applied to the specific case of clearance measurements. 
An interpretation that has often been given to Shannon's assumptions 
is that the intracellular substance B acts as a 11carrier". The carrier is 
1.2 
I I I.O ;;v=Y-rs 
0.8 
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0 2 4 
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Fig. 9 SHANNON'S EQUATION. 
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presumed to pick up the transported substance at one border of the cell, 
carry it across the cell, discharge it at the opposite border and return 
214. 
for more. The intracellular substance is thereby presumed to act in shuttle-
cock fashion. Though this view may be in part valid, Shannon did not localize 
the reactions to this extent. If the limiting component is considered to be 
an enzyme, the equations do not necessarily imply that this enzyme has a 
carrier function. 
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The renal tubules and the liver are capable of excreting a variety of 
organic acids against high concentration gradients. The hepatic and renal 
groupe of excreted compounds are not identical, though they are chemically 
very closely related. Some or the compounds are excreted by both organs. 
The substances excreted by either organ include carboxylic acids, sulfonic 
acids and sulfate esters. Some or the compounds under consideration are: 
Substances used to test for kidney or liver excretory function: 
p--aminohippuric acid (PAH), phenol red, bromsulfalein, 
Rose Bengal. 
Certain conjugates: 
hippuric acid, glycocholic acid, taurocholic acid, bilirubin 
diglucuronide. 
Urographic and cholecystographic agents: 
Diodrast, Skiodan, Cholografin, Priodax. 
241. 
The intimate manner in which the compounds excreted by either organ 
compete with each other for excretion has indicated to many workers that 
they are all excreted by the same mechanism. The close resemblance of 
hepatic and renal groups indicates the probability that the same basic 
excretion mechanism is involved in either organ, differing only in details 
of en~e specificity. The high concentration gradients attainable suggest 
that high-energy intermediates are involved in the excretion of these acids. 
Since many of the excreted compounds are sulfate derivatives, the 
possibility of the involvement of the sulfate-activating system in these e~ 
cretion mechanisms was tested in the experimental work of this thesis. This 
work was done with liver, since the reactions of sulfate activation have been 
characterized better in this organ than in kidney. (Lipnann: Science, 128: 
575, 1958). The results may therefore be considered to apply directly only 
to the hepatic excretion mechanism. The assumption tested was that the ex-
cretion of these compounds involves their activation b.1 the same en~atic 
system (specifically involving ATP-sulturylase) which activates sulfate in 
the reaction sequence of sulfate esterification. The compounds excreted b.1 
the liver, as presumed alternate substrates of ATP-sulturylase, would thereb,y 
be expected to be inhibitory to sulfate esterification. 
The en~e preparation was made by lOO,OOOX g ultracentrifugation of 
a lamb liver homogenate (Hilz and Liplann: Proc. Natl. Acad. Sci. U. s., 
~: 880, 1955). About 40 different compounds were tested for their ability 
to inhibit the sulfate esterification of p-nitrophenol in a s.ystem containing 
enzyme, magnesium ion, ATP, sulfate and p-nitrophenol in imidazole buffer. 
Among the compounds tested, a close relationship was found between the extent 
to which a compound is excreted by the liver and the inhibitory effect of the 
242. 
compound in a sul.f'ate-esterif'ieation system. Compounds excreted primarily 
by the kidney tubules were not very inhibitory in this liver enzyme system; 
although those also excreted by the liver were moderately good inhibitors. 
These results were generally conf'irmed and the inhibitory e.f'f'ects localized 
to the ATP-sul.f'urylase step by the use of a similar system in which molybdate, 
rather than sultate, was employed as an alternate substrate f'or this enzyme 
(Wilson and Bandurski: J. Biol. Chem., m: 975, 1958). These data indicate 
that ATP-sulf'urylase is directly involved in the hepatic excretion mechanism 
.f'or these compounds. The selectivity of' the excretion system for different 
acids is apparently mediated principally by this enzyme, and competition 
between excreted substances represents a competition for this enw.y.me. 
By analogy with the known reactions of' sulf'ate activation, the struc-
tures of' the intracellular intermediates of' this hepatic excretion process 
may vi th reasonable certtdnty be predicted to be PAP-containing compounds 
(PAP is adenosine-3•, 51-diphosphate). It is reasonable to expect that 
this information will be very help.f'ul. in efforts to define this system more 
firmly by isolation and identification of such intermediates. 
Similar derivatives, containing adenylic acid, have been suggested 
or investigated for their involvement in renal tubular excretion by Taggart 
and by Kellerman. 
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